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Abstract 
 
Lectins are a class of sugar-binding proteins of interest to pharmaceutical research 
due to their varied roles in diseases and specific presentation on different tissue 
types. Compounds that bind strongly to specific lectins may have potential both as 
drugs and targeting agents. The synthesis of multivalent scaffolds designed as lectin 
ligand mimics are presented in this work. Two different core scaffolds, calix(4)arene 
and Trizma base were used along with two sugar ligation strategies, Huisgen-
Sharpless cycloaddition (giving O-glycosides) and aminooxy based chemoselective 
ligation (giving N-glycosides). 
 
Three O-glycosidic tri-substituted ligand mimics using Trizma base as the central 
scaffold were synthesised using Huisgen-Sharpless cycloaddition. Similarly sized tri-
substituted aminooxy Trizma centred scaffolds were synthesised with the intention 
of comparing the effects of ligation strategy on lectin binding.  
 
Progress was made towards synthesising sugar-substituted calixarenes using both 
ligation strategies.
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1. Introduction 
 
1.1 Lectins and Multivalency 
 
Complex glycolipids and glycoproteins cover the surfaces of mammalian cells, 
controlling a wide variety of physiological processes via their interaction with and 
recognition by complementary proteins called lectins.
1 
Carbohydrate-lectin 
interactions mediate a host of processes such as cell adhesion and transport, the 
inflammatory response, recognition of pathogens and key stages of many diseases, 
eg attachment of bacterial toxins, bacterial and viral attachment to host cell 
membranes, and cancer metastasis.  
 
Natural
Ligand
Viral
Interaction
Bacterial
Interaction
Cell
Cell
 
Figure 1: Representation of some lectin-carbohydrate interactions at the cell surface, 
showing first stages of bacterial and viral invasion of cells and cell-cell adhesion. 
With oligosaccharides represented by triangles shown binding to lectin receptors 
sites. 
 
Protein-carbohydrate interactions are non-covalent and individual interactions 
usually display weak binding, with Kd values ranging from mM to µM.
2 
Multivalent 
display, both of the carbohydrate ligand and the carbohydrate recognition domain or 
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the entire lectin, causes a marked increase in the observed affinity, which is known 
as the glycoside cluster effect. This increase in affinity is greater than would be 
expected if it was caused by increased ligand concentration alone. The individual 
interactions enhance each other via two mechanisms: a chelate effect in which 
binding sites either on the same or adjacent receptors are crosslinked by multivalent 
ligands and a statistical effect where the local concentration of the ligand at a binding 
site is increased by its multivalent presentation.
3
 These effects are illustrated in 
Figure 2 below. 
 
(a) (b) (c)  
Figure 2: Illustration of the glycoside cluster effect, (a) cross linking of 
carbohydrate ligand by a lectin with multiple binding sites, (b) multiple monovalent 
lectins cross linked by a carbohydrate ligand, (c) statistical effect whereby array of 
displayed saccharides provides a higher local concentration of the ligand. With 
oligosaccharides represented by triangles shown binding to lectin receptors sites. 
 
As multiple ligands and binding sites are often displayed in a repeated fashion across 
cell surfaces chelation can occur between a single ligand and receptor or across 
multiple ligands or receptors, as illustrated below. These maxi and mini clustering 
effects can be seen separately or within the same system.
3
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Miniclustering Maxiclustering  
Figure 3: Mini and maxi clustering effects, possible forms of chelation between 
multivalent ligands and receptors. With oligosaccharides represented by triangles 
shown binding to lectin receptors sites. 
 
These cross linking binding mechanisms are behind the glycoside cluster effect, with 
the potential for exponential increases in binding affinity in systems that encourage 
chelation. As a result lectin ligand mimics almost invariably include multiple copies 
of the recognised saccharide to encourage a greater binding affinity with the target. 
But simply increasing the number of displayed sugars doesn’t always lead to 
increased affinity, especially in larger ligand mimics.
4
 Directly comparing binding 
results across different scaffolds can also be difficult, differing numbers of sugars 
and possible cooperative effects (when a binding event effects the likelihood of 
subsequent binding events, making them either more or less favourable) need to be 
taken into account.
5
 It is now generally accepted that the underlying scaffold has a 
substantial effect on binding affinity both by influencing the display and presentation 
of binding residues and by interacting directly with the lectin.
6
  
 
A variety of different synthetic approaches to lectin ligand mimics have been used 
and developed. Structures based on polymers, proteins, lipids and nanoparticles have 
all been used with some success but these approaches often result in poorly defined 
structures, where the exact location and number of sugar residues may be in doubt.
3
 
In this small molecules, glycoclusters and dendrimers have an advantage: smaller 
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clusters can usually be characterised by conventional methods while systematic 
approaches to dendrimer synthesis generally result in well defined and homogenous 
structures. Groups such as Roy et al showcase some of the variety of dendrimers 
now available using orthogonal building blocks and convergent synthesis.
7
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Figure 4: Examples of dendrimer structures developed by Roy et al using their 
‘onion peel approach’7 
 
In addition to homogeneity and relative ease of characterisation small molecules and 
glycoclusters may be incorporated into larger glycodendrimers at a later stage as in 
Scheme 1.  
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Scheme 1: Glycodendrimers can be built up of smaller clusters, as with this 
dendrimer with peripheral tri-mannosyl Tris clusters.
3
 
 
This project concentrates on producing small glycoclusters based around two 
different scaffolds giving small molecules with differing topologies and display of 
monosaccharides. The following sections discuss previous work in the field, 
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successful lectin ligand mimics based on a variety of scaffolds and a selection of 
medically relevant lectin targets. 
 
1.2 Lectins in Infection 
 
Adherence of lectins on the surface of bacterial cells and viral capsules to 
carbohydrates on host cell membranes (or vice versa) is the first stage of infection 
for many diseases, with lectins playing a role in E. coli,
8
 HIV
9
, Ebola virus
10
 and P. 
aeruginosa infections.
11
 
 
Additionally several species of bacteria utilise lectins as a way of delivering bacterial 
toxins to host cells. These include the cholera, E. coli heat labile and shiga toxins, all 
of which have the same basic AB5 structure, where B is a lectin and A is an enzyme 
responsible for the observed toxicity. The lectin portion binds to specific glycolipids 
present on the surface of intestinal cells (GM1 in the case of cholera and E. coli heat 
labile toxins, Gb3 in the case of shiga and shiga-like toxins, Figure 5). The toxin is 
then internalised via endocytosis and transported to the endoplasmic reticulum where 
it is broken down and the toxic subunit A is released into the cytosol. 
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Figure 5: Oligosaccharide portions of natural cholera and shiga-like toxin ligands, 
GM1 and Gb3. 
 
The diarrhoeal diseases caused by these toxins are a serious threat to human health 
and it has been suggested that suitable ligand mimics could prevent toxins entering 
host cells, avoiding or reducing serious symptoms. The affinity of monovalent GM1 
for cholera and E. coli toxins is unusually large for lectin-carbohydrate interactions 
(Kd = 10-40 nM).
12
 Despite this ligand mimics often rely on multivalency due to 
GM1’s complexity and the synthetic difficulty producing the carbohydrate portion. 
Simplified monovalent galactose based inhibitors that are commonly used are shown 
below with their dissociation constants.  
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Figure 6: Common monovalent ligand mimics for cholera toxin with dissociation 
constants.
12, 13
 
 
In contrast shiga toxin binds individual Gb3 molecules with a KD = 1 mM, within the 
usual range of monovalent lectin-carbohydrate affinities, relying on the glycoside 
cluster effect to function and bind strongly to cell surfaces. Shiga toxin has 15 
binding sites, all capable of simultaneous interaction with Gb3, its binding to whole 
cells is comparable to cholera toxin.
14 
 
Several inhibitors of shiga and shiga-like toxins have been produced; the Starfish 
dendrimer created by Bundle et al (Figure 7) is a notable example.
15
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Figure 7: Starfish dendrimer, a lectin ligand mimic for shiga-like toxins I and II.
15
 
 
The ligand was designed with reference to the target protein structure: as multiple 
binding sites are present per B subunit the shiga and shiga-like toxins have a range of 
inter-binding site distances from ~9 Å (within a B subunit) to ~50 Å (between B 
 20 
 
subunits).
16
 Branching at the end of each linker unit was intended to allow binding to 
two sites per B subunit (specifically binding sites 1 and 2 which were thought to be 
the highest affinity sites
15
), with each linker arm interacting with one of the five B 
subunits. However crystal structure of the complex revealed that Starfish crosslinks 
two proteins, one trisaccharide per linker binds a site on one B subunit creating a 
stable complex.
15 
 
The Starfish dendrimer showed an impressive 1-10 million fold increase in inhibition 
over monomeric Gb3 against shiga-like toxins I and II (Stx1 and Stx2).
15
 The 
ligand’s IC50, in a solid phase binding-inhibition assay with Stx2 was 6.0 nM, 
sufficient for Starfish’s therapeutic potential to be tested in vivo.17 Starfish can 
prevent mouse mortality when co-injected with a lethal dose of Stx1 (at 25 µg/g and 
2.5 µg/g Starfish) but despite strong in vitro binding was ineffective against Stx2.
17
 
Further investigation with radio-labelled toxins showed that Starfish altered the 
distribution of Stx1 in mouse tissues, substantially reducing toxin accumulation in 
the main target organs, brain and kidneys.
17
 This effect wasn’t evident in Stx2 tests. 
 
The group developed a second shiga-like toxin inhibitor, dubbed Daisy (Figure 8), 
with the same glucose core, but extended linker arms and Gb3 attached at the 
reducing position as it is in the natural ligand.
17
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Figure 8: Daisy dendrimer, a lectin ligand mimic for shiga-like toxins.
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Daisy was developed in an attempt to create a lectin ligand mimic that provided 
protection against Stx2. The group chose to lengthen the dendrimer linker arms in 
part because Stx2 has bulkier residues between binding sites 1 and 2 than the Stx1 
equivalent, they theorised that longer linkers might encourage binding to both sites.
17
  
 
Initial results were discouraging with Daisy showing a substantial increase in IC50 
for solid phase Stx2 binding inhibition assays (296 nM compared to 6 nM for 
Starfish).
17
 Daisy also had a higher IC50 in Stx2 cytotoxicity assays using Vero cells 
although the increase was less dramatic than in the solid phase assays (11 µM 
compared to 1.6 µM for Starfish).
17
 Despite this Daisy protected mice from lethal 
doses of both Stx1 and Stx2 when administered with the toxin, and also increased 
survival in mice that were orally infected with Stx2 producing E. coli.
17
 
 
Other groups have also successfully attempted to target shiga-like toxins. Nishikawa 
et al synthesised a series of carbosilane dendrimers that were also targeting Stx1 and 
Stx2, the Supertwigs (Figure 9).
18
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Figure 9: Supertwig dendrimers, lectin ligand mimics for shiga-like toxins I and II.
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Supertwigs A and B were designed so that the binding trisaccharides would be ~30 
Å from the central silicone in order to access as many binding sites as possible on the 
toxins. Both showed stronger binding affinity towards immobilised Stx1 then the 
shorter C, (KD values of 1 µM, 0.2 µM and 22 µM respectively).
18
 Binding 
inhibition assays using Vero cells also showed promising results; Supertwig A had 
an IC50 of 0.33 µM against Stx1 and 3.5 µM against Stx2 while Supertwig B had 
IC50s of 0.16 µM against Stx2 and 2.0 nM against Stx1.
18, 19
 In contrast C had an 
IC50 270 times higher. Cell viability was also tested, none of the Supertwig 
compounds caused cell mortality but both Supertwigs A and B inhibited the 
cytotoxic effect of Stx1 (IC50 of 30 nM and 25 nM respectively) and Stx 2 (IC50 of 
43 nM and 29 nM respectively) in Vero cells.
18
 Like Starfish the Supertwig 
dendrimers were then used in in vivo mouse models. 
 
Rather than testing both toxins Nishikawa et al focused on Stx2, due to its greater 
clinical significance and toxicity. When intravenously administered to mice with a 
lethal dose of Stx2, Supertwig C showed no inhibitory effect, as might be expected 
since C didn’t inhibit cytotoxicity in cells. However results for Supertwigs A and B 
were markedly different, despite giving similar protection against cytotoxicity in 
vitro. Supertwig B lengthened the average survival time of infected mice to 4 days 
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(compared to 3 in the control) but failed to counteract the lethal effect of Stx2.
18 
Despite being the weaker Stx2 inhibitor Supertwig A showed greater therapeutic 
potential. Mice treated with Supertwig A (at 5µg/g) survived over 2 months with no 
symptoms and the compound was also found to be effective at treating infection by 
Stx-producing E. coli.
18
 Intravenous administration of Supertwig A to orally infected 
mice almost abolished mortality, with six of the seven treated mice surviving without 
neurological symptoms for 40 days, while the entire control group died within 14 
days.
18
 Further investigation revealed that, similarly to Starfish with Stx1, Supertwig 
A dramatically changed accumulation of labelled Stx2. Treated mice had 3.8 times 
less toxin in their brains and 1.7 times less toxin in their kidneys than controls, 
indicating a degree of protection for the toxin’s target organs.18 Follow up 
investigations using labelled Stx2 in Vero cells suggested that Supertwig A triggered 
uptake and degradation of the Stx2 toxin by cells though the mechanism was unclear. 
Supertwig B showed a similar effect, though much reduced compared to A.
18
 
 
The group expanded on their series of dendrimers with a second generation of larger 
carbosilanes, with 18 and 36 sugar-bearing linkers, shown below (Figure 10).
19
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Figure 10: Second generation Supertwig dendrimers
19
 
 
Supertwigs 2A and 2B showed broadly similar dissociation constants with 
immobilised shiga-like toxins, 0.45 and 0.2 µM with Stx1 and 0.57 and 0.23 µM 
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with Stx2. Binding inhibition assays using Vero cells gave identical IC50s of 0.21 µM 
against Stx1 and IC50s of 2.1 and 9.5 µM for Stx2 with 2A and 2B respectively, 
values that were not a substantial improvement on first generation Supertwig A.
19
 
Differences between Supertwigs 2A and 2B were observed in cytotoxicity assays 
with 2A giving lower IC50s against both Stx1 and Stx2 (0.18 and 0.26 µM 
respectively) compared to 2B (17 and 19 µM respectively).
19
 
 
As with the first generation structures A and B a dramatic difference was observed 
between Supertwigs 2A and 2B in vivo. When coadministered to mice with a lethal 
dose of Stx2, Supertwig 2A prevented mouse mortality, while 2B only resulted in a 
slight increase in average survival, with all mice dead within 4 days (control mice 
died within 3).
19
 The group repeated investigations into induced cellular uptake of 
labelled Stx2, using U937 rather than Vero cells. As previously observed first 
generation Supertwig A triggered uptake of Stx2. Supertwig 2A also triggered 
uptake of the toxin, to an even greater extent than the first generation compound, 
while Supertwig 2B had a much smaller effect, further supporting the groups’ 
conclusion that induced uptake of the toxin was crucial in protecting mice from 
Stx2.
19
 
 
Several crucial elements of the structures were identified: the hydrophobic central 
core Supertwigs A and 2A share, with at least six total trisaccharides, arranged in 
clusters at each end.
19
 This combination of characteristics seemed to be essential for 
enhancing binding and uptake of shiga-like toxins. 
 
Nishikawa et al also attempted to extend their dendrimer series using a simpler, more 
easily synthesised disaccharide in an attempt to see whether similar binding affinities 
and biological effects could be obtained with a shorter oligosaccharide (Figure 11).
20
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Figure 11: Third generation Supertwig dendrimers
20
 
 
Unfortunately the third generation Supertwigs generally showed lower binding when 
screened against immobilised and labelled shiga-like toxins.
20
 Supertwigs 3A and 3B 
had KDs roughly 10 and 50-100 times higher than the first generation Supertwig A. 
Supertwigs 3A and 3B were also less effective than Supertwig A at inhibiting Stx1 
and Stx2 binding to Vero cells.
20
 Supertwig 3C showed broadly similar activity to 
the less active Supertwig C.  
 
While both groups produced ligand mimics with high affinity to isolated lectins 
these results didn’t immediately translate to success in vivo. Starfish, Daisy and the 
Supertwigs were all effective lectin ligand mimics designed with knowledge of the 
protein structure, lectin binding sites and the natural ligand. The different series of 
dendrimers appear to target different binding sites on the toxins, with sites 1 and 2 
acting as the main targets for Starfish and Daisy, while for successful Supertwigs A 
and 2A site 3 was essential.
15, 19 
Despite having higher in vitro IC50s for shiga-like 
toxins, Supertwig A proved to be more effective than Starfish in vivo. Daisy also had 
poor in vitro results but showed substantial improvement protecting mice from Stx2. 
While Supertwig 2A showed many of the same properties as the first generation 
Supertwig A, but in vivo experiments used a higher dosage (50 µg/g of Supertwig 
2A was required while Supertwig A gave the same results with 5 µg/g).
19
 
Additionally Nishikawa et al didn’t use Stx1 in any in vivo tests; while both Starfish 
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and Daisy were screened with both shiga-like toxins the Supertwigs ability to 
combat Stx1 is unknown. 
 
Although there were some differences in the binding residues used by both groups 
(trisaccharides in Starfish are not attached via the reducing end) differences in 
selectivity and in vivo activity seem to be largely due to the underlying scaffold and 
linkers, controlling the topography and clustering of sugar residues and hence their 
ability to interact with their target. The work of these two groups highlights both the 
effectiveness and complexity of targeting therapeutically relevant lectins. Their 
ability to understand the target and optimise the ligand structures was key to their 
eventual success. 
 
1.3 Galectins 
 
Galectins are a family of lectins recognising β-galactose with a wide variety of 
functions and expression. Fifteen galectins are known to be expressed in mammals 
affecting an array of biological processes including the activation and selection of T 
cells, transport of cell membrane glycolipids and glycoproteins and receptor kinase 
signalling.
21
 They’re also known to play a role in cancer metastasis and HIV 
infection.
9, 22
   
 
The eleven human galectins are classified according to their structures into 
prototypical, tandem-repeat and chimeric, shown below (Figure 12). Prototypical 
galectins contain one binding domain, with proteins associating to form 
homodimers. Tandem repeat galectins contain at least two distinct binding domains, 
linked by a short peptide (5-50 amino acids). Chimeric galectins, only galectin-3 in 
humans, have a single binding domain and a large amino terminal domain which 
enables the proteins to aggregate, commonly forming pentamers.
23
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Figure 12: Representation of the structures of human galectins. Galectins 1, 2, 7, 10, 
13 and 14 are prototypical. Galectins 4, 8, 9 and 12 are tandem repeat. Galectin 3 is 
the only chimeric galectin in humans.
23
 
 
A variety of lectin ligand mimics targeting galectins have been developed, many of 
which focus on galectin 1 (Gal-1) and galectin 3 (Gal-3). Both galectins are known 
to play important roles in cancer progression and the inflammatory response. Gal-1 
is thought to reduce inflammatory responses, it can inhibit production of some pro-
inflammatory cytokines (such as interferon-γ and interleukin-2) and induce 
production of anti-inflammatory cytokines (interleukin-10, interleukin-5 and 
transforming growth factor-β).23 In contrast Gal-3 can inhibit production of 
interleukin-5 in some cells and activate mast cells and neutrophils (both of which can 
be involved in inflammation).
23
  
 
In addition to being upregulated in many cancers Gal-3 can promote metastasis by 
binding to cadherins, transmembrane proteins responsible for cell-cell adhesion. By 
binding to N-glycans on these proteins Gal-3 reduces homotypic adhesion, causing 
tumour cells to detach and promoting metastasis.
21
 High serum levels of Gal-3 have 
been linked to higher instances of metastasis in cancer patients.
22
 Gal-1 has been 
shown to contribute to tumour cell survival and experiments with knockout cells 
showed it to be essential for angiogenesis.
23
 Natural ligands for Gal-1 and Gal-3 
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have also been linked to poor cancer prognosis. High serum levels of LGalS3BP, a 
glycoprotein ligand for both galectins which is known to be capable of bridging 
galectins on tumour cell surfaces, has been linked to metastasis.
22
 As a result Gal-1 
and Gal-3 have been suggested as possible therapeutic targets in a range of 
conditions, with several groups aiming to create selective inhibitors of one or both of 
these galectins.
22, 24
 
 
Pieters et al produced several effective monovalent ligand mimics for Gal-1 and Gal-
3, such as those shown in Figure 13. 
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Figure 13: Thiodigalactoside derivative, ligand mimics for Gal-1 and Gal-3. R2 
shows a preference for Gal-3.
24
 
 
The monovalent compound R1 above was developed by Pieters et al in an attempt to 
create a ligand specific for Gal-3, showing impressive affinity for both Gal-1 and 
Gal-3 (KDs of 0.013 and 0.022 µM respectively, determined using fluorescence 
polarisation assay).
24
 While this was the best overall binding affinity for both 
galectins the group did achieve better specificity with related compound R2. R2 
showed a markedly greater affinity for Gal-3 than Gal-1, with KDs of 0.36 and 84 
µM respectively.
24
 All the compounds produced by Pieters et al for this study were 
monovalent and (as discussed in previous sections) multivalent display of binding 
sugars can result in considerable enhancements in binding affinity and specificity.
3
 
 
Aiming to produce effective inhibitors using systematic synthetic modifications Yao 
et al created a series of simple structurally diverse glycoclusters as Gal-3 ligand 
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mimics. Using small generic scaffolds and C-lactose as the binding moiety, they 
synthesised mono, di, tri and tetra valent glycoclusters with a variety of linker 
lengths and topologies. Surface plasmon resonance (SPR) was then used to 
determine KD values with Gal-3. The group used lactose as a comparison, and 
measured its KD as 342 µM, the monovalent compounds produced had significantly 
higher KDs (most could not be measured accurately) which the group suggested was 
due to the lack of an anomeric oxygen.
25
 The divalent examples are shown (Figure 
14). 
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Figure 14: A selection of divalent Gal-3 ligands with KD values.
25
 
 
The divalent compounds gave a wide range of binding affinities, even when the 
scaffold backbones are similar lengths. The higher affinity of compound E, 
compared to C and B which have similarly spaced sugar groups, could be due to 
favourable interactions between the scaffold free amine and the lectin but further 
investigation into the binding mode of these compounds wasn’t carried out. A large 
range of KDs was also seen for the trivalent compounds (Figure 15). 
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Figure 15: Trivalent Gal-3 ligands with KD values shown.
25
 
 
Although compounds F, G and H are structurally similar they showed significant 
differences in KD values and while G and I have very different structures and 
spacing between sugar groups their KDs were similar.  
 
Without further study (for example using xray crystallography or computational 
modelling) the precise cause of these differences in affinity is unclear. None of the 
compounds produced showed particularly impressive binding affinities, with KDs 
ranging from 1970-15.8 µM.
25
 But the study neatly demonstrates how much the 
underlying scaffold, linkers and display of sugar residues effects interaction with 
lectins.  
 
While Yao et al’s choice to use simpler sugar units made the synthesis of their 
library quicker and easier than it would have been with a more complex glycoside it 
also resulted in less potent products despite the glycoside cluster effect. Their 
ligation strategy (Huisgen-Sharpless cycloaddition) also allows attachment of more 
complex saccharides. The potential to vary and improve the inhibitors was 
considered when the synthesis was planned, results from the C-lactosyl substituted 
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scaffolds could be used to identify the most effective display of saccharides, 
concentrating later synthetic efforts. 
 
1.4 Ficolins 
 
Several classes of lectins are involved in activating the complement system as part of 
innate immunity; the three human ficolins are one of them. Ficolins and mannose 
binding lectin (MBL) both activate the complement system via the lectin pathway. 
The lectins act as pattern recognition molecules triggering the activation of MASPs 
(mannose binding lectin associated serum proteases). A lectin-MASP complex binds 
to carbohydrates on pathogens, which allows MASP-2 to convert into an active 
form. Activated MASP-2 then cleaves C4 and C2 (similarly to activated C1s in the 
classical pathway) eventually forming C4b2a which cleaves C3. The fragment C3b 
then triggers formation of a membrane attack complex, forming a hole in the target 
membrane.
26
 MBL and ficolins play an essential role in innate immunity by 
activating the complement system in this way. 
 
Ficolins are GlcNAc binding oligomeric lectins made up of fibrinogen-like and 
collegen-like domains.
27
 The human ficolins (L, M and H) are made of several units 
arranged in a ‘bouquet-like’ structure, with each unit formed of a trimer.  
 
 
Figure 16: Bouquet-like 12-mer structure typical of ficolin-L.
27
 
 
The triple helix collagen-like stalk domains form disulfide crosslinkages which allow 
assembly of the oligomers, and also contain the binding site for MASPs essential for 
triggering the lectin complement cascade.
28
 The globular fibrinogen-like domains 
contain multiple binding sites which are repeated structures in ficolins H and M, 
while ficolin-L has three distinct binding sites per subunit.
28
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Binding is centred on the acetyl group but most ficolins and all human ficolins show 
a preference for GlcNAc with ficolin-L showing a KD of 2.3 nM (measured by 
surface plasmon resonance using immobilised GlcNAc on bovine serum albumin).
27
 
While GlcNAc is their main ligand human ficolins are promiscuous, recognising a 
variety of acetylated ligands summarised in Table 1 below.  
 
Ficolin Known Ligands Known Functions Protein Expression 
L GlcNAc, galactose, 
β (1-3) D-glucans,28 
lipoteichoic acid,
27
 
DNA
29
 
Opsonin and 
complement 
activation 
Serum and plasma 
M GlcNAc, GalNAc, 
sialic acid
28
 
Complement 
activation and 
phagocytic receptor 
Plasma, 
monocytes, 
alveolar epithelial 
cells, neutrophils 
H GlcNAc, GalNAc, 
acetylsalicylic 
acid,
30
 fucose,
28
 
polysaccharide 
preparations from S. 
typhimurium,
30
 E. 
coli,
31
 A. viridans.
30
 
Opsonin and 
complement 
activation 
Serum, plasma, 
bronchus, alveolus, 
bile duct 
Table 1: Human ficolin ligands and functions 
 
As they were discovered fairly recently (1996) the full scope of ficolin activity isn’t 
known.
32
 Ficolin-L is known to bind several capsulated bacteria (including 
Salmonella typhimurium, E. coli, Staphylococcus aureus and Staphylococcus 
pneumoniae) and activate the lectin pathway in response to binding.
26, 33
 Ficolin-L 
can bind to influenza A virus, inhibiting infection in vitro and in mouse models, 
possibly by binding to hemagglutinin and neuraminidase, viral glycoproteins 
common on influenza strains.
34
 It can also interact with hepatitis C virus, binding 
glycoproteins E1 and E2 and activating the lectin pathway pf complement.
35
 Binding 
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to a saprophytic mould responsible for fungal infections (Aspergillus fumigatus, live 
and fixed conidia) has also been demonstrated.
36
 Ficolin-H binds Aerococcus 
viridans cells and influenza A virus strains inhibiting viral infectivity in vitro.
37, 38
 
Ficolin-M has been shown to bind S. aureus and some S. typhimurium strains but it 
has also known to bind Ebola virus glycoproteins with high affinity, enhancing 
Ebola infection.
39, 40
  
 
Despite the potential therapeutic benefits to date there have been no attempts to use 
glycodendrimers to target ficolins. 
 
1.5 Proposed Lectin Ligand Mimics 
 
This project focuses on the synthesis of small glycoclusters intended to be lectin 
ligand mimics. Three monosaccharides were chosen, galactose and GlcNAc as they 
could potentially be used to target therapeutically relevant lectins (such as human 
galectins and ficolins) and glucose as a negative control. As the small selection of 
lectin ligand mimics discussed shows a wide variety of scaffolds, linkers and ligation 
strategies have been successfully employed in the past. Two core scaffolds and two 
ligation strategies were chosen as the synthetic focus: 
tris(hydroxylmethyl)aminomethane (Tris) and calix(4)arene cores with Huisgen-
Sharpless azide-alkyne cycloaddition and secondary aminnoxy ligation.  
 
By utilising two concurrent ligation strategies (aminooxy ligation and azide-alkyne 
cycloaddition, both of which are discussed further in subsequent chapters) it was 
hoped that some of the synthetic challenges associated with saccharides, such as 
complex protecting group strategies, low yields and long synthetic routes, could be 
circumvented. The planned synthetic routes, especially in Tris scaffolds, allow for 
systematic variation of the eventual structure. Varying the length and flexibility of 
linker arms would permit the scaffolds to be tailored to individual lectins, giving a 
synthetically straightforward starting point for development of high affinity ligands.  
 
Proposed structures are for both scaffolds and ligation methods are shown below 
(Figure 17-18), tri valent Tris compounds and di valent calixarenes were chosen for 
synthetic expediency.  
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Figure 17: Proposed glycoclusters with central Tris scaffold, secondary aminooxy 
ligation of galactose is shown on the left and Husigen-Sharpless cycloaddition on the 
right. R is any suitable chromophore or fluorophore. 
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Figure 18: Proposed glycoclusters with central calix(4)arene scaffold, secondary 
aminooxy ligation of galactose is shown on the left and Husigen-Sharpless 
cycloaddition on the right. R is any suitable chromophore or fluorophore and a 
suitable linker. 
 
The following chapters detail synthetic routes aimed at producing lectin ligand 
mimics bearing fluorophores or chromophores. 
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2. Synthesis of Tris based glycodendrimers 
 
2.1 An overview of Trizma 
 
Trizma base (Tris) is a well known and widely used biological buffer with an 
effective buffering range of pH 7-9. The compound is readily available, cheap and 
known to be non-toxic. Its structure, shown in Figure 19, is simple and flexible with 
easily distinguished functional handles. This combination of properties makes it an 
attractive starting point for biological scaffolds especially when the precise structure 
of the target binding site is unknown.  
 
NH2
OHHO
HO  
Figure 19: Molecular structure of Trizma buffer 
 
If the primary amine is first protected a wide variety of structures can be coupled to 
the available alcohols allowing the construction of moderately sized scaffolds or 
clusters displaying one type of moiety at the alcohols and another at the amine.
41, 42
 
The choice of lectins as a target and their improved binding to multiple carbohydrate 
groups makes the alcohols the obvious choice for attachment of these sugar residues. 
This would leave the amine available for attachment of fluorophores or 
chromophores resulting in small probes, which could be easily varied via relatively 
short and straight forward synthesis. An example of the type of structure proposed is 
illustrated below in Figure 20.  
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Figure 20: A proposed structure for a Tris based lectin ligand mimic and probe. 
Made up of a central Tris core, simple chromophore coupled to the amine and linkers 
bearing terminal sugar residues coupled to the alcohols. 
 
By utilising linkers to attach the desired carbohydrate residues the properties of the 
scaffold can be fine-tuned to a far greater extent before any sugars are introduced. 
This reduces the number of synthetic steps carried out on the carbohydrate, an 
important consideration when simple di and tri saccharides are often expensive or 
difficult to synthesise, reducing the loss of precious material. Such an approach 
would also increase the variety of the ligand mimics. Control of linker functionality 
could be used to adjust the solubility of the scaffold. Introducing branching to the 
linkers also allows alteration of the number and arrangement of displayed sugar 
groups while adjusting the length and flexibility sufficiently can dramatically alter 
interaction with lectins.
43, 44, 45 
 
 
Our synthetic route was intended to allow linkers to be changed and adjusted as 
necessary, to improve a scaffold’s interaction with specific targets or physical 
properties. It seemed reasonable to use a flexible core and linkers as a starting point. 
Binding to a specific target might be improved by adjusting the linkers to change the 
length, flexibility or number of sugars displayed on a Tris core. Linkers coupled to 
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the Tris alcohols can be varied easily, allowing straightforward investigation of these 
effects.  
 
Direct attachment of galactose to the Tris alcohols (illustrated in Figure 21) was 
previously performed by Biessen et al, as part of a series of Tris-based ligands aimed 
at targeting the  hepatic asialoglycoprotein receptor, a liver cell-surface lectin.
46
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Figure 21: An example of a Tris based scaffold with galactose directly coupled to 
alcohol groups (Ki = 390 µM) and a Tris based scaffold with galactose attached 
using a polyethylene glycol linker (Ki = 0.2 µM).
46
 
 
The compound shown above (Figure 21) with galactose directly attached to the Tris 
scaffold was a poor binder and could not displace the chosen control, indicating a Ki 
greater than 390 µM.
46
 For comparison the best binder in the series (with galactose 
attached via a flexible polyethylene glycol linker) had a Ki of 0.2 µM, providing 
another example of the importance of linker length and the display of binding sugars 
in creating a successful ligand. Yields varied throughout the series from 67-24%, 
direct attachment of galactose to the Tris scaffold was low yielding (36%).
46
 The 
combination of low yield and poor binding in previous studies made it seem likely 
direct attachment of sugars to Tris was not worth pursuing.  
 
A small Tris based cluster, similar to our intended targets, has been made previously 
as part of a series by Yao et al aimed at producing galectin-3 ligands (Figure 22).
25
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Figure 22: Tris based C-lactosyl glycocluster produced by Yao et al.
25
 
 
Designed by Yao et al as part of a series of small, flexible click-coupled compounds, 
it showed reasonable binding affinity towards galectin-3, with a KD of 65.9µM 
which compared favourably with the other tri-glycosylated compounds tested (KDs 
ranged from 239 to 38.5 µM).
25
  
 
The choice of click chemistry allowed a series of 16 scaffolds to be created in a 
relatively straight forward manner: an azide appended C-lactosyl derivative was 
synthesised and reacted with small, propargyl containing molecules. The group also 
took advantage of click chemistry to extend the linkers on one of their core scaffolds, 
improving the KD considerably (from 239 µM on the original scaffold to 38.5 µM 
with extended linkers).
25
 While their use of click chemistry allowed simple 
production and refinement of the small clusters investigated removing the anomeric 
oxygen from the binding residues has potential disadvantages. The anomeric oxygen 
can be essential for recognition: removing it may reduce enzymatic degradation of 
the scaffolds but it may also hinder lectin binding. We chose to use azido-sugar 
derivatives with the anomeric oxygen intact. 
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Tris has also been used to build up glycodendrimers, often either as a branching unit 
close to the core or as a glycocluster controlling display of sugar units at the 
periphery.
3,
 
45, 47, 48
 
 
A 2002 review by Turnbull et al provides multiple examples of glycodendrimers 
using Tris based glycoclusters as their peripheral layer.
3
 A prominent example is a 
series of dendrimers synthesised by Ashton et al, using a trisubstituted Tris 
glycocluster to build up 9-, 18- and 36-mer dendrimers, the 9-mer is shown below 
(Figure 23).
49
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Figure 23: 9-mer mannose glycodendrimer, using Tris to display the 
monosaccharides.
49
 
 
As expected the dendrimers all showed greater inhibition of lectin Concanavalin A 
than the trisubstituted glycocluster in an Enzyme Linked Lectin Assay (ELLA), with 
the 9-mer exhibiting a reasonable IC50 of 0.65 mM, four times greater than the Tris 
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cluster.
49
 However  differences between the 9- and 18-mer were small and the 
activity of the 18- and 36-mer were similar.
49
 This effect has been seen previously in 
high valence compounds with binding plateauing in high valency compounds and it 
has been suggested that the origin is steric.
3
 A high number of tightly packed ligands 
may not be able to interact well with lectin binding sites simply because the ligands 
are too crowded, an effect that might be mitigated by the structure of the underlying 
scaffold or by using linkers at the branching points of the dendrimer, increasing the 
distance between ligands.  
 
Some approaches have utilised click chemistry in combination with Tris to quickly 
build up large, branched dendrimers such as that illustrated in Figure 24.
50, 51, 52, 53
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Figure 24: A dendrimer produced by Chabre et al utilising Tris cores and click 
chemistry.
50
 
 
The structure shown in Figure 24 was synthesised by Chabre et al as part of a series 
aimed at targeting LecA of P. aeruginosa, a known virulence factor associated with 
infections by this opportunistic bacteria. The series contained dendrimers of varying 
sizes with 3-36 C-galactose residues, although several of the larger compounds were 
too hydrophobic to dissolve readily in water preventing ELLA analysis of the entire 
series. In this case dendrimer design was aided by crystal structures of the target 
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lectin and computational docking studies. The results confirmed that in this lectin 
binding site the anomeric oxygen is exposed to the solvent leading the group to 
suggest that C-galactose residues could be employed without negatively affecting the 
binding interaction.
50
 The group synthesised and screened several potential 
monomers before choosing to use azido and propargyl substituted derivatives, 
allowing them to build up their dendrimers in a straight forward manner via click 
chemistry. 3- and 6-mer derivatives were designed around the same aromatic core as 
the Tris based 9-mer and a 3-mer Tris based cluster was also synthesised. Of the 
dendrimers tested, the Tris based compound in Figure 24 had the best binding to 
LecA, with an impressive Kd value of 230 nM.
50 
 
 
As a small scaffold Tris appeared to meet our requirements, being flexible, nontoxic, 
soluble and easy to synthetically manipulate. As discussed it has previously been 
used to create successful lectin ligand mimics both as small clusters and as a display 
or branching agent in larger dendrimers. We anticipated that it could be used to 
create compounds suitable for use as probes or for screening. With careful choice of 
linking strategy these could later be optimised for more specific interactions by 
manipulating the length, rigidity and functionality of the linker arms. With this in 
mind we began to look at using azide alkyne click chemistry the uses and advantages 
of which are discussed in the following section. 
 
2.2 An overview of click chemistry 
 
The term ‘click chemistry’ refers to a variety of procedures which aim to meet the 
same set of exacting criteria, originally defined by Sharpless. Click reactions should 
be stereospecific, high yielding, tolerant of a wide range of functionality, simple to 
perform, conducted in benign or easily removed solvents, have high atom efficiency 
and result in high purity products without chromatography.
54
  
 
Several synthetic procedures meet all or most of these conditions. Nucleophilic 
attack on aziridines and epoxides, radical reactions between thiols and alkenes, the 
Diels-Alder reaction, non-aldol carbonyl reactions such as urea or oxime formation 
and some cycloaddition reactions have all been described as click chemistry.
54
 Our 
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synthetic strategy focused on one particular click reaction, formation of triazoles 
from the cycloaddition of azides and alkynes. 
 
Huisgen-Sharpless azide alkyne 1,3-dipolar cycloaddition, one of the most common 
reactions referred to as click chemistry, is a well-known and robust procedure which 
has been used on a diverse array of compounds. Examples include proteins, mono 
and polysaccharides (functionalised at several positions), nucleic acids, 
biomacromolecules, dendrimers, aromatic heterocycles, spiropyrans, porphyrins, 
resins and small molecules.
55, 56, 57
 The reaction is extremely orthogonal, most other 
functional groups are stable to the reaction conditions and protecting groups are 
generally unnecessary adding to its popularity. Usually copper(I) catalysed (although 
a ruthenium catalysed method has been developed giving the opposite 
regioselectivity) the method is generally fast, high yielding, regioselective and 
tolerant of a broad range of functional groups.
58
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Scheme 2: Summary of the two common metal catalysed azide-alkyne click 
procedures, each producing a majority of one of the two possible regioisomers. 
 
The triazole linkage formed is known to be chemically and enzymatically stable as 
well as nontoxic.
59
 The reactive species themselves rarely occur in nature and 
typically react specifically with each other.
59
 This combination of properties makes 
the azide-alkyne click reaction an extremely attractive method for coupling diverse 
components, especially when the eventual aim is to produce molecules for biological 
testing. The two common metal catalysed azide-alkyne click reactions (hereafter 
simply click reactions) are illustrated above in Scheme 2. Since Cu(I) is essential for 
copper catalysis a reducing agent such as sodium ascorbate is often present in the 
copper catalysed reaction to maintain Cu(I) in the mixture. The mechanism for the 
copper catalysed procedure is shown below in Scheme 3.
60
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Scheme 3: Mechanism proposed by Sharpless et al for the copper(1) catalysed click 
reaction.
60
 
 
The click reactions tolerance of varying functionalities allows the synthesis of a 
single base scaffold that can be coupled to multiple sets of linkers and saccharides, 
cutting out the need to synthetically tweak each scaffold to a particular ligand 
monomer. An initial set of flexible lectin ligand mimics could be synthesised 
relatively straightforwardly and then adjusted giving several generations of ligand 
mimics with a consistent coupling strategy throughout. With this in mind we planned 
an initial set of Tris based, click coupled scaffolds bearing three distinct 
monosaccharides. 
 
2.3 Synthesis of Tris based scaffolds 
 
Inspired by the numerous uses of click chemistry to build up Tris based dendrimers 
we planned to begin with small, simple and flexible tri-substituted Tris scaffolds, 
with monosaccharides coupled through short linkers via click chemistry. The 
proposed synthetic route is shown below in Scheme 4.  
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Scheme 4: Proposed synthetic route to initial small, simple Tris based lectin ligands. 
 
The tri-propargyl substituted Tris scaffold (2) was produced in reasonable yield 
(69%) following literature procedures which are shown below in Scheme 5.
47
 With a 
suitable starting scaffold in hand attention turned to choice of monosaccharides and 
the remaining portion of the linker. 
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Scheme 5: Synthesis of tripropargyl Tris scaffold (2) 
 
D-Galactose, D-glucose and N-acetyl D-glucosamine (GlcNAc) were chosen as 
initial monosaccharides of interest: galactose has a high presentation in biological 
systems and the large number of lectins recognise and interact with galactose. 
GlcNAc was selected as the ligand of choice for ficolins, a family of lectins which 
activate the complement pathway, and as the preferred ligand of a plant lectin stored 
in house (wheat germ agglutinin). Glucose was chosen as a negative control.  
 
Although there are lectin ligand mimics using sugars that lack an anomeric oxygen it 
was felt that since this position is important for recognition by some lectins our first 
generation scaffolds should include it.
61, 62
 With this in mind, simple 2-azidoethanol 
(3) was chosen as an initial linker component, this was also synthesised according to 
literature procedures.
63
 3 was then coupled at the anomeric position to D-galactose 
pentaacetate using boron triflouride etherate as an activator as illustrated in Scheme 
6.
64
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Scheme 6: Synthesis of azido-coupled galactose (4) 
 
The β anomer (4) was isolated in 53% yield and reaction with tripropargyl Tris (2), 
catalysed by copper (I) formed in situ by copper sulfate and sodium ascorbate, gave 
the fully protected tri-galactose Tris scaffold (5) illustrated in Figure 25. Unusually 
for click reactions it was necessary to purify 5 by flash column chromatography and 
the product was isolated in 66% yield. Due to the reaction taking place at multiple 
sites a slight excess of the azide (4) was used; the product was purified to ensure its 
complete removal and that any residual azide would not interfere with planned 
binding experiments. A small amount of 4 (11mg) was recovered during 
chromatography.  
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Figure 25: Tri substituted galactose bearing Tris scaffold (5) 
 
Product formation was suggested by IR, with the absence of characteristic strong 
absorption for both terminal alkynes (3291 cm
-1
 in Tris core 2) and azides (2103 cm
-1
 
in azido-galactose compound 4). Further confirmation came from NMR (fully 
assigned with the aid of COSY and HSQC) and mass spec experiments.  
 
Peaks associated with the terminal alkyne groups of 2 at 2.42 ppm in the proton 
spectrum and at 79.7 and 74.7 ppm in the carbon spectrum disappeared while peaks 
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associated with the ethyl linker in 4 between the azide and galactose shifted 
significantly. Both CH2 groups were shifted downfield on reaction: from 3.49-3.43 
and 3.29-3.23 ppm to 4.64-4.61 and 4.54 ppm for the environments adjacent to the 
azide or triazole respectively while for the environments next to the anomeric 
position shifts were from 4.09-4.04 and 3.68-3.62 ppm to 4.26 and 3.96-3.90 ppm. 
This together with the appearance of peaks consistent with a triazole ring at 7.62 
ppm in the proton and 144.7 and 124.3 ppm carbon spectra (carbon peaks assigned 
as the quaternary and protonated carbons of the ring respectively) strongly suggested 
that the click reaction had occurred, linking the Tris scaffold and galactose.  
 
Regioselectivity of the tri-galactose product (5) was confirmed by the NMR. Proton 
shifts for the 1,4 triazole are significantly higher than for the equivalent 1,5 triazole, 
generally coming at 7.50 ppm or higher while the 1,5 triazole would be expected at 
around 7.30 ppm. A difference in expected shifts is also observed in the carbons of 
the triazole ring, with the protonated environment of the 1,4 triazole usually coming 
upfield of its 1,5 equivalent, at around 120 ppm rather than 130 ppm.  
 
Final confirmation came from high resolution mass spec results, with a prominent 
positive mass ion observed at 1587.5954 m/z, in good agreement with the predicted 
value of 1587.5956 for the product. 
 
Encouraged by this initial success an attempt was made to synthesise the GlcNAc 
equivalent using the same boron triflouride etherate based procedure. However this 
was unsuccessful, probably due to the stability of the α starting material 6, which 
was used as it was the major product of reactions to acetate protect GlcNAc. The α 
starting material was recovered.  
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Scheme 7: Initial unsuccessful attempt to synthesise azide linked GlcNAc (8) 
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In order to encourage reaction with 2-azidoethanol (3) the acetylated GlcNAc 
starting material was activated by acid induced cyclisation, creating the oxazoline, 
using trimethylsilyl trifluoromethanesulfonate (TMSOTf).
65
 This neighbouring 
group participation is known to increase the selectivity at the anomeric position.
66  
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Figure 26: Oxazoline 7 compared to the oxonium ion equivalent formed when an 
ester protected hydroxyl is present at the 2 position  
 
This cyclisation also occurs with ester protection of a hydroxyl at the 2 position, 
however this oxonium ion is considerably less stable and so unlike the oxazoline (7) 
it cannot generally be isolated. Both derivatives are illustrated in Figure 26. 
 
Due to its reactive nature 7 was used as a crude however full characterisation was 
still possible. Comparison of mass spec data for acetate protected GlcNAc 6 and 
oxazoline 7 suggested that cyclisation had occurred. The most prominent mass ion 
for 7 was at 330.1 m/z, matching well with the predicted value for MH
+
 (330.3). 
Compared to the observed ions in the spectra of 6, which showed a prominent ion at 
412.1 m/z (MNa
+
), this suggested a mass loss consistent with formation of the 
oxazoline product.  
 
Large differences in specific rotation between 6 and 7 also supported the idea of 
product formation. At similar temperatures and concentrations the specific rotation 
for 6 was recorded as +89.4
o
 in methanol, while 7 was recorded as +6.0
o
 in the same 
solvent. Literature values (taken in chloroform) showed a similarly large change in 
specific rotation going from the acetate protected GlcNAc (+94, 21
o
C)
67
 to the 
desired oxazoline (+12.2, 18
o
C)
68
, suggesting that the product had been successfully 
synthesised. 
 
Product formation was confirmed by NMR. Loss of acetate peaks in both the proton 
and carbon spectra of 7 (characteristically at ~2.10 ppm in the proton and ~170 ppm 
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and ~20 ppm in the carbon) strongly suggested loss of an acetate group, consistent 
with the intended cyclisation. Further assignment, assisted by COSY and HSQC of 
both starting material 6 and product 7, revealed large shifts for the anomeric and 2 
position in both proton and carbon spectra. The anomeric proton was observed at 
6.17 ppm with a J coupling of 3.6 Hz in 6 whereas for the product 7 it was shifted 
upfield to 5.96 ppm with a much higher J value of 7.2 Hz.  In contrast the anomeric 
carbon shifted downfield from 90.8 ppm in 6 to 99.5 ppm in 7. More dramatic shifts 
were observed at the 2 position, with the proton signal moving from 4.48 ppm to 
4.13 ppm on reaction and the carbon from 51.2 ppm to 65.1 ppm.  
 
Subtler difference in the NMR spectra of 6 and 7 also supported formation of the 
oxazoline: no proton signal for N-H was observed in 7 and two signals in the carbon 
spectrum of 7 came close to, but upfield from, characteristic acetate peaks suggesting 
imine formation. These peaks came at 166.8 ppm for C=N (compared to 168.7 ppm 
for the most shielded C=O group in starting material 6) and 14.1 ppm for the 
associated methyl (compared to 20.7 ppm for the most shielded methyl carbon in 6). 
 
Having obtained 7, reaction with 2-azidoethanol (3) was attempted again. Several 
different methods were trialled, each conducted under dry conditions in DCM or 
dichloroethane using an acid catalyst. Previously established literature procedures 
were followed or used as starting points in each case, using TMSOTf, concentrated 
sulfuric acid and copper (II) chloride.
65,
 
69, 70
  
 
A significant mass loss was recorded for reaction with sulfuric acid, 28 mg of crude 
material were recovered from a 100 mg scale reaction. The material recovered was a 
mixture of starting material and product (~ratio of 1:1.5) which was not purified 
further.  
 
Reaction with TMSOTf was conducted over two days as TLC consistently showed 
that the starting material 7 had not been consumed. Purification did give the azide-
linked product 8 but with an extremely low yield of 7%. Use of copper (II) chloride 
increased the yield slightly to 16% over the same time period allowing the 
production of the azide-linked GlcNAc 8 as illustrated in Scheme 8.  
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Scheme 8: Synthetic route to azide linked GlcNAc 8 via oxazoline 7.  
 
IR and mass spec both suggested azide 8 had been successfully synthesised: with a 
characteristic azide peak recorded at 2111 cm
-1
 and a mass ion at 417.1 m/z 
comparing well to the predicted value for MH
+
 (417.16 m/z). NMR spectra 
confirmed both the formation of the azide 8 and the anomeric form; J coupling for 
the anomeric proton was 8.4 Hz which strongly suggests the β form. Additional 
peaks were observed in the carbon (at 68.6 and 50.6 ppm) and proton spectra (at 
4.07-4.02, 3.75-3.68, 3.54-3.45 and 3.29-3.23 ppm) associated with the ethyl linker 
and were positively identified with reference to COSY and HSQC.  Large shifts in 
the proton and carbon spectra were observed for position 2, going from oxazoline 7 
to azide 8. Proton peaks shifted from 4.13 ppm to 3.81 ppm on reaction and those for 
the carbon from 65.1 ppm to 55.0 ppm. This along with the appearance of an N-H 
signal in the proton spectra of 8 (at 5.58 ppm) established that the oxazoline ring of 7 
was no longer present, confirming that the azide 8 had been synthesised as intended. 
 
Reaction of the β anomer (8) with tripropargyl Tris scaffold (2) catalysed by copper 
(I) successfully produced the protected tri substituted GlcNAc scaffold (9) shown in 
Figure 27 but the yield was extremely low (5%). Several impurities were isolated 
along with a significant portion of the azide starting material 8 suggesting that 
despite a reaction time of 22 hrs the reaction had not gone to completion. This 
coupled with the similar Rf values of the product and impurities meant that very little 
pure 9 was isolated from the initial reaction although it is likely that by adjusting the 
reaction and purification conditions the yield could be significantly improved.  
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Figure 27: Tri substituted GlcNAc bearing Tris scaffold (9) 
 
Both IR and initial mass spec suggested product formation. The IR spectra of 9 
lacked the characteristic azide peak (observed at 2111 cm
-1
 in 8) and the C-H signal 
characteristic of terminal alkynes (seen at 3291 cm
-1
 in propargyl Tris scaffold 2). 
The lack of these functional groups suggested that the click reaction had occurred. 
Prominent mass ions were observed at 1486.8 m/z and 1609.0 m/z, corresponding 
well to predicted values for (M
+
 -Boc) and MNa
+
 (predicted to be 1484.4 m/z and 
1607.5 m/z) strongly suggesting product formation. Due to the size of the intended 
product MALDI was used in preference to ESI, so lower weight mass ions associated 
with the starting materials 2 and 8 were not easily detectable. Confirmation of the 
product mass ion came from high resolution mass spec, with a clear ion at 1584.6428 
m/z (matching well with the predicted value for M
+
 of 1584.6430). 
 
Further confirmation came from proton and carbon NMR spectra (fully assigned 
with the aid of COSY and HSQC). In the proton spectrum the triplet associated with 
the terminal alkyne of the Tris starting material 2 (at 2.42 ppm) was absent, while a 
prominent singlet at 7.70 ppm suggested the presence of a 1,4 triazole ring. The 
presence and regioselectivity of the triazole was further supported by peaks in the 
carbon NMR spectrum at 144.4 ppm (the quaternary carbon) and 124.5 ppm (the 
protonated carbon). Large shifts were observed in both the proton and carbon spectra 
for the ethyl linker. In the azide linked GlcNAc 8 protons from the linker, adjacent to 
the anomeric position, were observed at 4.07-4.02 ppm and 3.75-3.68 ppm. In 9 they 
appeared at 4.67-4.61 ppm and 4.50-4.44 ppm, suggesting a significant change in the 
local magnetic (and hence chemical) environment. A similar large downfield shift 
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was seen for the protons adjacent to the azide in 8 and the triazole in 9, going from 
3.54-3.45 ppm and 3.29-3.23 ppm in 8 to 4.32-4.23 ppm and 3.86 ppm in 9. The 
attached carbon shifted from 50.8 ppm in 8 to 64.3 ppm in 9, while the carbon 
adjacent to the anomeric position moved from 68.6 ppm to 50.2 ppm on reaction. 
Together the spectroscopic data confirms that 9 was synthesised as intended and the 
lack of peaks that can not be assigned to the product in the mass spec, proton and 
carbon NMR strongly suggests a high purity for isolated 9. 
 
Attention then turned to creating the final glucose bearing scaffold. Initial attempts 
to synthesise the azide linked glucose derivative 11 directly by coupling with 2-
azidoethanol (3) were unsuccessful. Scheme 9 shows the general strategy attempted. 
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Scheme 9: Attempts to synthesise azide-linked glucose derivative 11 directly using 
2-azidoethanol (3) were unsuccessful 
 
Crude NMRs from the reaction shown in Scheme 9 showed that product was 
formed, but after 2 days the starting penta-acetyl glucose still predominated. This 
was determined by comparing integral values for the anomeric protons of azide 
linked glucose 11 (at 4.60 ppm) and the penta-acetyl starting material (at 6.33 ppm) 
in the crude NMRs after 1 and 2 days. The integrals showed that after two days 
approximately 60% of the starting material is still present. 
 
As a result an alternative strategy was attempted and found to be successful. Penta-
acetyl glucose was coupled with bromoethanol using boron trifluoride etherate and 
the bromide 10 subsequently converted to the azide 11 as illustrated in Scheme 10.
71 
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Scheme 10: Synthesis of azide-linked glucose derivative 11 via bromide derivative 
10 
 
Low recorded yields of the bromide derivative 10 (9%) were due to purification 
difficulties; in the solvent systems used for column chromatography 10 co-eluted 
with a small amount of penta-acetyl glucose starting material which was removed by 
successive recrystalisation. This drastically reduced the initial overall yield from 
approximately 65% (estimated using integration of anomeric peaks in proton NMR).  
 
Since the sodium azide in the subsequent step could only be expected to react with 
bromide 10 the reaction was conducted using crude 10. This gave the desired azide 
linked glucose derivative 11 in low to moderate yield of 23% over two steps (from 
the penta-acetyl glucose), suggesting an average yield of approximately 35% for the 
second step. The bromide derivative 10 was not recovered from the reaction mixture, 
though significant proportions of penta-acetyl glucose were.  
 
Successful azide formation was strongly suggested by the IR, showing a 
characteristic azide peak at 2105 cm
-1
. This was supported by mass spec, with the 
azide 11 showing a prominent ion at 440.1 m/z, consistent with predicted values for 
MNa
+
, while the most intense ion peak in spectra of bromide 10 was at 476.9 m/z 
(assigned as MNa
+
), consistent with the heavier bromide isotope. 
 
Confirmation came from the proton and carbon NMR (fully assigned with the aid of 
COSY and HSQC). Proton environments adjacent to the bromide in 10 were 
extremely close together, effectively forming one multiplet at 3.48-3.44 ppm. In 
azide 11 the environments had shifted enough to be distinct and were observed at 
3.52-3.46 ppm and 3.29 ppm. Success of the reaction was further confirmed by shifts 
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in the carbon spectra, going from 30.0 ppm in starting material 10 to 50.7 ppm in 
azide 11. The β anomeric form was confirmed by the shift and J coupling values of 
the anomeric proton in 11 (4.59 ppm, 8 Hz) and to a lesser extent by the optical 
rotation, which was similar to literature values although the concentration and 
solvent differed ([α]D
25.0 
-48.4
 
(c 1.96, MeOH) (lit.,
72
 [α]D
20 
-31.2
 
(c 1.14, CH2Cl2)).  
 
The click reaction between the β azide linked glucose 11 and the tri propargyl Tris 
scaffold 2 was copper (I) catalysed as for the previous derivatives. Following the low 
yield and partial completion of the reaction with the GlcNAc derivative 9, (which 
had extremely similar Rf values to the azide starting material 8 and mono or di 
substituted scaffolds) the reaction was left for five days instead of overnight. The 
expected tri substituted glucose scaffold (12 shown in Figure 28) was successfully 
synthesised and isolated in moderate 36% yield. A small amount of partially reacted 
material was recovered, suggesting that once again the reaction had failed to go to 
completion.  
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Figure 28: Tri substituted glucose bearing Tris scaffold (12) isolated in 36% yield 
 
Both IR and initial mass spec results suggested 12 had been successfully synthesised. 
As in the previous examples (compounds 5 and 9) characteristic peaks in the IR 
associated with azide (2105 cm
-1
 for starting material 11) and terminal alkynes (3291 
cm
-1
 in tri propargyl Tris core 2) were absent. MALDI showed a prominent peak at 
1611.31 m/z, consistent with MNa
+
 which combined with the IR strongly suggested 
that the click reaction had occurred. Further support came from the high resolution 
mass spec, with a peak at 1587.5938 m/z corresponding well with the calculated 
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value for M
+
 (1587.5937 m/z), strongly suggesting that the intended tri-glucose 
substituted Tris scaffold 12 had been synthesised as intended. 
 
Confirmation of the structure of 12 came from the proton and carbon NMR, fully 
assigned with the aid of COSY and HSQC. A prominent singlet in the proton 
spectrum of 12 at 7.60 ppm, characteristic of the 1,4 triazole, along with the absence 
of a triplet at 2.42 ppm (assigned to the terminal alkyne in Tris core 2) strongly 
suggested the formation of the 1,4 triazole. Peaks in the carbon spectrum at 145.0 
ppm (assigned as the quanternary triazole carbon) and 124.0 ppm (assigned to the 
protonated triazole carbon) also supported this. Large shifts in the protons of the 
ethyl linker also strongly suggested the click reaction had occurred, although unlike 
the previous sugar bearing scaffolds (tri galactose 5 and tri GlcNAc 9) shifts in the 
carbons were small. The carbon adjacent to the azide in 11 was observed at 50.7 
ppm, and shifted to 50.0 ppm on reaction, with a similarly small shift from 68.5 ppm 
to 67.9 ppm for the carbon adjacent to the anomeric position. However the attached 
protons (adjacent to the anomeric position) shifted from 4.03 ppm and 3.73-3.66 
ppm in the azide starting material 11 to 4.27-4.21 ppm and 3.97-3.91 ppm in the 
product 12. The proton environments adjacent to the azide in 11 and the triazole in 
12 showed larger downfield shifts, from 3.52-3.46 ppm and 3.29 ppm in 11 to 4.62-
4.56 ppm and 4.74-4.54 ppm in 12.  
 
Together the spectroscopic data supported that the tri-glucose bearing Tris scaffold 
12 had been synthesised as intended, with the region and anomeric selectivity shown, 
as with the previous scaffolds tri-galactose 5 and tri-GlcNAc 9. Purity of the isolated 
tri-substituted scaffolds was strongly supported by the lack of unassigned peaks in 
mass spec, proton and carbon NMR in all cases. 
 
Despite multiple issues with low yields the three simple target scaffolds 5, 9, and 12 
were all successfully synthesised and purified. The scaffolds were stored at -18
o
C as 
the acetate-protected structures.  
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2.4 Chapter Summary 
 
To begin with a simple tri-propargyl Tris core 2 was synthesised, along with a short 
azide linker 3. D-galactose derivative 4 was then synthesised using azidoethanol 3. 
By using copper catalysed click reaction 4 was linked to Tris core 2, creating tri-
galactose bearing scaffold 5 (Scheme 11). 
 
O
AcO
AcO
AcO
OAc
O
N3
HO
N3
BF3.Et2OO
AcO
AcO
AcO
OAc
OAc
4
53%
DCM
O
AcO
AcO
AcO
OAc
O
N3
NHBoc
O
O
O
N
N
N
NN
N
N
N
N
O
O
AcO
AcO
OAc
OAc
O
AcO
AcO
OAc
O
OAc
O
AcO
AcO
OAc
OAc
O
NHBoc
O
O
O
5
66%
CuSO4
Sodium Ascorbate
DMF
2
3
 
Scheme 11: Synthetic route to azide-linked D-galactose 4 and hence tri-galactose 
bearing Tris scaffold 5 
 
The azide-linked GlcNAc derivative 8 was also produced using azidoethanol 3, via 
the oxazoline 7. 8 was then clicked to the Tris core 2 giving the tri substituted 
GlcNAc bearing scaffold 9 (Scheme 12). 
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Scheme 12: Synthetic route to azide-linked GlcNAc derivative 8 and hence tri 
substituted GlcNAc bearing scaffold 9 
 
The glucose equivalent, 11, was synthesised via bromoethanol rather than 
azidoethanol as shown below in Scheme 13, before reacting with tri propargyl Tris 
core 2 as previously. This gave the final scaffold, tri substituted glucose scaffold 12, 
in moderate yield (35%). 
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Scheme 13: Synthesis of azide-linked glucose derivative 11 and tri substituted 
glucose bearing scaffold 12. 
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In order to expand on the scaffold series we next turned to alternative ligation 
methods and began to investigate methods for synthesising aminooxy bearing Tris 
scaffolds described in the following chapter. It was hoped that the lectin binding 
ability of these scaffolds could be directly compared at a later date. 
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3. Synthetic approaches to Aminooxy substituted Tris scaffolds  
 
3.1 An overview of aminooxy coupling 
 
A pure unprotected hexose in solution spontaneously converts to a minority of the 
ring opened aldehyde form, which can then interconvert between the ring closed 
alpha or beta pyranose or furanose forms with the exact proportions of each 
dependent on the conditions and the hexose used.
66 
This is illustrated below in 
Scheme 14. 
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Scheme 14: Interconversion between pyranose ring-closed and ring-opened forms of 
glucose 
 
Aminooxy groups rely on this interconversion as they react with the aldehyde of the 
ring opened sugar under acidic conditions.
73
 Reaction occurs via a mechanism 
similar to imine formation; it is unusual in that it proceeds with unprotected sugars, 
giving addition specifically at the anomeric position, with a marked preference for 
the beta pyranose form.
73, 74 
Primary aminooxy functionality traps the ring opened 
form but secondary aminooxy groups tend to give a single pyranose form as the 
major product. In most cases the β anomer is formed almost exclusively although 
there are some exceptions; mannose tends to give almost equal proportions of alpha 
and beta pyranose forms.
75
 The mechanism for this reaction is shown below in 
Scheme 15. 
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Scheme 15: Mechanism for the reaction between a secondary aminooxy compound 
and glucose. 
 
This strategy has several synthetic advantages: reactions can be performed in water 
or buffers, are often high yielding and enantioselective, with no activating or 
protecting groups necessary.
76
 This combination of properties can result in a shorter 
synthetic route to the desired compound, compared to the O-glycoside equivalent 
and usually requires less synthetic steps on the saccharide itself, increasing overall 
yields.
76
 There are some disadvantages. As illustrated in Scheme 15 the reaction is 
reversible at low pH (although products are stable at neutral and high pH) which can 
lead to product decomposition or mixtures of products and starting material.
77
 These 
mixtures can have low solubility in organic solvents and so can be difficult to purify 
by flash column chromatography on silica.  
 
Aminooxy linked sugars are not always recognised by their biological target, 
especially when bulky R groups are present on the starting secondary aminooxy and 
when tested alongside O-glycoside equivalents aminooxy linked compounds are 
sometimes less active.
76, 78
 However activity and selectivity trends observed in 
secondary aminooxy linked compounds are often mirrored in their O-glycoside 
equivalents.
76 
Along with the simpler synthetic process this can make aminooxy 
compounds useful for screening, identifying the most interesting saccharides without 
the complex synthesis of an O-glycoside library.
79
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While the reaction between hexoses and secondary aminooxy functionality produces 
almost exclusively pyranose structures (as shown above in Scheme 15) using 
primary aminooxy functionality results in an equilibrium mixture of two linear and 
one ring closed product, illustrated below in Scheme 16. 
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Scheme 16: Interconversion between glyco-oxime isomers 
 
Although preservation of the pyranose structure is often thought to be essential for 
lectin recognition
80, 81
 several groups have found primary aminooxy functionality 
advantageous. The presence of a minority ring-closed saccharide allows recognition 
with less risk of false negatives from aminooxy R groups interfering with binding.
82
 
A single ring opened sugar can function almost as part of a linker, displaying 
terminal residues, so long as the saccharide is large enough that the ring-opened unit 
doesn’t have a significant effect on binding.83, 84 
 
Feizi et al developed primary aminooxy compounds for use in microarray analysis to 
further assign oligosaccharide-protein interactions, an example in shown below in 
Figure 29.  
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Figure 29: Primary aminooxy compound used to immobilise oligosaccharides for 
microarray analysis by Feizi et al
82
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The attraction of an aminooxy based compound for Feizi et al was the minority of 
ring closed oligosaccharide in the equilibrium mixture formed. Previous 
immobilisation techniques either required chemical synthesis of the ligand, limiting 
the number of compounds available compared to isolated natural products, or relied 
on reductive amination as a method of choice, a process that leaves core 
monosaccharides in a ring opened state (example compound shown in Figure 30).  
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Figure 30: Immobilisation of oligosaccharides using reductive amination
82
 
 
An aminooxy based approach makes up for many of the shortcomings of reductive 
amination, which can be unsuitable for smaller saccharides or systems where the 
core saccharides contribute to strong binding because of the ring opened structure of 
the resulting ligand.  
 
Feizi et al produced a series of primary aminooxy based neoglycolipids to 
investigate any differences in lectin binding compared to equivalent neoglycolipids 
produced via reductive amination.
82
 They first conducted an NMR study using a 
primary aminooxy based test compound (shown below Figure 31) to confirm that 
ring closed saccharides would be present. Their results, that 15% of the mixture was 
ring closed in solution, are supported by Thygesen et al who found up to 20% of the 
equilibrium mixture was ring closed in their previous NMR studies using a variety of 
mono, di and trisaccharides.
82, 85
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Figure 31: Compound used by Feizi et al to investigate the proportion of ring closed 
sugar at equilibrium
82
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Feizi et al then produced Le
x
 trisaccharide probes using primary aminooxy ligation, 
secondary aminooxy ligation and reductive amination (Figure 32).  
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Figure 32: Neoglycolipid probes used by Feizi et al in microarrays
82
 
 
Their binding to anti-L5 and anti-SSEA-1 antibodies was compared in a microarray 
format. These antibodies were chosen because previous work showed they require 
intact core monosaccharides for binding.
86
 Neither antibody bound the ring opened, 
reductive amination based probes and both bound with primary aminooxy based 
probes.
82
 Results from secondary aminooxy probes were more complex, with no 
binding to anti-SSEA-1 observed but significant binding to anti-L5, with the 
fluorescence three times that of the primary aminooxy probe (~30,000 and ~10,000 
flourescence units respectively at 7 fmol, possibly due to the greater proportion of 
ring closed sugar in secondary aminooxy compounds).
82
 The group suggested that 
having a methyl group close to the anomeric position might interfere with anti-
SSEA-1 recognition.
82
 
 
As a result Feizi et al decided to concentrate on primary aminooxy probes, 
contrasting them with reductive amination based probes for a wide range of lectins 
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and ligands. Results for the three siglecs tested broadly supported the suggestion that 
siglecs interact with monosaccharides distant from the primary binding site.
82,
 
87
 All 
siglecs (hSiglec-7, hSiglec-9 and mSiglec-E) exhibited differences in binding to 
primary aminooxy and reductive amination probes bearing the same ligand. Each 
siglec tested showed markedly stronger binding to a primary aminooxy probe 
bearing trisaccharides NeuAcβ-3Galβ-4Glc, compared to the ring opened equivalent. 
hSiglec-7 showed little appreciable binding to other primary aminooxy or reductive 
animation based probes but hSiglec-9 and mSiglec-E both showed preferences for 
two other carbohydrate ligands in the series, both primary aminooxy probes.
82
  
 
These results underline the importance of the pyranose form to binding interactions 
with a variety of lectins. While primary aminooxy ligation allows the possibility of a 
pyranose structure the majority is in the ring open form, potentially reducing binding 
interaction compared to a linkage that traps the glucoside in a pyranose form. When 
larger or longer polysaccharide chains are employed primary aminooxy groups can 
be effective and the minority of ring closed saccharide in solution allows some 
binding even in smaller ligands. However when monosaccharides are employed the 
pyranose form is highly desirable, which contributed to the choice of secondary 
aminooxy functionality as a ligation strategy in this project.  
 
So far the majority of secondary aminooxy linked therapeutics have shown moderate 
to low activity.
 75, 79, 88 
Some of the most detailed studies have focused on digitoxin, 
aiming to improve the drug’s anticancer properties.76 Digitoxin’s target, Na+, K+-
ATPase, is unregulated in several cancers and previous studies have shown replacing 
the molecule’s natural trisaccharide with certain monosaccharides improves the 
drugs performance against several cell lines.
79
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Figure 33: Mono and trisaccharides digitoxin analogues
79
 
 
Iyer et al screened the mono and tri saccharide analogues shown above in Figure 33, 
against a library of 58 cancer cell lines which consistently showed lower GI50 
concentrations for the monosaccharide. The improvement against colon cancer line 
HCT-116 and melanoma line SK-MEL-5 was particularly marked, going from 5.4 
nM in the monosaccharide to 25 nM in the trisaccharide for HCT-116 and from 5.5 
nM to 37.1 nM for SK-MEL-5.
79
 
 
Work on digitoxin analogues by Iyer et al went on to directly compare the cytotoxic 
effects of aminooxy linked variants of these O-glycosidic compounds (Figure 34).  
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Figure 34: O-glycosidic and aminooxy linked digitoxin analogues.
79
 
 
Aminooxy compounds showed lower anti-cancer activity in all cell lines screened, 
but patterns of selectivity and relative potency seemed to be retained.
79
 In apoptosis 
assays against NCI-H460 cells the monosaccharide analogues for both O-glycosidic 
and aminooxy compounds were consistently more potent, followed by the di and 
trisaccharides. But the difference in potency between O-glycosidic and aminooxy 
analogues was marked, with the O-glycosidic monosaccharide inducing apoptosis in 
72% of cells at the highest concentration while the aminooxy equivalent only 
induced apoptosis in 30%.
79
 Screening against four cancer cell lines with both sets of 
compounds showed broadly similar selectivity patterns, with the two 
monosaccharide analogues both having their lowest IC50 concentrations against NCI-
H460 cells (11 nM and 24 nM for the O-glycosidic and aminooxy analogues 
respectively).
79
 However there were some exceptions: the aminooxy trisaccharide 
analogue showed much greater potency than expected against SK-OV-3 cells, with 
an IC50 similar to the aminooxy monosaccharide (0.86 µM and 0.98 µM 
respectively).
79
 In contrast the O-glycosidic trisaccharide had lower activity against 
SK-OV-3 than the O-glycosidic monosaccharide (0.097 µM and 0.05 µM 
respectively), demonstrating that while useful aminooxy compounds do not perfectly 
predict their O-glycosidic equivalents.
79
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Given the synthetic difficulty involved in preparing O-glycoside analogues of 
complex pharmaceuticals the similar selectivity and potency patterns of aminooxy 
analogues, coupled with the discovery that both sets of analogues had a similar 
mechanism of action, is a significant find.
79
 It suggests screening libraries of 
aminooxy based compounds could be used to confidently predict the properties, 
potency and mechanism of action of O-glycosidic therapeutics.  
 
Producing secondary aminooxy Tris scaffolds would enable us to compare their 
ligand properties with the click-coupled O-glycosides described earlier (Chapter 2) 
and investigate whether the aminooxy scaffold patterns of activity and selectivity are 
similarly predictive of O-glycoside properties.  
 
3.2 Attempts to synthesise tri-aldehyde bearing scaffolds 
 
One of the most common synthetic strategies for producing aminooxy functionalised 
molecules is to reduce oximes previously produced by reacting aminooxy salts with 
aldehydes. As a result a tri-aldehyde Tris scaffold was thought to be the most 
convenient route to the tri-aminooxy. The intended route is shown in Scheme 17.  
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Scheme 17: Proposed route to tri-oxime scaffold 
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Direct coupling of aldehydes seemed likely to be problematic: formation of hydrates 
can occur under the basic conditions used in the substitution reaction, suitable short 
linkers are not readily commercially available and common synthetic routes involve 
forcing conditions heating in strong acid.
89
  Synthetically, 3-bromopropanal is 
commonly used to introduce bromide functionality
90, 91
 while 2-bromoethanal is 
generally used to create fused ring systems.
92, 93
 Both applications suggest that the 
aldehydes are reasonably reactive and that protection would be a sensible precaution 
to prevent side reactions. 
 
2-bromoethyl-1, 3-dioxane was chosen as a simple, commercially available molecule 
with masked aldehyde functionality. The dioxane protecting group can be easily 
removed with acid and the subsequent steps, shown on benzaldehyde in Scheme 18, 
which proceed in good yield on a wide variety of scaffolds are a common route to 
the desired aminooxy functionality.
 94, 95, 96 
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Scheme 18: Common synthetic route to aminooxy functionality and neoglycoside 
equivalent.
77,
 
97, 98
 
 
The reaction shown in Scheme 19 was attempted under a variety of conditions, using 
different bases, additives, and equivalents of reagents (Table 2). Where a mixture of 
water and THF was used, the hydroxides were added as an aqueous solution, in dry 
solvent they were added as a finely ground powder. In each case the Tris scaffold 
was mixed with the base then the dioxane was added. All reactions were carried out 
overnight. 
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Scheme 19: Proposed method to couple Tris and 2-bromoethyl-1, 3-dioxane 
 
Equiv 
Dioxane 
Base Equiv 
Base 
Solvent Temp Additives 
5 KOH 4 THF:water RT NA 
5 NaOH 4 THF:water RT NA 
5 NaH 4 dry DMF RT NA 
5 NaH 4 dry THF RT NA 
5 KOH 4 dry DMF RT NaI 
5 NaH 4 dry DMF RT NaI 
5 KOH 6 dry DMF RT NA 
6 KOH 6 dry DMF 50
o
C NA 
Table 2: Conditions for coupling attempts 
 
Under the conditions tested coupling to the Tris scaffold was not detected by proton 
or carbon NMR. 2-Bromoethyl-1, 3-dioxane was recovered in all cases, often as a 
mixture with 2-vinyl-1,3 dioxane which was produced by decomposition of the 
starting material under basic conditions. The Tris starting material was detected but 
not recovered as its high aqueous solubility meant it was removed during the work 
up. 
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Scheme 20: Decomposition of 2-bromoethyl-1,3 dioxane via E2 elimination. 
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A greater proportion of the alkene side product was observed when sodium hydride 
was used as the base. Since the electrophile used in this case is a primary alkyl halide 
the elimination mechanism is likely to be E2 and the desired substitution is likely to 
be SN2. E2 elimination is encouraged by stronger, less hindered bases, so recovering 
a greater proportion of the elimination product with sodium hydride is not surprising. 
The mechanism for this decomposition is shown above in Scheme 20.  
 
Generally the vinyl-1,3 dioxane was recovered and no coupling with the Tris was 
detected. Since no coupling was observed it was concluded that the Tris scaffold was 
unreactive towards the dioxane.  
 
An alternative strategy was envisioned using tri-nitrile substituted Tris and followed 
by conversion to the tri-aldehyde. The tri-nitriles shown below in Scheme 21  had 
been previously synthesised in good yield and was chosen partly on this basis.
99
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Scheme 21: Synthesis of tri-nitrile Tris compounds 13 and 14. 
 
Compound 14 was originally synthesised from Boc protected Tris 1, however the 
yield using this method was much lower (9%) and as a result the procedure 
illustrated above in Scheme 21 was preferred.  
 
Presence of the Boc group in 14 was suggested by a prominent carbonyl peak in the 
IR at 1708 cm
-1
 and confirmed by strong, characteristic peaks in the proton and 
carbon NMR. Strong peaks for Boc methyl groups were found at 1.42 ppm in the 
proton and 28.4 ppm in the carbon NMR, while the carbonyl was present at 154.9 
ppm.  
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The presence of the nitrile groups was supported by IR with signals in at 2251 cm
-1
 
for both 13 and 14 characteristic of aliphatic nitriles. Further support came from the 
carbon NMR with the nitrile carbon present at 118.1 ppm for 13 and at 118.0 ppm 
for 14. Structures of both compounds were confirmed by mass spec, MNa
+
 ions were 
found for both 13 and 14 at 302.9 m/z and 403.0 m/z. 
 
Although multiple reagents are used for conversion of nitriles to aldehydes in the 
literature more reactive reducing agents, such as diisobutylaluminum hydride 
(DIBAL) and lithium aluminium hydride are necessary for the reaction to proceed in 
aliphatic nitriles.
100
 Reaction with lithium aluminium hydride and metal 
hydrogenation catalysts can risk reducing nitriles too far. DIBAL is known to 
reliably produce the aldehyde. It was thought that using DIBAL would prevent the 
formation of mixed products, with a combination of terminal aldehyde, alcohol and 
possibly amine functionalities on the scaffold.  
 
Conversion was attempted both with the Boc protected (14) and unprotected tri-
nitrile scaffold (13). Different reaction times, temperatures and quenches were used 
(Table 3). Dry solvents and glassware were used throughout and 4.5 equivalents of 
DIBAL were added over at least five minutes in each case. The initial test reaction 
was conducted using DIBAL that was over a year old and the starting material was 
recovered which led to replacement of the DIBAL stock. The DIBAL used 
subsequently had been open for less than a month, ensuring that degradation of this 
reagent was not a factor. 
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Scheme 22: Proposed route to tri-aldehyde via nitrile, from compounds 13 
(unprotected) and 14 (Boc protected). 
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Starting 
Material 
Time Quench Temp  
o
C 
13 20min water -5 
13 1 hr water -5 
13 2 hr water -5 
13 3 hr water -5 
14 1 hr water -5 
14 2 hr water -78 
14 2 hr methanol -78 
Table 3: Conditions for attempted nitrile conversion 
 
Unfortunately no aldehyde conversion was detected under the reaction conditions 
used. Use of active DIBAL resulted in significant mass loss with only the starting 
material and solvents readily identifiable in the crude. A greater proportion of 
starting material was recovered when shorter reaction times were used and when the 
Boc protected 14 was used under comparable conditions. Conducting the reaction at 
lower temperature and varying the quench in an attempt to reduce decomposition did 
not improve the reaction.  
 
Typical proton NMRs of the crudes produced showed strong peaks corresponding to 
the starting material and DCM. Experiments using 13 showed multiple broad peaks 
in the region 1-2 ppm, likely decomposition products, and multiple small peaks at 
approximately 9.8 ppm which could be residual aldehyde containing compounds. 
Any aldehyde present was in minority, with integration of the collected peaks having 
a ratio of approximately 1:18 compared to one proton from the starting material. 
Experiments using 14 showed less of the broad decomposition peaks upfield and a 
higher proportion of possible aldehyde peaks at 9.8 ppm (ratio of approximately 1:9 
compared to one starting material proton). Formation of some aldehyde was 
supported by carbon NMR, showing a small peak at 201.15 ppm. Longer reaction 
times at lower temperature, in an attempt to assure conversion while reducing 
decomposition, resulted in greater mass loss and the absence of even small quantities 
of aldehyde from the crude.  
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It was concluded that either the aldehyde was formed but unstable or the starting 
materials used decomposed under the reaction conditions more quickly than the 
aldehyde was formed. 
 
Finally, inspired by Willand-Charnley et al, a strategy was developed based on 
ozonolysis. Work by this group suggests that pyridine catalyses ozonolysis 
reactions.
101
 This was of interest since the standard conditions used to convert 
aldehydes to oximes are stirring with an aminooxy salt in the presence of a tertiary 
amine base such as pyridine.
98,
 
102
 A one-pot, two step conversion directly to the 
desired tri-oxime was envisioned (Scheme 23).  
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Scheme 23: Proposed one-pot ozonolysis conversion 
 
In order to confirm that conversion to the oxime was possible under ozonolysis 
conditions, a test reaction was carried out using styrene. The reaction was carried out 
under standard ozonolysis conditions, all reagents and solvents were dried and a 
mixture of pyridine and dichloromethane used as solvent (1.1:1). 2.5 equivalents of 
O-methylhydroxyamine hydrochloride was added, the mixture cooled to -78
o
C and 
ozone bubbled through for 45 minutes. The reaction was then purged with oxygen 
and quenched with dimethylsulfide. The mixture was extracted and washed with 
water repeatedly to reduce the presence of pyridine before investigation of the crude 
mixture by proton and carbon NMR. 
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Scheme 24: One-pot conversion of alkene to oxime 
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Styrene was completely consumed. Formation of both benzaldehyde and O-
methylbenzaldehyde oxime 43 was observed by NMR but the mixture was not 
purified and the oxime not isolated. Characteristic peaks for both compounds were 
clearly visible in the proton spectrum, the initial mixture was estimated to be 7:3 
oxime to aldehyde with pyridine also present. The presence of both compounds was 
further confirmed by carbon NMR. The mixture was then left to stir overnight, since 
oxime formation was expected to be the slower reaction. The proportion of oxime 
compared to aldehyde was indeed seen to increase, though only slightly. The 
conversion under these conditions was estimated at 74% by integration of proton 
NMR peaks. 
 
 
Figure 35: Proton NMR of one pot ozonolysis reaction in the presence of O-
methylhydroxylamine hydrochloride (H2NOMe.HCl) with styrene in CDCl3. 
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Figure 36: Carbon NMR of one pot ozonolysis reaction in the presence of O-
methylhydroxylamine hydrochloride (H2NOMe.HCl) with styrene in CDCl3. 
Aldehyde peak and O-methylbenzaldhye oxime peaks highlighted. Allyl peaks 
absent. 
 
Encouraged by this result tri-allyl Tris compound 15 was synthesised as shown 
below in Scheme 25. 
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Scheme 25: Synthesis of tri-allyl Tris 15 
 
Proton and carbon NMR both strongly suggested the reaction had been successful. 
The allyl CH was observed at 5.93-5.83 ppm in the proton and at 134.9 ppm in the 
carbon while the terminal CH2 carbon was seen at 116.9 ppm with proton peaks at 
5.28-5.14 ppm, consistent with the product. The structure was confirmed by mass 
spec with a significant mass ion at 364.0 m/z, consistent with MNa
+
. 
 75 
 
 
Once satisfied that 15 had been synthesised the one pot ozonolysis reaction was 
attempted. Conditions used were similar to the conditions used in the styrene test 
reaction (three equivalents of aminooxy salt per allyl group were used in reaction 
with 15). Unfortunately neither aldehyde nor oxime were detected by NMR.  
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Scheme 26: One pot ozonolysis reaction attempted with tri allyl Tris compound 15  
 
The crude was subjected to two different work up conditions in order to ensure that 
aldehyde or oxime containing products were not being removed by, or reacting with, 
aqueous washes. Aqueous organic extraction resulted in an NMR spectrum that 
mostly showed solvent peaks. A group of broad peaks at 1.57-1.41 ppm might have 
represented the Boc group but other characteristic peaks relating to the scaffold, 
including methylenes, methoxy and allyl peaks were absent.  
 
Alternately, concentrating the crude and washing with small volumes of hexane did 
not entirely remove pyridine or the DMSO side product caused by quenching the 
ozonolysis reaction. No obvious aldehyde or oxime peaks were observed. Small 
peaks were seen at 1.32, 1.26, 3.97 and 3.70 ppm. These did not seem to correlate to 
peaks on the intact Tris scaffold.  
 
A carbon NMR was taken of this sample in an attempt to understand what the 
mixture was decomposing in to and confirm that mixed allyl, aldehyde and oxime 
substituted scaffolds were not present. DMSO was clearly visible and although at 
first glance it appeared to contain pyridine the expected peak at 136.0 ppm was 
absent. The loss of peaks at 134.9 ppm and 116.9 ppm confirmed that the allyl 
functionality had been completely consumed during the reaction. Unidentified peaks 
were observed at 163.3, 143.4, 143.3, 126.3 and 28.0 ppm. The minor peak at 28.0 
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ppm suggested Boc methyl groups but the corresponding carbonyl peak at 
approximately 155 ppm was not visible. The peak at 163.3 ppm was too low to 
represent aldehyde formation and higher than usual for an oxime, which generally 
occur at 155-145 ppm
103, 104
 although they can come in the mid to high 160s when 
electron withdrawing groups are present.
105
 The two prominent peaks at 143 ppm 
were also within the range of possible oxime shifts but the absence of a peak at 
approximately 62 ppm showed the expected methoxy was not present. The lack of 
peaks at approximately 75-70 ppm suggested both methylene groups associated with 
the scaffold were absent.  
 
It was concluded that the starting material was completely decomposing into an 
unidentifiable mixture, possibly on warming the ozonolysis mixture to room 
temperature. As oxime formation is probably the slow step and allyl groups were 
consumed during the reaction, it seemed likely that the aldehyde was formed and 
decomposed.  
 
It seemed reasonable at this point to assume that any aldehyde containing Tris 
scaffold formed was unstable. The mass loss observed during attempted nitrile 
conversions, combined with the lack of intact Tris in the ozonolysis mixture, 
supported this conclusion.  
 
Common alternative approaches to the desired aminooxy include substitution and 
conversion of phthalimide, which is cleaved with hydrazine, converted to an oxime 
and then reduced giving an R-O-N structure that links the aminooxy to the desired 
scaffold. An example is shown in the scheme below. 
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Scheme 27: An alternative strategy for introducing aminooxy groups 
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Although it was considered, this standard route required multiple synthetic steps on 
the scaffold and multiple purifications also seemed likely. A shorter, or convergent, 
route was thought to be more convenient. With this in mind we began to consider 
click chemistry as a method for introducing aminooxy functionality.   
 
3.3 Using click chemistry to attach aminooxy functionality 
 
As synthesising the tri-aldehyde scaffold had so far failed, with degradation under 
relatively mild conditions, an alternative approach seemed necessary. Propargyl 
groups had previously been coupled to Tris scaffolds as part of the project (see 
Chapter 2) and click reactions with azide linked monosaccharides had been carried 
out successfully, though yields varied. Using click chemistry to attach aminooxy 
functionality directly therefore seemed like a reasonable route to the target scaffold 
shown below. 
 
NHBoc
O
O
O N
NN
N
N
N
NN
N
N
H
NH
HN
O
O
O
 
Figure 37: Target tri-aminooxy Tris scaffold 
 
Attention shifted to producing a small linker containing both aminooxy and azide 
functionality. Ideally the link between them would be an ethyl chain since this would 
give any sugar substituted aminooxy scaffolds the same size and spacing between 
sugars as equivalents synthesised by directly clicking azide linked sugars to the tri-
propargyl scaffold 2. Any difference in lectin binding between them would then be 
due to the differing functionality at the anomeric position or the labile nature of the 
aminooxy bond.  
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The previously synthesised azido-ethanol 3 seemed a reasonable starting point. It 
was proposed that the alcohol group could be replaced with the target aminooxy via 
a simple substitution by first converting the alcohol to a tosyl group (Scheme 28).  
 
Concurrently a route starting from bromoethanol was investigated since direct 
conversion from alcohol to azide groups is known (Scheme 28).
106,
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Scheme 28: Proposed routes to azide, aminooxy linker 
 
Synthesis of 2-azidoethyl tosylate 16 was straightforward but low yielding (9%). The 
tosylate 16 was refluxed in ethanol with three equivalents of the aminooxy salt and 
sodium hydroxide was added (to produce the neutral O-methylhydroxylamine in 
situ). The mixture was monitored by periodic NMR of samples taken from the 
reaction. Over three days the observed tosylate 16 decreased but product formation 
was not observed. As a result this route was abandoned. 
 
The alternative route, starting from bromoethanol, to give of 2-methoxyamino 
ethanol 17 was similarly low yielding although it was improved by using a solution 
of the free O-methylhydroxylamine rather than the equivalent hydrochloric salt 
(from 4% to 17%). An attempt was made to convert 17 directly to the desired azide 
using conditions similar to those suggested by Rokhum et al illustrated below in 
Scheme 29.
107
 This paper theorised that by adding sodium azide to a mixture 
classically used to convert alcohols to iodides the desired azide might be isolated in a 
one-pot process, they successfully applied the method to a variety of alcohols. The 
reported reactions were fast and high yielding.
107
  
 
A solution of the alcohol 17, sodium azide and imidazole was mixed with a solution 
of triphenylphosphine and iodine. The mixture was monitored by periodic proton 
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NMR, with samples removed, quenched with sodium thiosulfate solution, extracted 
with ethyl acetate and subjected to a small-scale aqueous work up. Neither the 
desired product nor the alcohol starting material were detected by NMR, although 
triphenylphosphine and imidazole were both visibly present. Absence of the 
expected triplets was especially troubling as it indicated that the ethyl chain was 
missing. 
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Scheme 29: Direct conversion of 2-methoxyamino ethanol to N-(2-
azidoethyl)methylhydroxyamine failed 
 
Given the disappearance of the starting materials in both reactions and the absence of 
obvious side products it seemed reasonable to conclude that the product was forming 
and either unstable or difficult to isolate. In both cases only the reaction solvent and 
additives such as triphenyl phosphine were observed by NMR after aqueous work 
up. High aqueous solubility or low boiling point were both possible and would have 
made the product extremely difficult to isolate with the work up conditions 
employed.  
 
To reduce any instability and avoid complicated work up procedures, O-
methylhydroxylamine was Boc protected, which should limit the possibility of side 
reactions, raise the boiling point and lower the aqueous solubility of the resulting 
linker. Boc groups could be removed once the azide linker had been coupled to the 
desired scaffold, giving the free aminooxy as planned.  
 
Initially reaction directly with bromoethanol was attempted, as shown in Scheme 30 
and detailed in Table 4, in the hope of avoiding further protection and deprotection 
steps. Reactions using triethylamine as the base also used it as the reaction solvent, 
while reactions with sodium hydride used dry THF. Initial reactions with 
triethylamine, using two equivalents, were conducted in the dark although 
subsequent reactions were carried out allowing exposure to light with no difference 
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in results. In each case the expected product was not detected though both starting 
materials were present. The reactions were monitored by periodic NMR of samples 
but later synthesis and characterisation of the target compound 21 confirmed that the 
product was not present. 
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Scheme 30: Attempted coupling of bromo ethanol and Boc-protected aminooxy 
 
Base Time Temperature
 
o
C 
Equiv 
Base 
NEt3 2 days RT 2 
NEt3 3hr 50 2 
NEt3 5hr 50 2 
NEt3 5hr 50 3 
NEt3 overnight 50 2 
NaH 1hr RT 1.1 
NaH overnight RT 1.1 
Table 4: Conditions used for attempting reaction of bromoethanol and Boc protected 
aminooxy 18 
 
Triethylamine was initially used as the base since it was expected that the pKa of the 
aminooxy based material would be much lower than the pKa of bromoethanol which 
is thought to have a pKa of 13-14. The pKa of O-methylhydroxylamine and N,O 
dimethylhydroxylamine are known to be approximately 4.60 and 4.75 respectively, 
the Boc protected aminooxy derivative was expected have a similar pKa or lower 
due to the conjugating effect of the Boc carbonyl.
108
 It was therefore expected that 
even an excess of triethylamine would deprotonate the aminooxy group in preference 
to the alcohol.  
 
Use of a stronger base such as sodium hydride would have ensured deprotonation of 
the aminooxy starting material 18 but even under these conditions no product 
formation was observed. Before NMR monitoring, sodium hydride reactions were 
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quenched with methanol and concentrated while the concentrated triethylamine 
reactions were diluted with deuterated solvent. Under these conditions previous 
issues due to possible water solubility or low boiling points seemed unlikely to be 
the problem. The most likely explanation for the lack of observed product was that 
the reaction was simply not occurring. 
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Scheme 31: Possible resonance structures of the deprotonated aminooxy starting 
material, 18 
 
This could be due to the presence of the Boc group which stabilises the conjugate 
base as shown by the resonance structures in Scheme 31. If sufficiently stabilised the 
anion may not react with bromoethanol. Alternative protecting groups would prevent 
this problem but the use of Boc was particularly attractive as it would allow 
aminooxy groups and the amine of the eventual scaffold to be deprotected 
simultaneously.  
 
More forcing conditions could have been applied in an attempt to drive the reaction 
but it seemed likely to result in the degradation of the starting materials and result in 
the alcohol group participating in side reactions.  
 
Instead bromoethanol was acetate protected, giving 19, to prevent the alcohol 
participating in the reaction. Since the aminooxy starting material 18 was thought to 
be stable the reaction was originally conducted using an excess of sodium hydride (3 
equivalents) to ensure deprotonation of 18, while a small amount of iodine (0.1 
equivalents) was mixed with the acetate protected starting material 19 in order to 
produce the more reactive 2-iodoethyl acetate in situ. Product was detected by proton 
NMR of the crude mixture when the procedure was performed using dry solvents, in 
the dark, overnight with a two-fold excess of 2-bromoethyl acetate, 19.  
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Scheme 32: Initial coupling conditions for production of 20 
 
Shifts in the suspected CH2 signals adjacent to the bromine or aminooxy group from 
3.50 ppm to 3.72 ppm strongly suggested product formation, but this put the CH2 
signal in the same region as the expected methoxy signal. COSY experiments 
confirmed that the signal at 3.71-3.68 ppm was interacting with a signal at 4.23 ppm, 
suggesting that these were the ethyl protons. HSQC showed that the signal at 3.71-
3.68 ppm was made up of two environments, with carbons at 62.5 ppm and 47.9 ppm 
consistent with the expected ethyl and methoxy groups rather than impurities. This 
confirmed the idea that the multiplet represented overlapping ethyl and methoxy 
peaks. Successful synthesis was further confirmed by carbon NMR and mass 
spectrum.  
 
However the product could not be isolated. Attempts at column chromatography on 
silica resulted in significant loss of material with proton NMRs of isolated fractions 
showing more peaks, especially those associated with degradation, than the original 
crude. After several unsuccessful attempts it was theorised that the product 20 was 
either reacting with, or sticking to, the silica column. Adding clean, dry silica to 
NMR samples of the crude material caused a loss of the product signals. Attention 
therefore shifted from purification method to the reaction procedure in the hope that 
a higher quality crude could be produced and used without further purification.  
 
Replacing iodine with sodium iodide, which is a better source of iodide in solution, 
resulted in reduced observable side products. The major impurities in the crude when 
this method was used were DMF (the chosen solvent) and 2-bromoethyl acetate 19, 
which could both be significantly reduced by repeated aqueous washes and long 
periods under vacuum.  
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Scheme 33: Synthetic route to tert-butyl 2 hydroxyethyl(methoxy)carbamate 
 
Following these adjustments to the procedure acetate deprotection was attempted on 
crude 20. This was successful under Zemplén conditions as shown in Scheme 33. 
Aqueous work up was avoided in case the product was water soluble, the mixture 
was instead filtered through activated protonated cation exchange resin and solvent 
removed giving the expected alcohol 21 in reasonable yield (47% over two steps 
from 18) and good purity. 
 
Once isolated direct conversion of the alcohol to an azide was attempted again. 
Initially the conditions favoured by Rokhum et al were used and the reaction 
progress investigated by NMR.
107
 Samples were quenched with sodium thiosulfate 
solution, extracted with chloroform, subjected to aqueous washed and dried over 
magnesium sulfate before the residual solvent was removed. A sample was taken 
after an hour, as there was a rapid loss of colour in the mixture over this period, but 
the NMR showed only starting materials. Further samples were taken after leaving 
the mixture overnight with the same result. 
 
A similar strategy was then attempted, using a mixture of triphenyl phosphine, 
tetrabromomethane and sodium azide in dry DMF as shown below in Scheme 34. As 
with the previous method the reagents facilitate the conversion of an alcohol to a 
halide, which is then converted in situ to the desired azide. After stirring overnight 
only the starting materials were detected by NMR. 
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Scheme 34: One pot conversion of alcohol to azide via halides was unsuccessful 
 
As the starting materials were recovered it seemed reasonable to assume that 
conversion to the halide was not taking place under the conditions employed. An 
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alternative strategy utilising a combination of DPPA, DBU and sodium azide was 
next attempted. This method produces an activated phosphate compound which then 
reacts to form the desired azide.  
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Scheme 35: Proposed one-pot route to azide linker, 24 
 
The reaction was conducted under anhydrous conditions and stirred overnight before 
quenching with dilute acid and extracting with chloroform. As proton NMR of the 
crude showed a combination of starting materials and possible products the mixture 
was purified by column chromatography on silica.  
 
The isolated product was originally thought to be a mixture of the desired azide co-
eluting with a phenyl phosphate as there was a clear shift in ethyl triplets in the 
proton NMR but aromatic peaks were also still present. Purification by column 
chromatography was attempted a second time but the mixture appeared no purer 
which prompted further characterisation to confirm that the mixture contained azide. 
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Scheme 36: Synthesis of phosphate 22 
 
IR spectroscopy was deemed unsuitable: excess DPPA had been used and if the 
observed phenyl peaks were due to DPPA an azide peak would be visible at 
approximately 2100 cm
-1
 even if the desired product was not present. Phosphorous 
NMR confirmed that a single phosphate environment was present in the mixture. 
Close examination of the carbon NMR revealed splitting in both the aromatic and 
CH2 environments of the linker. This indicated that the phosphorous was in close 
proximity to the ethyl chain. Both CH2 peaks appeared as doublets: at 65.23 ppm 
with a coupling constant of 6.2 Hz and at 49.66 ppm with a coupling constant of 8 
Hz. This suggested that the pure phosphate 22 had been isolated rather than a 
 85 
 
mixture of azide and phosphate containing components. Mass spectra confirmed that 
22 had been synthesised.  
 
 
Figure 38: Carbon NMR of phosphate 22 with splitting in the aromatic and ethyl 
carbons shown. 
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Figure 39: Carbon NMR of phosphate 22 with O-CH2 and methoxy carbons shown, 
splitting in O-CH2 present. 
 
Several attempts were then made to convert the phosphate 22 to the desired azide 
(Scheme 37). The progress of the reaction was monitored by phosphorous NMR, if 
conversion to the azide occurred then new phosphorous peaks were expected to 
appear. The phosphate was dissolved in 1,4 dioxane, a large excess of sodium azide 
added and heated to 50
o
C. NMRs were taken after three hours and after leaving 
overnight but the phosphate starting material still visible in each. The mixture was 
then heated to reflux. After stirring overnight the results were investigated by NMR 
and once again only the starting material was observed. Finally an excess of DBU 
was added to the refluxing mixture in order to further solubilise the sodium azide. 
After refluxing overnight the mixture was then extracted with chloroform, washed 
with brine, dried over magnesium sulfate and the solvent removed. This gave a pale 
oil which appeared to be a mixture of DBU, starting material and degradation 
products by NMR. 
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Scheme 37: Isolated phosphate could not be converted to azide 
 
Following failure to produce the azide from the isolated phosphate the idea of a one-
pot conversion directly from alcohol 21 was abandoned in favour of a traditional two 
step procedure. Mesylate 23 was synthesised in reasonable yield with no further 
purification necessary as shown in Scheme 38. 
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Scheme 38: Proposed synthetic route to the azide 24 via mesylate substituted linker 
23 
 
The mesylate was originally identified by proton and carbon NMR. As expected the 
O-CH2 triplet shifted from 3.77 ppm to 4.36 ppm, shift in the N-CH2 triplet from 
3.60 ppm to 3.78 ppm was also observed along with a characteristic singlet at 3.02 
ppm for the sulfonate methyl group. The sulfonate methyl was also observed in the 
carbon NMR at 37.7 ppm. Its identity was confirmed by IR spectroscopy, which 
showed strong peaks at 1350 cm
-1
 and 1171 cm
-1
, consistent with sulfonate groups, 
along with a lack of the distinctive peak at 3435 cm
-1
 showing that the alcohol was 
no longer present. The assignment was further supported by mass spectroscopy, with 
a mass ion 292.1 m/z found in positive ion electrospray, consistent with MNa
+
.  
 
Conversion to the azide (24) was successful though slow but yields were improved 
by warming the mixture to 50
o
C. However full characterisation proved problematic. 
Characteristic IR peaks suggested the product had been synthesised and changes of 
shift in the proton and carbon NMR confirmed this. Sulfonate peaks were absent 
from the IR while a strong peak at 2100 cm
-1
 indicated the presence of azide. 
Likewise proton and carbon NMR strongly suggested the synthesis was successful.  
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Figure 40: Comparison of proton NMRs for mesylate 23 and azide 24 
 
Sulfonate associated peaks were absent from the proton and carbon while large shifts 
were observed for both CH2 groups in the proton and for the azide bound carbon in 
the C
13
 spectrum. Triplets associated with CH2 were detected at 3.63 ppm and 3.46 
ppm, consistent with displacement of the sulfonate in favour of a less electronegative 
group. A similar result was seen in the carbon spectrum, with both CH2 carbons 
appearing upfield compared to the methoxy; the alpha carbon underwent a shift from 
62.7 ppm in the mesylate to 48.5 ppm in the azide. Despite this evidence strongly 
suggesting the presence of product, confirmation by mass spectroscopy was not 
possible. Multiple attempts to obtain spectra using electrospray were made and a 
sample was submitted for accurate mass but in all cases the mass ion was not 
detected. 
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Scheme 39: Click reaction to produce Tris-based aminooxy scaffold 25 
 
Since the azide product 24 was clearly detected by the majority of spectroscopic 
methods available, the reaction was deemed successful and the material carried 
through. Click reaction was successful giving scaffold 25 in 79% yield (Scheme 36). 
Removal of copper salts was difficult in some cases, aqueous washes were 
occasionally sufficient although efficiency was improved by adding small amounts 
of EDTA to the aqueous wash. Column chromatography on silica also appeared to be 
successful.   
 
IR spectra strongly suggested that the click reaction between azide 24 and tri 
propargyl Tris core 2 was successful. Peaks at 2100 cm
-1
 and 3291 cm
-1
 
characteristic of azides and terminal alkynes weren’t present in the spectrum for the 
product 25, suggesting neither functional group was present in 25.  
 
Mass spec provided further confirmation with MALDI showing a prominent peak at 
1007.22 m/z, corresponding well with MNa
+
. High resolution mass spec also 
supported successful synthesis of the scaffold 25, with an intense peak at 984.5460 
m/z, comparing well with the predicted value for MH
+
 of 984.5473 m/z. 
 
Proton and carbon NMR (fully assigned with the aid of COSY and HSQC) 
confirmed that 25 had been synthesised as intended. Peaks associated with the 
terminal alkyne of Tris core 2 (a triplet at 2.42 ppm in the proton and carbons at 79.7 
ppm and 74.7 ppm) were absent. The presence of the triazole was supported by 
observation of characteristic peaks at 7.60 ppm in the proton and in the carbon at 
145.1 ppm (for the quaternary carbon) and 123.5 ppm (for the protonated carbon). 
As discussed in Chapter 2 shifts in this range strongly suggest the expected 1,4 
triazole as opposed to the 1,5 triazole.  
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Protons associated with the ethyl linker shifted downfield on reaction. Protons 
adjacent to the Boc protected aminooxy group came at 3.63 ppm in the azide starting 
material 24 but were visible at 3.94 ppm in the product 25. Larger shifts were 
observed for the protons next to the azide in 24 and the triazole in 25, which shifted 
from 3.46 ppm to 4.59-4.56 ppm on reaction. Shifts in the carbon environments were 
smaller: the azide linked carbon was observed at 48.5 ppm in 24 and the triazole 
linked carbon at 47.3 ppm in 25. The carbon adjacent to the aminooxy environment 
in the linker also shifted slight, from 48.3 ppm in starting material 24 to 49.1 ppm in 
the product scaffold 25. Taken together the spectroscopic data confirms the synthesis 
of Tris based scaffold 25 illustrated below in Figure 41. 
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Figure 41: Boc protected Tris-based aminooxy scaffold 25, and deprotected scaffold 
26 
 
The final scaffold 25, was subjected to global Boc-deprotection. This was initially 
carried out using TFA but this caused degradation of the product in larger scale 
reactions. Hydrochloric methanol was found to give the best results.  
 
The deprotected scaffold 26, shown above in Figure 41, was isolated as a crude and 
not purified further. Estimation by NMR integration suggested impurities were 
minor and impurity peaks in the mass spec were significantly less intense than peaks 
consistent with MH
+
 and MNa
+
 supporting the idea that impurities were present as 
traces.  
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Appearance of a broad peak at 2439 cm
-1
 in the IR (characteristic of N-H in 
ammonium ions) suggested the deprotection reaction was successful which was 
supported by intense peaks in the mass spec at 584.3 m/z (MH
+
) and 606.3 m/z 
(MNa
+
).  
 
Confirmation was provided by the NMR. Scaffold 26 was not soluble in chloroform, 
suggesting a more polar compound than the starting material 25 which supported the 
idea that a salt had been created. The change of solvent and pH for the NMR makes 
direct comparison of the shifts in spectra for Boc protected starting material 25 and 
deprotected scaffold 26 problematic as changes to both are known to effect chemical 
shift. However Boc protecting groups tend to show intense, characteristic peaks in 
both the proton and carbon spectra, which were present in spectra of 25 and absent in 
spectra of 26. Proton spectra of 25 showed two strong peaks at 1.40 ppm, associated 
with the methyls of the Boc protecting groups. Additionally 25 showed strong peaks 
in the carbon NMR at 155.7 ppm and 154.9 ppm, consistent with Boc carbonyl 
groups, as well as at 28.5 ppm and 28.2 ppm, consistent with the methyl carbons. 
Less intense peaks were observed in the carbon spectrum of 25 both at 82.2 ppm 
which were identified as the quaternary carbons of the Boc groups. All of these 
characteristic peaks were absent from spectra of product 26, confirming that the Boc 
groups had been removed. 
 
With a successful route to the secondary aminooxy substituted Tris scaffold 26, 
(Figure 41), available the focus shifted to reaction with free sugars. The results of 
these experiments are discussed in the following chapter. 
 
3.4 Chapter Summary 
 
Initially attempts to produce an aminooxy functionalised scaffold focused on 
introducing aldehydes to the Tris scaffold as these could be easily converted to the 
oxime by reaction with aminooxy salts. This was unsuccessful, attempts are 
summarised below (Scheme 40). 
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Scheme 40: Attempts to synthesis Tris scaffold with attached aldehydes failed 
 
Conversion was attempted via the alkene using a one pot procedure: ozonolysis in 
the presence of pyridine and O-methylhydroxylammonium chloride. Test reaction 
with styrene was successful, however reaction with allyl substituted Tris scaffold 15 
was not. Under the reaction conditions 15 appeared to decompose. 
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Scheme 41: One pot ozonolysis conversion of allyl groups to oximes was successful 
in test reactions but not using Tris compound 15 
 
Next we attempted to produce aminooxy substituted Tris scaffolds using click 
chemistry to introduce aminooxy groups to the scaffold. A suitable azide linker with 
a Boc protected aminooxy group was synthesised using the route shown below in 
Scheme 42. 
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Scheme 42: Synthetic route to short linker with aminooxy and azide functionality 
 
Click reaction between propargyl Tris 2 and azide linker 24 proceeded in good yield 
(79%) as shown below in Scheme 43.  
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Scheme 43: Synthesis of target scaffold 25 
 
Boc deprotection then gave the desired scaffold (isolated as crude) illustrated below 
in Figure 42 subsequent experiments focused on reaction with free sugars and are 
discussed in the following chapter. 
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Figure 42: Target Tris based scaffold 26 with secondary aminooxy functionality 
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4. Further Investigation of Aminooxy substituted Tris scaffolds 
and chemoselective ligation 
 
4.1 Initial incubation experiments 
 
The Boc deprotected Tris scaffold 26 was synthesised as the hydrochloride salt. Its 
initial pH in solution, according to pH paper, was ~1. Adjusting the pH to a higher 
value was deemed preferable. Although reaction between aminooxy moieties and 
unprotected sugars requires acidic conditions, previous work by Finlay strongly 
suggested that milder conditions resulted in a higher percentage conversion.
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 Initial 
experiments were not conducted in the presence of lectins but it was felt that 
confirming formation of the sugar substituted product (such as the galactose example 
illustrated in Scheme 44) should be done with biologically compatible conditions in 
mind. 
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Scheme 44: Example of proposed sugar-aminooxy coupling on Tris scaffold 26, 
using galactose 
 
The initial investigation was conducted in D2O to allow detailed periodic monitoring 
of the mixture by proton NMR. Deprotected scaffold 26 was dissolved in D2O and 
the pH*, the observed pH in a deuterated solvent, adjusted by careful addition of 
10wt% NaHCO3 in D2O to ~pH* 5 (monitored using pH paper).  
 
Prior to addition of monosaccharides a proton NMR experiment was performed at 
the new pH* so that any effect on the chemical shift of proton signals for scaffold 26 
could be accounted for in the subsequent measurements. 
 
Four equivalents of galactose (relative to the scaffold, giving 1.3 equivalents of 
galactose per aminooxy group) were added and the mixture stirred in a sealed vial 
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for 15hr. HSQC allowed identification of three distinct anomeric environments 
which are highlighted in the spectrum below, Figure 43. This was used in preference 
to 1D proton NMR alone as scaffold signals for 26 at this pH* were observed in the 
same region the anomeric protons were expected to appear. 
 
 
Figure 43: HSQC of reaction mixture containing galactose and scaffold 26, three 
distinct anomeric environments are highlighted. 
 
Coupling constants confirmed that two of the environments were cyclic β 
conformation while one was α. Comparison with literature values for galactose 
anomeric protons and previously synthesised galactose substituted aminooxy 
compounds made it possible to distinguish free and bound galactose. As the triazole 
C-H environment was also clearly visible at 7.94 ppm the proportions of free 
galactose (4.59 ppm for β and 5.27 ppm for α), aminooxy galactoside (4.18 ppm) and 
core scaffold could be easily compared. Integral values clearly showed that after 
15hrs the free galactose predominated, as shown in Figure 44 below.  
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Figure 44: Reaction of 26 and galactose after 15hr with free galactose and aminooxy 
galactoside anomeric protons highlighted. Integration clearly shows the free β 
galactose predominates 
 
It was estimated that approximately 8% of the galactose present was bound to the 
scaffold. The mixture was monitored for a further day with little change. This can be 
seen by comparison of Figure 44 and Figure 45. 
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Figure 45: Reaction of 26 and galactose after 38hr with free galactose and aminooxy 
galactoside anomeric protons highlighted. Integration clearly shows the free β 
galactose predominates as in Figure 44 
 
After 38hrs estimation from the integrals suggested approximately 9% of the 
galactose was bound to the scaffold 26, an incredibly low proportion of the four 
equivalents in solution. A further two equivalents of galactose, relative to the 
scaffold, were added in an attempt to shift the position of equilibrium in favour of 
the sugar-substituted scaffold. This gave a total of two equivalents of galactose per 
aminooxy unit. Increasing the equivalents of galactose to a large excess would likely 
have further encouraged product formation but may have made it difficult to observe 
by NMR. The mixture was warmed to 30
o
C but as can be seen from Figure 46 these 
measures did not produce a marked increase in aminooxy galactoside; suggesting 
that equilibrium had been reached and in this case it favoured the starting materials 
over the desired product. 
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Figure 46: Adding 2 more equivalents of galactose did not substantially increase the 
proportion of aminooxy galactoside 
 
Similar experiments were attempted with glucose and GlcNAc, using nine 
equivalents of monosaccharide relative to the scaffold (three equivalents per 
aminooxy) and conducted at 35
o
C in D2O at ~pH* 5. While the anomeric protons 
were not as distinct for these monosaccharides as for galactose the free sugar was 
similarly seen to predominate. Anomeric signals for the β conformation of free 
glucose and GlcNAc were significantly closer to the D2O solvent peak, so similar 
percentage estimates based on integration would be misleading. As previously the 
anomeric signals were identified using a combination of HSQC, coupling constants 
and comparison with the literature. In the case of GlcNAc the doublet corresponding 
to free β form sugar was entirely masked by the solvent peak. For glucose the β 
anomeric signal was similarly problematic, coming close to the solvent peak and 
overlapping with broad scaffold signals at 4.70-4.63 ppm (these were CH2 
environments adjacent to the nitrogen of the triazole ring and the quaternary carbon 
of the triazole ring, pH adjustment significantly shifted many of the proton 
environments). An NMR of the experiment with glucose, highlighting the anomeric 
environments and problematic overlap, is shown below in Figure 47.    
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Figure 47: Reaction of 26 and glucose after 16hr with free glucose and aminooxy 
glucoside anomeric protons highlighted. Integration shows the free glucose 
predominates. 
 
The NMR experiments suggested that the equilibrium under conditions tested was 
strongly in favour of the free sugar. An attempt was made to monitor the reaction by 
mass spec using both MALDI and ESI, but Tris scaffold based materials failed to 
ionise. Separation, while possible, would have required fast removal of solvent from 
each fraction to prevent equilibrium being re-established and was therefore 
impractical. A large excess of sugar may have led to product formation, but could 
also result in a majority of the undesired mono or disubstituted scaffold with 
interconversion between the two as shown in Scheme 45.  
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Scheme 45: Potential interconversion between di and mono substituted scaffolds 
makes the ability to monitor product formation important. 
 
A method to monitor reaction progress, which could detect Tris containing fractions 
even in the presence of vast excess of monosaccharide, was clearly needed. High 
performance liquid chromatography (HPLC) was considered and separation of small 
fractions of the equilibrium reactions attempted but these efforts were hampered by 
the lack of UV absorption for all components. Detection of the scaffold in its current 
form was difficult but monitoring Tris scaffold containing components was essential 
for optimising the reaction conditions. As a result an analogue of the core scaffold 
was synthesised with a chromophore label coupled to the free Tris amine.    
 
4.2 Synthesis and properties of UV active Tris scaffold 
 
The Boc protecting group was removed from the tri propargyl Tris scaffold 2 by 
stirring in 2M hydrochloric methanol giving the salt 27.  
NH3
O
O
O
Cl
27
 
Figure 48: Compound 27, produced by removing Boc protecting group from Tris 
core 2. 
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The crude salt 27 was fully characterised and product formation confirmed. The IR 
spectrum showed a peak at 2884 cm
-1
, consistent with an ammonium ion, and still 
had a peak at 3287 cm
-1
, consistent with a terminal alkyne but the peak at 1711 cm
-1
 
in the Boc protected starting material 2 (assigned as the C=O) was absent. Removal 
of the Boc group was further supported by the mass spec with an intense ion at 236.0 
m/z (close to the predicted value for MH
+
, 236.3 m/z) and by the proton and carbon 
NMR, which lacked characteristic peaks for the Boc methyl groups (at 1.42 ppm and 
28.5 ppm in starting material 2) and the Boc carbonyl (observed at 154.9 ppm in 2). 
This was not purified further and used as crude after removal of the solvent and 
volatile acid. 
 
With the scaffold amine free the choice of UV active agent was considered. 4-
Nitrobenzoyl chloride was chosen as it was relatively small (reducing the likelihood 
of it blocking binding sites), readily available, and because NMR shifts from this 
chromophore in both the proton and carbon spectra were unlikely to overlap with 
signals from saccharide groups or the majority of the scaffold.  
 
4-Nitrobenzoyl chloride was coupled to deprotected Tris core 27 under conditions 
shown in Scheme 46. Yield for the test reaction was a moderate 38% but conducting 
the reaction on a larger scale resulted in an even lower yield (14%) of compound 28. 
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Scheme 46: Reaction of deprotected Tris core 27 with 4-nitrobenzoyl chloride 
giving the UV active Tris core 28 
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Changes in the IR spectra going from compound 27 to compound 28 supported 
product formation; new peaks were observed at 1663 cm
-1
 consistent with a carbonyl 
group and at 1523 cm
-1
 and 1346 cm
-1
, consistent with an aromatic nitro group, 
while the peak at 3289 cm
-1
, characteristic of terminal alkynes, was still present. 
Further support for the synthesis came from the proton and carbon NMR. Although 
NMRs for starting material 27 and UV active Tris core 28 can’t be directly compared 
(differences in solubility meant different solvents were used) the appearance of new 
peaks in regions characteristic of aromatic protons and carbons strongly suggested 
the reaction was successful. Proton NMR of product 28 had two multiplets at 8.28-
8.25 ppm and 7.92-7.89 ppm while the carbon NMR showed peaks at 149.7 ppm, 
140.9 ppm, 128.3 ppm and 123.9 ppm consistent with the expected aromatic 
carbons, along with a peak at 165.5 ppm, consistent with the carbonyl of the amide. 
The structure was confirmed by mass spec, with prominent ions observed at 385.1 
m/z and 407.0 m/z, consistent with MH
+
 and MNa
+
 respectively.  
 
Click reaction between UV active Tris core 28 and the aminooxy-azide linker 24 
(shown in Scheme 47) was conducted using copper (I) which was formed in situ 
using copper sulfate and sodium ascorbate.  
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Scheme 47: Synthesis of scaffold 29 via click reaction of aminooxy-azide linker 24 
and UV active Tris core 28 
 
The product, UV active Tris scaffold 29, was purified by silica column 
chromatography to ensure both the excess azide 24 and any copper salts were 
removed giving a moderate yield of 49%. 
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IR supported the formation of 29, with signals at 3289 cm
-1
 and 2100 cm
-1
, 
characteristic of the terminal alkynes in Tris core 28 and the azide in linker 24 
respectively, absent. Shifts in the proton and carbon NMR spectra also strongly 
suggested product formation. The triplet at 2.45 ppm in proton spectrum of starting 
material 28, characteristic of the terminal alkynes, was absent, which along with the 
appearance of peaks at 7.50-7.49 ppm suggested the click reaction had occurred, 
forming the 1,4 triazole as expected. Carbon NMR confirmed the absence of the 
alkyne and formation of the 1,4 triazole. Characteristic peaks were present at 144.9 
ppm and 123.3 ppm (assigned as the quaternary and protonated carbon of the triazole 
ring, with reference to the HSQC) and a lack of peaks at 79.6 ppm and 75.0 ppm (the 
quaternary and protonated carbons of the alkyne in starting material 28). Significant 
downfield shifts in signals associated with protons from the ethyl linker were also 
observed on reaction, suggesting product formation. Protons adjacent to the azide in 
24 originally appeared at 3.46 ppm but shifted to 4.52-4.48 ppm on reaction while 
protons adjacent to the aminooxy group appeared at 3.63 ppm in the linker starting 
material 24 but at 3.93-3.85 ppm in the product 29.  
 
Low resolution mass spec gave further supporting evidence of product formation, 
with prominent ions observed at 1033.7 m/z and 1055.6 m/z, consistent with MH
+
 
and MNa
+
 respectively. Confirmation came from high resolution mass spec which 
showed an intense peak at 1033.5069 m/z, compared to the calculated value for M
+
 
of 1033.5070 m/z, making it extremely likely the click reaction was successful. 
Taken together the spectroscopic data confirmed the formation and structure of UV 
active scaffold 29.  
 
With 29 available it seemed reasonable to test the scaffold’s UV properties to 
confirm that the chromophore would be detectable at relevant concentrations during 
HPLC. A UV-Vis spectrum of the compound’s absorbance from 220-600 nm was 
conducted in order to determine λmax, which was found to be 264 nm (ε = 9804 M
-
1
cm
-1
). 
 
With the scaffold’s UV properties confirmed the aminooxy groups were deprotected 
by stirring 29 in 2M hydrochloric methanol. The deprotected Tris product 30 (shown 
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in Figure 49) was obtained as the crude hydrochloric salt by removing the methanol 
solvent and volatile acid but was not purified further. 
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Figure 49: Deprotected, UV active Tris scaffold 30 
 
The Boc deprotection was confirmed by a combination of NMR and mass spec, 
although an IR spectrum was taken and a peak observed in the starting material 29 at 
1701 cm
-1
, consistent with a carbonyl, was absent. Differences in solubility between 
29 and product 30 meant that different NMR solvents were used, preventing direct 
comparison of chemical shifts. However the proton and carbon NMR of deprotected 
Tris scaffold 30 lacked peaks characteristic of the Boc methyl and carbonyl groups. 
These were observed at 1.32 ppm for the methyl protons and 155.6 ppm and 28.2 
ppm for the carbons of the Boc carbonyl and methyl groups respectively, in the 
starting material 29. Further support for the deprotection came from low resolution 
mass spec, which showed a prominent peak at 755.4 m/z, consistent with MNa
+
, 
with final confirmation coming from the high resolution mass spec. This showed an 
intense peak at 733.3487 m/z, in good agreement with the calculated value 
(733.3488 m/z) for M
+
. 
 
As with scaffold 29, the UV properties of 30 were investigated. An accurately 
weighed sample was dissolved in water and the pH adjusted to ~pH 6 (measured 
using pH paper) by addition of saturated sodium hydrogen carbonate solution. Water 
was used both because 30 was only sparingly soluble in methanol and because future 
attempts to couple 30 with sugars were likely to be conducted in water. As 
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previously a UV-Vis spectrum of the compound’s absorbance from 220-600 nm was 
obtained in order to determine λmax. The λmax was 269 nm (ε = 4699 M
-1
cm
-1
), quite 
similar to the value obtained for the starting material 29. This suggests that 
functionality at the linker termini does not have a large affect on the absorption 
properties of the scaffold, so it is likely that unsubstituted 30 and multiply sugar 
substituted scaffolds based on 30 could all be detected using the same wavelength. 
 
Having shown that the scaffolds were UV active it seemed likely that HPLC would 
be a suitable method for monitoring the position of equilibrium and product 
formation in reactions between 30 and various monosaccharides. With this 
established, attention turned to creating a suitable HPLC method for monitoring such 
reactions. 
 
4.3 High Performance Liquid Chromatography experiments 
 
In order to draw meaningful conclusions from the planned equilibrium experiments 
(such as that illustrated in Scheme 48) identification and accurate appraisal of the 
concentration of unsubstituted starting material 30 in HPLC traces of mixtures was 
necessary. Creating a calibration curve for pure 30 was seen as an essential starting 
point to meeting this aim.  
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Scheme 48: Proposed reaction between Tris scaffold 30 and galactose, showing only 
tri substituted product and unsubstituted starting material. Mono and disubstituted 
products are also likely. 
 
In preparation for this a fresh sample of 30 was synthesised. Both pH and 
concentration of salts in solution are known to affect HPLC retention times in some 
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cases so these factors were taken into account when preparing solutions of UV active 
scaffold 30.
109
 Rather than using sodium hydrogen carbonate to neutralise 30 as 
previously, an excess of ammonium bicarbonate was added. Unlike the sodium 
hydrogen carbonate, ammonium bicarbonate is volatile and can be removed under 
vacuum, reducing the overall salt content.  
 
Solutions were then diluted in phosphate buffered D2O with a buffer concentration of 
100 mM. Deuterated solvent was used so that any effect of the buffer on the shifts of 
proton peaks in 30 could be established at this point. pH* of the buffer was 
established to be 5.84. Using the pH-pD conversion constant (established to be 0.4) 
this gave a pD of 6.24 for the buffer.
110
 pH* was measured again when 30 was added 
to ensure it did not break the buffer and was found to be pH* 5.92, giving an 
acceptable pD of 6.32.  
 
A series of seven solutions of different, known concentrations were then prepared 
from the stock using ultrapure water. All samples were run using the same method 
and solvents (methanol and water with 0.05% TFA) with the same volume injected 
into the HPLC for each run. Peak detection was conducted at 250 and 270 nm 
throughout.  
 
However a calibration curve could not be produced because HPLC traces of UV 
active scaffold 30 showed multiple peaks; despite NMR showing that the injected 
sample of 30 contained no major impurities. Several attempts were made to identify 
the impurity and its source. An HPLC trace of the Boc protected scaffold 29 also 
showed two major peaks, both HPLC traces are shown below in Figure 50. The two 
major peaks in the starting material 29 were separated and analysed by mass spec. 
The peak eluting at 16.1 min was identified as 29, with prominent peaks for both 
MH
+
 (1033.8 m/z) and MNa
+
 (1055.8 m/z) but the peak eluting at 15.2 min could not 
be identified. 
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Figure 50: HPLC traces for, A: compound 30, B: compound 29 both detected at 270 
nm. 
 
This suggested that the excess peaks in HPLC traces of 30 were caused by an 
impurity carried over from the starting material. Comparison of mass spec data for 
29 and the two peaks present in its HPLC traces confirmed that the impurity was 
present in the original sample despite previous purification. It was anticipated that 
some of the impurity peaks in samples of 30 could be caused by in situ Boc 
deprotection of impurities from starting material 29 as the HPLC solvents contained 
a small amount of TFA. While TFA was not tested as a way of deprotecting 29 it had 
previously been trialled as a way of removing Boc groups from similar scaffold 25 
and had successfully deprotected the compound. In 25 prolonged exposure to TFA 
caused decomposition but this was not expected to be a problem for 29 due to the 
lower concentration of TFA and shorter exposure times. 
 
In order to establish their identity two major peaks present in the HPLC trace of UV 
active tri-aminooxy scaffold 30 were separated and collected. Both purified peaks 
were then reinjected in order to confirm their purity, note any change in retention 
A 
B 
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time and show that the peaks had been separated correctly. Major changes were 
observed in retention time and number of observed peaks on subjecting the samples 
to a second HPLC run. In both samples the major peak observed was at a different 
retention time to the peak originally separated with at least one other impurity 
present; suggesting the situation was more complex than a simple Boc deprotection 
of one pre-existing impurity. Repeating the procedure with freshly prepared solvents 
and fresh, concentrated samples confirmed that the samples were not accidentally 
contaminated and the results were not the product of experimental error. HPLC 
traces for both purified peaks are shown below in Figure 51. 
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Figure 51: HPLC traces for A: compound 30, B: reinjected peak eluting at 11.3 min, 
C: reinjected peak eluting at 11.9 min 
 
A 
B 
C 
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There were several possible causes for these results. Retention time could have 
originally been affected by other components in the mixture, giving a ‘true’ retention 
time for the purer, separated peaks. Collection of fractions was automated and it was 
possible that the HPLC was simply collecting too broadly, selecting the wrong peaks 
or that the dead time for collection had been altered. In situ reaction was another 
possibility, as was decomposition on the column.  
 
In order to test that the HPLC was collecting fractions correctly a stock sample of 
FmocGlyOH amino acid was prepared and injected. The amino acid was separated 
and reinjected three times concurrently with no change in retention time, or extra 
peaks observed. This showed that the HPLC was correctly collecting desired 
fractions. 
 
The two major peaks in the HPLC trace of 30 were separated and analysed by mass 
spec. Mass ions corresponding to 30 (previously observed at 733.4 m/z for MH
+
 and 
755.4 m/z for MNa
+
) were not observed in either sample and the observed mass ions 
did not correspond to simple Boc deprotection of the impurity seen in the starting 
material 29. The impurities could not be identified based on the mass spec. Reaction 
of 30 with one or more unidentified reagents seemed increasingly likely. The 
terminal aminooxy groups were chosen for their reactivity towards aldehydes which 
allows coupling to sugars. Reaction with trace carbonyl containing components in 
solvents was a possibility.  
 
Further evidence for reaction during the HPLC process came with confirmation that 
the additional peaks in the separated fractions were truly new. Portions of the 
original stock solution of 30 were spiked with each separated fraction. If the 
changing retention time was caused by purifying the initial mixture, removing inter 
molecular interactions between components, then mixing the original stock and 
fractions should give HPLC traces identical to the original stock. HPLC traces for 
mixtures of stock and separated fractions can be seen in Figures 52.  
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Figure 52: HPLC traces of A: compound 30, B: separated peak eluting at 11.3min, 
C: solution B spiked with compound 30, D: separated peak eluting at 11.9min, E: 
solution D spiked with compound 30 
 
It became clear that the traces for both solutions showed two distinct peak patterns 
superimposed, the stock solution and the respective fraction. This gave further 
support to the idea that the injected material was either reacting or decomposing. 
Several different solutions were prepared in an attempt to find the cause of this 
problem. 
 
The HPLC solvents were considered as a possible cause for concern, initially due to 
the added TFA. As discussed previously TFA had caused decomposition in related 
scaffold 25, over a period of time similar to that taken to run an HPLC experiment, 
collect and re-submit samples. To test whether TFA was causing decomposition a 
A 
B 
C 
D 
E 
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sample of 30 was prepared in HPLC water (0.05% TFA) left for over an hour and 
then submitted to the HPLC. Very little difference could be seen between the pattern 
of peaks prepared in phosphate buffer and HPLC water. This seemed to indicate that 
TFA was not causing the observed changes in peak pattern and retention time. 
 
We next considered the possibility of the free aminooxy groups reacting with trace 
contaminants. Reaction with a common solvent, such as acetone which was used to 
clean all glassware, was thought to be a likely cause as the products were expected to 
be unstable and might decompose in a number of ways. To investigate this a sample 
of 30 was dissolved in ultrapure water and spiked with excess acetone. The sample 
was left overnight before being submitted to the HPLC but the trace appeared the 
same as the original stock. 
 
Metal chelation by the scaffold 30 was seen as another possible cause of the shift in 
retention time and peak patterns, either by mediating subsequent unidentified 
reactions or by a metal exchange process affecting the retention time itself. In order 
to rule this out as a factor a series of six samples of the same concentration were 
prepared in ultrapure water. Five were spiked with an excess of common metal salts, 
sodium chloride, potassium chloride, calcium chloride, magnesium sulfate and 
copper sulfate, the samples then were run concurrently. These traces also showed no 
significant differences from traces for the original stock solutions of 30. 
 
Having ruled out common metal ion contaminants, TFA and acetone as possible 
factors triggering decomposition we re-examined the experimental method for 
sources of contamination. Oxidation in air seemed unlikely, as NMR solutions in 
D2O did not show any decomposition over a period of weeks while the time between 
separation and reinjection of collected fractions was in the range of 30 min. Samples 
of Tris aminooxy scaffold 30 both in solution and as the pure compound, had been 
left exposed to air in the laboratory at room temperature for several days with no 
observed decomposition. Both HPLC solvents had been changed repeatedly 
throughout and the column was flushed with solvent for at least twenty minutes prior 
to experimental procedures. Blanks were run prior to samples further limiting the 
possibility of contamination from the column.  
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In an attempt to recreate the conditions separated fractions were subjected to, a fresh 
sample of 30 was synthesised and prepared by dissolving in HPLC solvent at 
roughly eluting proportions (approximately 75% methanol, 25% water). After 30 
min this was submitted to the HPLC the trace is shown below in Figure 53 A.  
 
 
Figure 53: HPLC traces of A: compound 30 prepared in 75% HPLC methanol and 
25% HPLC water, B: compound 30, C: separated peak eluting at 11.3 min, D: 
separated peak eluting at 11.9 min 
 
The peak pattern suggested a combination of the original sample and both separated 
fractions, with large peaks eluting uncharacteristically late for the stock but 
significant peaks present earlier that are less intense in the separated fractions. This 
change in peak pattern seemed to suggest a process of conversion, supporting the 
idea of reaction or decomposition of UV active tri-aminooxy scaffold 30.  
 
A 
B 
C 
D 
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However it shed no further light on the question of how or why 30 might be reacting; 
previous exposure to ultrapure water and HPLC water had not produced similar 
results, suggesting the presence of TFA and water was not the cause. It was tempting 
to consider the presence of a high proportion of acidic methanol the source of the 
problem, but synthesis of 30 was conducted in acidic methanol (2M HCl methanol) 
and the product was fully characterised without incident. Contamination of the 
HPLC methanol also seemed unlikely as the solvent had been replaced several times 
over the course of the troubleshooting process.  
 
At this point it seemed clear that the tri-aminooxy scaffold 30 was undergoing 
multiple reaction or decomposition processes under HPLC conditions used although 
what products were being formed and how was still unclear. Change in HPLC 
solvents and conditions may stop the decomposition but it is likely that this 
instability makes 30 unsuitable as a lectin ligand mimic. However the 
straightforward synthesis of compounds like 30 should make modifications easier, 
simplifying the search for more stable analogues. 
 
4.4 Chapter Summary 
 
Although tri-aminooxy Tris scaffold 26 was successfully synthesised the compound 
could not be detected by UV, making it difficult to monitor the progress of reactions 
with monosaccharides by HPLC. A chromophore bearing analogue was synthesised, 
starting from the tri propargyl Tris core 2 (Scheme 49). 
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Scheme 49: Reaction of Tris core 27 with 4-nitrobenzoyl chloride giving UV active 
product 28 
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Click reaction between UV active Tris core 28 and azide linker 24 gave 29, a UV 
active Tris scaffold with protected aminooxy groups (Scheme 50). 
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Scheme 50: Click reaction between UV active Tris core 28 and azide linker 24 to 
produce UV active scaffold 29. 
 
This was subjected to global Boc deprotection using acidic methanol. Deprotected 
scaffold 30 was used as crude. 
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Scheme 51: Boc deprotection to produce scaffold 30 
 
Unfortunately although compound 30 could be detected by UV it proved unstable 
and decomposed under HPLC conditions, making it unlikely that 30 could be used as 
a starting point for lectin ligand mimics. However the synthetic route could allow a 
variety of analogues to made in a straightforward manner and simple changes to the 
azide linker component or the chromophore may yield a more stable scaffold. 
 116 
 
 
5. Initial approaches to Calixarene based scaffolds 
 
5.1 An introduction to calixarenes 
 
In order to compare lectin ligand mimics displayed on different scaffolds, synthesis 
of sugar substituted calix(4)arenes was investigated.  
 
Calixarenes are macrocycles of varying size (4-8 repeated units are common) 
derived from phenol and formaldehyde.
111
 This project concentrates on calix(4)arene 
which is made up of four phenols connected by methylene bridges.  
 
OHOH HOOH  
Figure 54: A typical calix(4)arene cone structure with tert-butyl groups on the upper 
rim and phenols at the lower rim 
 
Hydroxy groups make up the narrow lower rim, while the substituents in the para 
position are the wide upper rim of the calix.
111
 Both positions can be functionalised 
and a range of groups (such as alkyl chains, halides, alkenes, phosphates, peptides 
and glycosides) have been introduced.
111, 112, 113, 114, 115 
 The number of available sites 
for functional groups on the calix upper and lower rim, along with its ability to hold 
them in a stable but not immobile cone structure makes it an attractive scaffold for 
ligand mimic design.  
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Figure 55: Alternate conformations of calixarenes 
 
The position of ligands, the distance between them, the face they’re displayed on, 
and the scaffold can be tailored to the receptor either by reference to crystal 
structures of the natural receptor-ligand complex or by systematic variation of the 
scaffold.
116, 117
 Using click chemistry to couple glycosides to the calixarenes scaffold 
allows for a variety of glycocalixes to be synthesised with relative ease. 
 
There are numerous examples of calix based lead compounds displaying multiple 
active groups. Para-guanidinoethylcalix(4)arene shown in Figure 56 is one such 
example.
118
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Figure 56: Para guanidinoethylcalix(4)arene salt produced by Grare et al.
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A simple calix(4)arene based compound with four guanidine groups displayed on the 
upper rim it was intended to mimic the properties of known quaternary ammonium 
and biguanidine based antiseptic agents.
119
 The compound shows broad spectrum 
activity against both Gram positive and negative bacteria, including some drug-
resistant strains.
 118,
 
119
 This activity is due to the calixarene structure as studies with 
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a related phenol-based compound showed no anti-bacterial activity.
120
 Interestingly 
while the antiseptic agents that inspired it are cytotoxic the guanidine-calix has 
showed low cytotoxicity making it a potential antibiotic.
119,
 
120
 
 
Calixarene based anti-bacterial, anti-fungal
121
 and anti-viral
122
 compounds have been 
produced previously. Harris et al described numerous compounds including 
calixarenes linked to known antibiotics, however when linked to calixarenes the 
antibiotics do not appear to be as effective as current commercially available anti-
bacterials.
123
 Calixarenes have also been used as carriers for prodrugs, but have so 
far shown more limited activity.
124
  
 
Numerous examples of sugar substituted calixarenes also exist in the literature and a 
wide variety of synthetic strategies are in use.
125
 Glycosylation, nucleophilic 
substitution, the Wittig reaction and amino or thiol based bridges have all been used 
successfully.
126, 127, 128
 Huisgen cycloaddition, also known as click chemistry, is a 
particularly popular method for introducing sugars and has been utilised on the upper 
and lower rim using both azido and alkyne based calixes.
 43,
 
129, 130 
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Figure 57: Sugar substituted calixarene utilising click chemistry.
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Examples of high affinity lectin binding calixarene compounds with biological 
activity have been developed, the cholera toxin ligand produced by Ungaro et al is a 
prominent example.
116
 In designing their cholera toxin binding calixarene they first 
developed a tri-glycoside-like mimic of the natural ligand shown in Figure 58.  
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Figure 58: Natural cholera lectin ligand and mimic, where R is the chosen 
scaffold.
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The eventual calixarene arrangement and the length and rigidity of the linkers used, 
were then designed with reference to the crystal structure of the lectin so that 
multiple binding sites were within reach of the displayed glycosides.
116
 The result 
was a 1,3 disubstituted calixarene (shown in Figure 59) with significantly stronger 
binding to the target lectin than the natural ligand (shown in Figure 58), recorded 
Kds were 48 nM and 219 nM respectively.
116
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Figure 59: 1,3 disubstituted calix developed as a cholera toxin ligand by Ungaro et 
al.
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Ungaroi’s approach concentrated on the potential for tailoring calixarene scaffolds to 
a particular target. Cecioni et al have successfully used an alternative strategy; 
utilising differences in calix conformation and the number of sugar substituted sites 
to produce molecules with different binding strengths. 
 
Cecioni et al designed and screened a series of calixarenes with the aim of targeting 
the galactose-binding PA-IL lectin responsible for the initial stages of Pseudomonas 
aeruginosa infection.
117
 The tested series included calixarenes of different 
conformations and topologies as well as di, tri and tetra galactose substituted 
derivatives. These variants could be synthesised relatively easily as the same 
monosaccharides, linkers and coupling strategies were used throughout. The tetra 
substituted compounds are shown below in Figure 60. 
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Figure 60: PA-IL binding calixarene ligands, illustrating the variety that can be 
achieved by controlling calix conformation. 
 
While the di substituted derivatives did not bind the expected increase in binding 
was observed going from the tri to tetra calixarenes. The highest affinity was 
observed for the tetra substituted, 1,3 alternate example which had the highest known 
affinity for PA-IL at the time the paper was published, with an IC50 of 500 nM.
117
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Figure 61: High affinity PA-IL ligand based on 1,3 alternate calixarene.
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Both examples illustrate advantages particular to the scaffold, with Ungaro et al 
using the cone conformation in order to ensure the binding moieties were correctly 
spaced and Cecioni et al using the possible conformations as a way of producing 
variation in their screened compounds.
116, 117
 These examples show the potential of 
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calixarenes as scaffolds, highlighting how both simple systematic variations and 
design based on the structure of the targeted binding sites can yield excellent results.   
 
The synthetic approach Cecioni et al took, using click chemistry on the calixarene 
lower rim, allows straightforward production of analogues with different 
monosaccharides or different linkers. However the choice to leave t-butyl groups on 
the upper rim effectively prevents bi-functionalisation of the compounds. In order to 
preserve calix conformation large groups on both rims are necessary, complicating 
any adjustments to the synthetic route.
111
 Additionally the upper rim t-butyls may 
necessitate the use of long, hydrophilic linkers to ensure the calixarenes are 
sufficiently water soluble for biological testing.  
 
Strategies that introduce azides to the calixarene upper rim, such as that used by 
Baldini et al were judged to have more potential for introducing functional handles 
to both the upper and lower rim.
115 
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Scheme 52: Synthetic route to 1,3 diazido calixarene used by Baldini et al.
115
 
 
Synthetic routes from the starting calix(4)arene were longer compared to the Cecioni 
approach and varying conformation using the Baldini group methods would be 
complex. However routes to the target azide can utilise the 1,3 dialdehyde calixarene 
shown below in Figure 62. 
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Figure 62: 1,3 dialdehyde calixarene, often used to produce the alcohol shown above 
in Scheme 52. 
 
By utilising the bis aldehyde the same synthetic route can potentially be used to 
access azido and aminooxy substituted calixarenes, giving two methods for attaching 
sugars to the upper rim.  
 
5.2 Synthetic strategies based on 1, 3 disubstituted calixarenes 
 
Inspired by Baldini et al
115
 successfully synthesising 1,3 disubstituted  azido 
calixarenes and Bew et al
131
 subsequently producing tetra and dilactose substituted 
calixarenes via click chemistry we envisioned hybrid systems with sugars coupled to 
the upper rim and fluorophores coupled to the lower rim as shown below in Figure 
63. Disubstituted calixarenes were chosen, as opposed to trisubstituted equivalent, 
due to synthetic expediency. 
OO OO
N N N
N
N
N
O
HO
HO
HO
OH
O
HO
HO
HO
OH
O O
RR
R = O
O
or
or
O NHCbz
O NHCbz
or
 
Figure 63: Proposed 1,3-disubstituted glycol-calixarene with click linkage where R 
both locks the conformation and provides a functional handle for attaching 
fluorophores or chromophores 
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The aim was to investigate whether the differences in flexibility and display of 
ligands between Tris and calix based scaffolds would affect their ability to bind 
lectins. The distance, in terms of bonds, between sugars and between a sugar and the 
core of the scaffold is similar for both structures. However the calix(4)arene is 
comparably limited in terms of  how attached saccharides can be positioned. Once 
sufficiently bulky groups are coupled to the upper or lower rim steric hindrance 
prevents most changes in calix conformation (propyl groups and larger have been 
shown to be effective).
111
 With the conformation locked the number of positions 
allowing free rotation is vastly reduced compared to Tris based scaffolds such as the 
one in Figure 64.  
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Figure 64: Tris based sugar substituted scaffold. 
 
Calixarene based scaffolds, while less flexible than Tris, possess distinct faces 
allowing binding and non-binding functionality to be positioned so that non-binding 
structures are less likely to interfere with any sugar-protein interactions. Bulky 
flourophores positioned away from the binding pocket of a lectin may even act to 
increase specific binding by blocking the approach of competing molecules.
132
 The 
scaffold’s ability to adopt multiple conformers is an additional interesting structural 
feature which could affect binding. The central calixarene cavity can act as a 
hydrophobic pocket, mimicking analogous environments in natural proteins and 
might influence a glycocalix’s interactions with lectins. These combined features 
suggest calixarenes would be extremely interesting ligand mimics, making up for the 
complex, longer synthetic routes compared to their Tris equivalents.  
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Synthetic routes to 1,3-bifunctionalised calixes are well established. After referring 
to the literature two possible routes were investigated simultaneously, both 
beginning with the steps outlined below in Scheme 53. 
 
OPrOPr HOOHOHOH HOOHOHOH HOOH
31
16%
AlCl3
Phenol
Toluene
32
81%
MeCN
I
K2CO3
33
44%  
Scheme 53: Synthetic route to 1,3-bifunctionalised calixarenes 
 
First calix(4)arene 31 was synthesised from formaldehyde and t-butyl phenol 
according to well established literature methods.
133
 The upper rim t-butyl groups 
were then removed using a Friedel-Crafts procedure, commonly employed to access 
the calixarene upper rim, giving calix 32. Several characteristic changes to the proton 
NMR confirmed that the reaction was successful: in starting material 31 aromatic 
protons had appeared as one singlet at 7.19 ppm while in 32 there were two distinct 
aromatic proton environments, a doublet at 7.06 ppm and a triplet at 6.73 ppm. 
Additionally the bridging methylene groups changed from a pair of doublets at 4.38 
ppm and 3.51 ppm in 31 to a pair of broad signals at 4.26 ppm and 3.55 ppm in calix 
32, the broad signals indicate free rotation of the ring possible once the bulky upper 
rim t-butyl groups are removed.
111
 Reappearance of the methylene doublets (at 4.33 
ppm and 3.39 ppm) when 32 reacted with iodopropane to produce 33 indicated the 
product was once again constrained in the cone structure.
111
 Comparison with the 
literature confirmed that the 1,3 substituted calix 33 had been successfully 
synthesised and attention turned to the subsequent steps outlined in Scheme 54 
below.  
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Scheme 54: Synthetic routes to 1,3 dialdehyde calixarene 37; (i) Br2, dry conditions, 
in DCM (ii) Dichloro methyl methylether, tin (IV) chloride -15
o
C, in CHCl3 (iii) 
NaH, allyl bromide, in DMF (iv) a) Trimethyl orthoformate, para toluene sulfonic 
acid, b) NaH, allyl bromide, in DMF (v) DMSO, triethylamine 
 
Using literature procedures both the di bromo calix 34 and the di aldehyde calix 36 
were synthesised as detailed above.
134, 135
 The di allyl calixarenes 35 and 37 were 
synthesised from 34 and 36 respectively using procedures based on previously 
established literature methods (which produced the propyl rather than allyl calixes).  
 
The eventual aim was to synthesis the 1,3 di substituted azido calix shown in 
Scheme 55 below, with the proposed synthetic route from di allyl, di aldehyde calix 
37 outlined. 
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Scheme 55: Proposed synthetic routes to diazidocalixarene. (i) LiAlH4, dry 
conditions, reduced temperature, (ii) CBr4, triphenyl phosphine dry conditions, (iii) 
NaN3  
 
In both cases the azide would eventually be separated from the upper rim by a 
methylene group rather than attached directly to the aromatic rings. Previous work 
(personal communication, Dr Sunil Sharma, UEA) showed that without this spacer 
click reactions did not occur. Previously both Bew et al and Brimage have used the 
routes described in Schemes 53-55 to create upper rim substituted calixarenes with 
propyl groups at the R position to ensure the cone confirmation.
131, 136
 If suitably 
functionalised linkers are attached to the R position (such as those suggested in 
Figure 63) dual functional calixarenes could be produced, with sugars coupled via 
click chemistry to the upper rim and fluorophores or chromophores at the lower rim. 
 
Several strategies for coupling fluorophores to the lower rim were considered. 
Propargyl groups have been attached to calix lower rim positions previously
137
 but 
attempting separate click reactions on the upper and lower rim seemed unnecessarily 
complex. The coupling strategy needed to be high yielding, selective, involving 
functionality that could be attached to the lower rim in the presence of upper rim 
substituents and, if possible, biologically compatible. Photoclick reactions of 2,5-
diphenyl substituted tetrazoles with terminal alkenes,  which produce fluorescent 
pyrazoles (shown in Scheme 56), seemed ideal for this purpose as the strategy met 
all the relevant criteria and has been successfully conducted in living cells.
138, 139
  As 
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a result allyl groups were chosen as the first potential functional handle to 
investigate. 
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Scheme 56: Photoclick reaction of olefin and 2,5-diphenyl tetrazole, where R can be 
a variety of organic substituents. 
 
Both the di-aldehyde (36) and di-bromide (34) approach to introducing allyl groups 
require the same number of synthetic steps as 36 requires protection before any 
further coupling to the lower rim can proceed.  
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Scheme 57: This strategy was previously used (with propyl instead of allyl bromide) 
to successfully couple propyl groups to the lower rim.
136
  
 
The protected intermediate was used as a crude since it rapidly reformed the starting 
bisaldehyde 36 in solution. The initial protocol used trimethyl orthoformate in order 
to temporarily protect upper rim aldehydes, followed by reaction with sodium 
hydride and allyl bromide as similar conditions had previously been used to 
successfully attach propyl groups to the lower rim.
136
 This is shown in Scheme 57. 
 
Yields of 37 were low (highest isolated yield 16%) and this was thought to be due to 
the protected intermediate reverting to the starting material during work up, the 
process is illustrated below in Scheme 58. Dimethyl acetal protecting groups can be 
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removed with acid and it was observed that prolonged exposure to magnesium 
sulfate (which is a mild Lewis acid) during work up led to recovery of the starting 
dialdehyde 36 and no detectable product. Magnesium sulfate could not be 
completely eliminated from the procedure; the protected intermediate had to be dried 
for the reaction with sodium hydride to be effective as sodium hydride reacts 
spontaneously with water.  
 
OPrOPr HOOH
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Br
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36
37
Scheme 58: Suggested rational for poor yield of 37 and high recovery of 36. 
 
When exposure to magnesium sulfate was reduced (by reducing both the quantity of 
magnesium sulfate used and the length of exposure) the dimethyl acetal calixarene 
intermediate could be detected by NMR in base-filtered chloroform although this 
converted back to the starting dialdehyde 36 in solution, preventing complete 
characterisation. By minimising exposure to magnesium sulfate and using strictly 
anhydrous conditions for the next step with an excess of sodium hydride the diallyl 
product, 37, could be produced and isolated.  With these modifications the yield was 
16% (over two steps from 36) with a substantial portion of the starting material 
recovered. 
 
Initial attempts to attach allyl groups to the dibromo calixarene 34, using sodium 
hydride and allyl bromide, appeared to be successful. This route was abandoned in 
part because the yield was not significantly higher than for the dialdehyde 
equivalent, 37. The dibromo di allyl product 35, was also found to be unstable, 
storage at room temperature for several days resulted in an insoluble solid which 
precipitated from NMR solutions. The decomposition product was not characterised 
and as the dialdehyde based calixarenes 36 and 37 appeared to be stable for long 
periods of time concentrating on these derivatives seemed reasonable. 
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With an effective, if low yielding, route to 37 available it seemed reasonable to 
investigate the photoclick reaction we intended to conduct on the primary alkenes at 
the calixarene lower rim. Once the optimal photoclick conditions had been found the 
yield of diallyl calixarene 37 could be improved. As a result tetrazole 39 was 
synthesised according to literature methods Scheme 59.
140
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Scheme 59: Synthesis of tetrazole 39, diazonium and hydrazine intermediates were 
not isolated or characterised.  
 
Comparison with the literature confirmed that tetrazole 39 had been successfully 
synthesised.  
 
The low yield of diallyl calixarene 37 meant that little material was available, while 
tetrazole 39 was easily produced in high yield (86%) on a reasonable scale (2.16 g). 
A series of test reactions to determine the best reaction conditions was planned, 
using allyl phenol (38) in place of the calixarene 37. These reactions and the results 
are detailed in the following section. 
 
5.3 Tetrazole fluorophores and photo-click test reactions 
 
Tetrazoles are a class of stable heterocyclic compounds compromising a five 
membered ring with four nitrogen atoms. Compounds with a tetrazole core have 
been studied as potential explosives, for agricultural and pharmaceutical 
applications.
141, 142, 143, 144
 Tetrazoles decay, when heated or under UV, releasing 
nitrogen and forming reactive nitrile imines, which undergo concerted 1,3- 
cycloaddition reactions with olefins giving one major pyrazole product.
145, 146
 One 
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major isomer is produced due to the difference in electron density between the 
carbons of the alkene in this case. The regioselectivity can be reversed by changing 
which component is electron rich and which is electron deficient.
147 
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Scheme 60: Photoclick reaction between 39 and terminal alkene 
 
Recently biologists have taken advantage of this photochemistry in order to produce 
a new class of cellular probes based on 2, 5-diphenyl substituted tetrazoles.
139
 These 
probes have several potential advantages. The initial activation and cycloaddition 
proceed, in a variety of solvents and buffers, making the reaction biologically 
compatible. The ability to initiate the reaction under mild conditions with 
spatiotemporal control makes tetrazoles attractive as precursors to fluorescent 
biological probes. Recent work by Lin et al has also shown that tetrazoles can be 
activated and undergo cycloaddition in living cells without affecting cell 
mortality.
138,
 
139
 
 
The initial activation of tetrazole 39 by UV occurs quickly (in fractions of a second), 
while the subsequent reaction of the activated nitrile imine is relatively slow (in 
minutes).
138
 Optimising the reactions of the nitrile imine can be problematic; as 
dimerisation and reaction of the activated species with water are common side 
reactions.
148
  Some pyrazole products are also thought to break down under 
irradiation at similar wavelengths to that required to activate the tetrazole.
148
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Scheme 61: Some of the possible reactions of the activated nitrile imine 
 
Compound 39 was chosen based on work by Wang et al who reported high yields in 
reactions between allyl phenol (38) and tetrazole 39 using photoactivation.
149
 A 
series of reactions were then attempted using 38 as a model system in place of diallyl 
substituted calixarene 37.  
 
The experiments by Wang et al using allyl phenol were conducted in mixtures of 
aqueous buffer, acetonitrile and DMSO and were aimed at optimising the reaction 
for use in biological systems and eventually cells.
 139,
 
149 
Our aim of using photoclick 
as a novel method for efficiently attaching fluorophores to the calix lower rim 
required a different approach. Aqueous buffers were impractical as the diallyl 
calixarenes were insoluble in water and the high boiling point of DMSO would 
likely have made extracting the product difficult. Ethyl acetate, DMF and ethanol 
were used instead as the diallyl calixarenes were known to be soluble in these 
solvents. Since higher concentrations of both tetrazole and alkene were necessary in 
order to obtain the product on a chemically relevant scale; the reaction volume was 
limited by the size of the quartz cuvettes used. 
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Experiments were also attempted in open plastic petri dishes, as this allowed a 
greater dilution closer to the concentrations used by Wang et al. These experiments 
were physically difficult to set up; ensuring the entire sample was irradiated evenly 
was difficult, the solutions could not be stirred as this caused the reaction mixture to 
splash outside the dish which prevented even mixing.  
 
All experiments described in Table 5 and Table 6 were conducted using 302nm UV 
lamp. All experiments in EtOAc were conducted in quartz cuvettes, the final, low 
concentration experiment in EtOH was conducted in an open plastic petri dish. 
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Scheme 62: Test reactions between tetrazole (39) and allyl phenol (38) failed to 
produce pyrazole 
 
Time Irradiated 
min 
Equivalents 
alkene 38 
Solvent Concentration 39 
mM 
20 2 EtOAc 4.46 
60 2 EtOAc 9.26 
120 2 EtOAc 9.26 
120 5 EtOAc 10.31 
120 2 EtOH 7.6 
120 2 EtOH 1.81 
Table 5: Conditions used for attempted photoclick between compounds 38 and 39 
 
Additionally the reaction was attempted in ethyl acetate, irradiating for two hours 
and adjusting the concentration of 39 with time by periodically adding set volumes 
of stock solution. Concentration was changed from 11.50 to 48.21 mM over two 
hours. It was hoped that this would encourage the activated nitrile imine to react with 
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allyl phenol. Allyl phenol was stable under the reaction conditions and could not 
react with any of the components except the activated nitrile imine.  
 
Following irradiation, solvent was removed but no further work up procedures were 
conducted. All of the reactions were investigated by NMR. However possible 
product was only detected by NMR when the reaction was carried out at high 
dilution in ethanol. Under these conditions the percentage conversion, estimated by 
relative integration of proton NMR peaks, was low (~30%). In each case allyl phenol 
was clearly visible as a large proportion of the crude.  
 
Direct comparison with literature characterisation data was not possible, different 
deuterated solvents were employed resulting in significantly different chemical 
shifts.
149 
Minor multiplets at 5.99-5.89 ppm, 5.18-5.15 ppm, 5.14-5.12 ppm, 5.08-
5.04 ppm and 5.03-5.02 ppm, downfield of the allyl CH and terminal CH2, were 
observed in the high dilution reaction. These did not correspond to either starting 
material or solvent and could suggest a reaction at the allyl group of 38. However 
carbon NMR merely showed the expected peaks for 38, the active nitrile imine of 39 
and ethanol, leaving it unclear whether this minority material was the desired 
pyrazole or one of the many possible decomposition or side products. 
 
This was not investigated further as scaling up the reaction at high dilution was 
deemed impractical, (reaction scale was 10 mg of 38 in 23 ml of solvent). It was 
concluded that direct reaction between the diallyl calixarene and tetrazole was 
unlikely to occur.  
 
The photo-click reaction was next attempted using bromo-heptene and bromo-butene 
under various conditions. Since it is the pyrazole product that is fluorescent it was 
presumed that if direct photo-click reaction with calixarenes was impractical it might 
be possible to couple previously prepared pyrazoles to the calixarenes lower rim 
instead. Degradation was not observed for either alkene on irradiation in solution for 
the times and wavelength used. A greater excess of bromo-heptene was used for 
some experiments as its low boiling point meant it was easily removed and tetrazole 
based products could therefore be detected even when a vast excess of the alkene 
was used. 
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Scheme 63: Test reactions between tetrazole 39 and both bromo-alkenes tested were 
unsuccessful 
 
 Time Irradiated 
min 
Equivalents 
alkene 
Solvent Concentration 39 
mM 
Bromo-
heptene 
20 3 EtOAc 7.77 
 120 3 EtOAc 9.5 
 120 320 EtOAc 25.06 
 120 3 DMF 12.84 
Bromo-
butene 
120 3 EtOAc 8.72 
 120 30 EtOAc 4.28 
Table 6: Attempted photoclick between simple primary alkenes and tetrazole 39 
 
As previously, solvent was removed from the mixtures but they were subjected to no 
further work up conditions. The mixtures were then investigated by proton NMR. 
When no pyrazole was detected for these reactions a series of test reactions using 
bromo-heptene were conducted; attempting to activate the tetrazole by heating in the 
microwave. Previously tetrazole activation had coincided with an observable colour 
change in solutions containing tetrazole 39 from a light yellow to dark red. This 
colour change was not observed during microwave reactions, even after high heating 
for prolonged periods. Tetrazole activation by irradiation was previously confirmed 
by NMR, downfield shifts in both the proton and carbon spectra were observed 
corresponding to both the active nitrile imine and tetrazole based side products. 
NMR confirmed that under the microwave conditions used the tetrazole 39 was not 
activated.  
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As a result alternative methods for coupling fluorophores to the calixarenes lower 
rim were explored. 
 
5.4 Attempts to couple primary amines to the calixarene lower rim 
 
The large variety of commercially available fluorophores and dyes allows an almost 
limitless choice of functionality for attaching fluorophores to compounds of interest. 
Primary amines were chosen for several reasons. The proposed linkers could be 
quickly synthesised from cheap, commercially available materials, standard peptide 
coupling techniques could be employed if necessary and potentially the same 
fluorophores could be used for both Tris and calixarene scaffolds. 
 
Primary amines have been coupled to calixarenes lower rims in the past using 
phthalimides and nitriles.
150
 However the harsh conditions needed to deprotect or 
convert these groups would interfere with functional groups present on the upper rim 
of the planned calixarenes. Benzyl carbamate protection was seen as an alternative, 
which could potentially be deprotected at the same time the upper rim aldehydes 
were reduced to alcohols as shown in Scheme 64.  
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Scheme 64: Proposed method for coupling primary amines to calixarene (36) lower 
rim. 
 
Compound 42 (Scheme 65) was therefore synthesised with a view to coupling 
protected amines to the lower rim of 36. 
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Scheme 65: Synthetic pathway to potential benzyl carbamate protected linkers, 40 
and 42 
 
To begin with the reaction was carried out under the same conditions used 
previously to couple allyl bromide to the lower rim of dialdehyde calixarene 36 
(outlined in Scheme 57). The dialdehyde starting material was recovered but the 
benzyl carbamate linker 42 was not detected by NMR. Since a large excess of 
sodium hydride was used it was theorised that the linker was breaking down under 
the reaction conditions.  
 
This was confirmed by mixing the linker with excess sodium hydride for four hours, 
quenching and working up as previously. This produced a mixture of yellow oil and 
insoluble pale semi-solid. The intact linker was not observed by NMR, peaks 
consistent with polymerisation were detected and the insoluble solid was assumed to 
be a polymerisation product. 
 
The coupling reaction was repeated using lower equivalents of sodium hydride. 
Dialdehyde calix 36 was temporarily protected as the dimethyl acetal, promoting 
reaction at the phenolic groups on the lower rim. But the dimethyl acetal 
intermediate was previously found to be extremely sensitive, quickly reverting to the 
less reactive dialdehyde starting material 36 on exposure to mild acid, such as the 
drying agent magnesium sulfate. Using less sodium hydride was only possible if the 
dimethyl acetal intermediate was exposed to more magnesium sulfate for longer, 
encouraging it to revert to 36. As a result the change in procedure was expected to 
give a low yield. 
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Scheme 66: Dimethyl acetal intermediate quickly reverted to the less reactive 
dialdehyde 36 on exposure to mild acid, such as magnesium sulphate or deuterated 
chloroform. 
 
Both starting materials were recovered from the mixture but no product was 
detected. As stated previously similar conditions have led to successful reactions on 
the lower rim of dialdehyde calix 36 before (and were used to produce diallyl calix 
37), sodium hydride is a sufficiently strong base to initiate reaction.
136
 The 
phenoxide anion may not be sufficiently nucleophilic to react with benzyl carbmate 
linker 42 or the dimethyl acetal protected intermediate of 36 may be reverting to the 
less reactive aldehyde under the alternate conditions. 
 
As the linker was unstable more forcing conditions, such as high heat, were not 
attempted. Instead an alternative method for attaching fluorophores was once again 
sought. 
 
5.5 Towards bifunctionalised aminooxy-click calixarenes 
 
In order to use click chemistry on the lower rim without risking the production of 
numerous complex impurities a different method to attach sugars to the upper rim 
would be necessary. As discussed in previous chapters aminooxy chemistry 
represents an effective and increasingly widely used strategy for coupling 
unprotected sugars to a variety of molecules.
 75,
 
151, 152
 Propargyl groups could be 
attached to the lower rim using the same strategy as for allyl or propyl groups and 
the upper rim aldehydes then converted to oxime groups using commercially 
available aminooxy salts. Aminooxy groups are commonly synthesised via oximes 
and as a result the reduction step is well known.
97,
 
98,
 
153
 The mild reduction 
conditions used should not affect lower rim alkyne groups. 
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This strategy gives a slightly shorter synthetic route than the analogous click with no 
synthetic steps on the sugars used, eliminating potentially difficult synthetic and 
purification procedures. The planned synthetic route to bi-functionalised calixarenes 
is shown (Scheme 67). 
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Scheme 67: Proposed route to upper rim sugar substituted calix: i) Trimethyl ortho 
formate, paratoluene sulfonic acid, ii) NaH, propargyl bromide, iii) H2NOMe.HCl, 
pyridine, iv) NaBH3CN v) D-galactose, acetic acid, methanol 
 
A series of test reactions were conducted using benzaldehyde in order to confirm the 
proposed synthetic steps were effective and optimise the conditions if necessary. O-
methylbenzaldhyde oxime was isolated in good yield without column 
chromatography following a standard literature procedure.
153
 The following 
reduction proceeded quickly in moderate yield and sonication with D-galactose 
yielded the β-anomer (45) shown in Scheme 68 below.77  
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Scheme 68: Test reactions using benzaldehyde, compound 43 produced in similar 
yield to one-pot ozonolysis method shown in Chapter 3, Scheme 24. 
 
Using benzaldehyde and its derivatives the chemistry was robust and repeatable. But 
it has been previously shown that methods which are effective on benzene based 
systems are not necessarily practical for their calixarene based equivalents. For 
instance sodium hydride is not generally required to ensure reaction of phenol, but is 
commonly used to produce calixarenes that are tetra-substituted at the lower rim 
regardless of upper rim substituents. 
117,  126, 154
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Scheme 69: Synthetic route to oxime functionalised calixarene 
 
A small scale test reaction showed that the dioxime calix could be easily synthesised 
from the dialdehyde in good yield. Although time constraints prevented synthesis of 
the target sugar substituted calixarenes the results of these test reactions suggest that 
the strategy is sound and likely to be successful.  
 
5.6 Chapter Summary 
 
Calix(4)arene was synthesised according to literature methods and the upper rim t-
butyl groups removed. 1,3 Disubstituted calixarenes were chosen as the target due to 
synthetic expediency and the di-aldehyde derivative 36 was produced (Scheme 70). 
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Scheme 70: Synthesis of calix(4)arene starting material 32, and di-aldehyde calix 36 
 
Allyl groups were introduced to the calixarene lower rim as a functional handle for 
attaching flourophores, in a two step procedure via a protected dimethyl acetal 
intermediate. The dimethyl acetal intermediate was used as crude. 
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Scheme 71: Introducing allyl groups to the lower rim 
 
Tetrazole 39 was then synthesised as photoclick reactions between 39 and alkenes 
had been demonstrated as a reliable way to produce fluorescent pyrazoles previously. 
The tetrazole was produced in good yield but test reactions failed to produce 
significant quantities of pyrazole (Scheme 72). 
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Scheme 72: Synthesis of tetrazole 39 was successful but test reactions failed to 
produce a pyrazole fluorophore 
 
Di-oxime calixarene was produced in good yield as shown below in Scheme 73, 
suggesting that aminooxy functionality (an alternative way to attach saccharides to 
the upper rim) could be introduced to the calix with relative ease.  
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36
 
Scheme 73: Di-oxime calix 46 was successful synthesised from the di aldehyde 36 
in good yield 
 
Some progress has been made towards synthesising calixarene scaffolds with 
glycoside and fluorescent moieties on opposite faces. While using click chemistry on 
the upper rim was seen as desirable a complimentary method for attaching 
fluorophores to the lower rim was not found. The tetrazole based ‘photo-click’ 
reaction was found to be inefficient and impractical for large scale synthesis in the 
test reactions conducted. The alternate strategy of using aminooxy based chemistry 
to attach glycosides seems, given the results of test reactions, likely to be effective. 
This would enable the straight-forward use of click chemistry on the lower rim, 
allowing both the desired groups to be installed and varied with relative ease. 
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Introducing aminooxy functionality to the calix upper rim and using it to attach 
unprotected sugars should be the focus of any subsequent experiments.  
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6. Conclusions and Future Work 
 
The aim of this work was to investigate synthetic strategies for straightforward 
production of lectin ligand mimics. Three potential lectin ligand mimics based on 
Tris scaffolds were successfully synthesised using click chemistry (Figure 65) 
 
NHBoc
O
O
O
N
N
N
NN
N
N
N
N
O
Sug
Sug O
Sug
O
B-Gal = 5
B-GlcNAc = 9
B-Glc = 12  
Figure 65: Tri-substituted Tris compounds, with acetate protected galactose, 
GlcNAc and glucose. 
 
These compounds should be deprotected and their binding to relevant lectins, such as 
human galectins and ficolins, investigated. 
 
Secondary aminooxy Tris scaffolds were successfully synthesised via a convergent 
route allowing for considerable flexibility and fine tuning of the scaffold structure.  
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Figure 66: Tris based aminooxy scaffolds 26 and 30 
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However synthesis of Tris scaffolds with three aminooxy linked sugars and 
glycocalixes was not completed, in part because complete investigation of both 
scaffolds was not possible in the time available. Full development of aminooxy 
appended Tris scaffolds was hampered by difficulties in monitoring the progress of 
their reactions with simple monosaccharides. While coupling a simple chromophore 
to the scaffold gave a compound that was easily detected (30), observing any of the 
scaffold’s reactions by HPLC proved problematic as the pure scaffold decomposed 
during chromatography. 
 
Despite extensive investigation of the HPLC conditions used, it was unclear 
precisely why Tris scaffold 30 –Figure 66 – was unstable, or what the compound 
was reacting with or decomposing into.  
 
HPLC experiments performed when compound 30 was prepared in methanol 
suggested that this might be responsible for the breakdown process, although this 
could not be confirmed by NMR due to low solubility. Switching the HPLC solvents 
so that acetonitrile rather than methanol is used may address decomposition issues, 
allowing the creation of a calibration curve for 30 and subsequent incubation 
experiments with simple monosaccharides.  
 
If a change of solvent is enough to prevent degradation then work to separate and 
identify products of the reaction between a selection of simple sugars and 30 should 
be carried out. Once identified the reaction conditions could be modified to favour 
the tri-saccharide as far as possible. Binding studies with known lectins could then 
be carried out with comparison to purely O-glycoside products (Figure 65) 
 
If however compound 30 continues to decompose after a change in HPLC solvent, 
systematic synthetic changes to the scaffold may be necessary. Initial investigations 
of this nature should start by swapping the nitro benzoyl chromophore. If this fails, 
subsequent investigation should concentrate on adjustments to the aminooxy-azide 
linker, 24, used in the scaffold’s construction.  
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Boc
N
O
N3
24  
Figure 67: Aminooxy-azide linker, 24 
 
The direction of future work on related calixarene scaffolds is clearer. Successful 
synthesis of 46 in high yield (79%) suggests that introducing aminooxy functionality 
to the calix upper rim is likely to be a simple process comparable to that for its 
benzene equivalents. A proposed synthetic route is outlined below in Scheme 74. A 
variety of fluorophores or chromophores could be used as outlined and a small 
library of glycocalixes produced. Binding of these ligand mimics to relevant lectins 
could then be investigated. 
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Scheme 74: Proposed synthetic route to aminooxy linked glycocalixes with 
fluorophores or chromophores appended to the lower rim (where Fluor is any 
suitable fluorophore or chromophore). 
 
Future work should aim to further develop the scaffolds discussed and apply this 
approach to a wider selection of scaffolds.
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7. Experimental 
 
7.1 General 
Proton and 
13
C NMR spectra were recorded using Fourier Transform mode on a 
Bruker
TM
 Ultrashield PLUS 400 at 400 MHz and 100MHz respectively using Fourier 
Transform mode. Spectra were analysed and processed using Topspin 3.2 and 
MestReNova 6.0.2-5475 software. Chemical shifts are recorded in parts per million 
(δ) with spectra calibrated using CDCl3, MeOD, D2O and DMSO-d6. Samples in 
D2O were spiked with acetonitrile to allow referencing to 1.47 ppm in the carbon 
spectra. Carbon and hydrogen atoms were assigned using a combination of one 
dimensional proton and carbon spectra with reference to two dimensional spectra 
where appropriate (
1
H-
1
H COSY and 
1
H-
13
C HSQC). Coupling constants (J) are 
quoted in Hertz (Hz). The following abbreviations are used: s=singlet, d=doublet, 
t=triplet, dd=doublet of doublets, dt= doublet of triplets, q=quartet, dq=doublet of 
quartets, ddd= doublet of doublets of doublets, m=multiplet, br=broad peak. IR 
spectra were recorded as unaltered samples on a Perkin Elmer bx FT-IR system with 
an ATR (attenuated total reflection) sample stage using Spectrum v5.3.1 software. 
Electrospray mass spectra were recorded on a LCMS-2010 Shimadzu using 
methanol as the mobile phase. MALDI spectra were recorded using an Axima-CFR 
Kratos Analytical model. Accurate molecular masses were obtained by the National 
Mass Spectrometry Facility at Swansea University. Analytical HPLC was performed 
on an Agilent 1200 instrument with a UV-Vis diode array detector at 254 nm and 
270 nm. Mobile phases used HPLC grade solvents and reagents, mobile phase A was 
water with 0.05% TFA, mobile phase B was methanol with 0.05% TFA. Separation 
was performed using an Eclipse XDB-C18 column with the column temperature 
40
o
C. The flow rate was 1 ml/min and the injection volume varied between runs. The 
gradient started with 5% to 95% B over 15 min, during which all analytes eluted. 
The column was then returned to 5% B and equilibrated for a further 5 min. pD of 
solutions prepared in deuterated solvents was calculated using a low volume Jenway 
3510 probe and the established conversion factor (0.4).
110
 Where deuterated 
phosphate buffer was used the pD was 6.32 and the concentration 100 mM. UV-Vis 
spectra and absorbance measurements were taken using a PerkinElmer Lambda 25 
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uv/vis spectrometer. λmax was determined by measuring absorbance over the range 
220-600 nm and spectra were analysed using UV winlab software. Solutions of 
known concentration were prepared using accurate balances and volumetric flasks 
according to standard procedures. Dilutions were prepared using volumetric flasks 
and pipettes. Quartz cuvettes were used for all measurements which were performed 
in methanol for compound 29 and in water at ~pH6 for compound 30. Optical 
rotations ([α]D) were obtained using a Perkin-Elmer 241 Polarimeter, at the specified 
concentration in the specified solvent. Analytical TLC was carried out on aluminium 
backed Merck TLC Silica gel 60 F254 plates and visualised under UV light or by 
using basic potassium permanagante as a stain and heating. Flash chromatography 
was carried out using 60mM silica gel and the solvent systems specified. All 
chemicals were purchased from Sigma-Aldrich, Acros, Fluka or Alfa-Aesar. 
Anhydrous chloroform was prepared by drying over oven dried molecular sieves 
under an atmosphere of nitrogen. Other anhydrous solvents were purchased from 
Aldrich or Fluka. Petroleum ether refers to the 40-60
o
C boiling fraction. Where 
reactions are reported as being performed in oven dried glassware, under a nitrogen 
atmosphere standard inert reagent handling techniques were used. Where sonication 
was employed to aid reactions a Branson 2510 sonic bath operating at a frequency of 
40 kHz was used.  
 
7.2 Experimental methods 
 
Tert-butyl 1,3-dihydroxy-2-(hydroxymethyl)propan-2-ylcarbamate, 1: 
155
 
NHBoc
HO
HO
OH
 
Tris(hydroxymethyl)aminomethane hydrochloride (4.99 g, 31.65 mmol) was 
suspended in a mixture of dry methanol (90 ml) and triethylamine (10.89 g, 107.6 
mmol, 15 ml) A solution of di-tert-butyl carbonate (7.74 g, 35.47 mmol) in dry 
methanol (45 ml) was added over 15 min. The mixture was stirred at room 
temperature for 4 hrs before the solvent was removed under vacuum. The resulting 
solid was extracted with ethyl acetate (400 ml), washed with brine (50 ml) separated 
and solvent removed giving the product as a white solid (4.54 g, 65%). 
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mp 142.8-143.1
o
C (from ethyl acetate); υmax (ATR) 3413 (N-H), 3293 (O-H), 2961 
(C-H), 1677 (C=O), 1544 (N-H bend), 1466 (C-H bend), 1292 (C-O),  1257 (C-O); 
δH (400 MHz, DMSO) 5.75 (1H, s, NH), 4.49 (3H, t, J=5.6, OH), 3.51 (6H, d, J=5.6, 
CH2), 1.37 (9H, s, Me); δC (100 MHz, DMSO) 155.0 (C=O), 77.8 (C-Me3), 60.4 
(CH2), 60.2 (C-NH), 28.2 (Me); Calculated Mass for C9H19NO5 221.25 m/z (ES
+
) 
244.0 (MNa
+
) 
 
Tert-butyl 1,3-bis(prop-2-ynyloxy)-2-((prop-2-ynyloxy)methyl)propan-2-
ylcarbamate, 2: 
47
 
NHBoc
O
O
O
 
1 (1.00 g, 4.53 mmol) was dissolved in dry DMF (12 ml) in a round bottomed flask 
oven dried and cooled under nitrogen. The solution was cooled to -15
 o
C and 
propargyl bromide (3 ml, 4.01 g, 33.67 mmol) added. Ground potassium hydroxide 
(1.51 g, 26.87 mmol) was then added in portions over 15 min. The mixture was 
allowed to warm to room temperature and then heated to 50
o
C. The mixture was 
stirred at 50
o
C for two days and at room temperature for 24 hrs.  
The mixture was extracted with ethyl acetate (250 ml), washed with brine (150 ml, 
x3), separated, dried over magnesium sulphate, filtered and solvent removed under 
vacuum giving a brown oil. This was purified by flash column chromatography on 
silica using petroleum ether and ethyl acetate (17:3) giving the product as a yellow 
oil (1.05 g, 69%)   
υmax (ATR) 3427 (N-H), 3291 (C-H alkyne), 2975 (C-H), 2884 (C-H), 1711 (C=O), 
1500 (C-H), 1243 (C-O), 1164 (C-O), 1090 (C-N); δH (400 MHz, CDCl3) 4.92 (1H, 
s, NH), 4.15 (6H, d, J=2.4, O-CH2-CCH), 3.78 (6H, s, NC-CH2), 2.42 (3H, t, J=2.4, 
CH), 1.42 (9H, s, Me); δC (100 MHz, CDCl3) 154.9 (C=O), 79.7 (O-CH2-CCH), 79.4 
(C-Me3), 74.7 (CH), 69.1 (O-CH2-CCH), 58.8 (NC-CH2), 58.2 (NH-C), 28.5 (Me); 
Calculated Mass for C18H25NO5 335.39 m/z (ES
+
) 357.9 (MNa
+
) 
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2 Azidoethanol, 3: 
63
 
HO
N3
 
Bromoethanol (2.6 ml, 4.58 g, 36.68 mmol) was dissolved in a mixture of acetone 
(102 ml) and  water (18 ml). Sodium azide (3.48 g, 53.50 mmol) was added and the 
mixture heated to reflux for 16 hrs then allowed to cool to room temperature. 
The mixture was concentrated under vacuum and water added (150 ml). The mixture 
was extracted with ether (300 ml), separated, dried over magnesium sulphate, filtered 
and solvent removed under vacuum giving the product as a clear oil (2.70 g, 86%) 
υmax (ATR) 3354 (O-H), 2934 (C-H), 2877 (C-H), 2092 (N3), 1283 (C-H), 1061 (C-
O); δH (400 MHz, CDCl3) 3.81 (2H, t, J=4.8, CH2-OH), 3.47 (2H, t, J=4.8, CH2-N3), 
1.47 (1H, br, OH); δC (100 MHz, CDCl3) 61.6 (CH2-OH), 53.7 (CH2-N3); Calculated 
Mass for C2H5N3O 87.08 m/z (ES
+
) 104.9 (MH2O
+
) 
 
2-Azidoethyl 2,3,4,6-tetra O-acetyl β-D-galactopyranoside, 4: 
156
 
O
AcO
AcO
OAc
O
OAc
N3
 
D-Galactose pentacetate (508 mg, 1.3 mmol) and 3 (225 mg, 2.58 mmol) were 
dissolved in dry DCM (10 ml) in apparatus oven dried and cooled under nitrogen. 
The mixture was then cooled to 0
o
C and boron trifluoride diethyl etherate (0.2 ml, 
230 mg, 1.62 mmol) was added. The mixture was stirred at 0
o
C for an hour then 
allowed to warm to room temperature. The mixture was stirred at room temperature 
for 20 hrs then diluted with DCM (200 ml). The organic layer was washed with 
saturated sodium hydrogen carbonate solution (150 ml) and water (150 ml, x3), 
separated, dried over magnesium sulphate, filtered and solvent removed giving a 
clear oil.  
This was purified by flash column chromatography on silica using petroleum ether 
and ethyl acetate (1:1) giving the product as a clear oil (289 mg, 53%) 
[α]D
17.9
 -19.4 (c 1.13, MeOH) (lit.,
157
 [α]D
27
 -11.5 (c 1, CHCl3)); υmax (ATR) 2103 
(N3), 1741 (C=O), 1367 (C-O), 1211 (C-H); δH (400 MHz, CDCl3) 5.37 (1H, dd, J3-
4=3.4, J4-5=0.8, H-4), 5.21 (1H, dd, J1-2=7.8, J2-3=10.6, H-2), 5.00 (1H, dd, J2-3, J3-4, 
H-3), 4.54 (1H, d, J1-2, C-H anomeric), 4.16-4.09 (2H, m, H-6), 4.09-4.04 (1H, m, 
GalO-CH2), 3.91 (1H, dt, J4-5, J5-6=6.8, H-5), 3.68-3.62 (1H, m, GalO-CH2), 3.49-
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3.43 (1H, m, CH2-N3), 3.29-3.23 (1H, m, CH2-N3), 2.13 (3H, s, Me), 2.04 (3H, s, 
Me), 2.02 (3H, s, Me), 1.96 (3H, s, Me); δC (100 MHz, CDCl3) 170.5 (C=O), 170.3 
(C=O), 170.2 (C=O), 169.6 (C=O), 101.2 (C-H anomeric), 71.0 (C-3), 70.9 (C-5), 
68.6 (C-2), 68.5 (GalO-CH2), 67.1 (C-4), 61.3 (C-6), 50.6 (CH2-N3), 20.8 (Me), 20.7 
(Me), 20.7 (Me), 20.6 (Me); Calculated Mass for C16H23N3O10 417.37 m/z (ES
+
) 
439.9 (MNa
+
) 
 
Tert-butyl 1,3-bis((1-(2-ethyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside)-1H-
1,2,3-triazol-4-yl)methoxy)-2-(((1-(2-ethyl 2,3,4,6-tetra-O-acetyl-β-D-
galactopyranoside)-1H-1,2,3-triazol-4-yl)methoxy)methyl)propan-2-
ylcarbamate, 5: 
NHBoc
O
O
O
N
N
N
NN
N
N
N
N
O
O
AcO
AcO
AcO
OAc
O
AcO
AcO
OAc
O
OAc
O
AcO
AcO
OAc
O
OAc
 
 
4 (208 mg, 0.498 mmol) was added to a solution of 2 (52 mg, 0.154mmol) in DMF 
(4 ml) followed by copper sulphate (39 mg, 0.156 mmol) and sodium ascorbate (27 
mg, 0.134 mmol). The mixture was stirred at room temperature for 20 hrs. 
The mixture was then extracted with ethyl acetate (200 ml), washed with brine (100 
ml, x4), separated, dried over magnesium sulphate, filtered and solvent removed 
under vacuum giving a pale oil. This was purified by flash column chromatography 
on silica using ethyl acetate and methanol (19:1) giving the product as a clear oil 
(161 mg, 66%) 
[α]D
18.0 
-15.4 (c 1.19, MeOH); υmax (ATR) 2959 (C-H), 1744 (C=O), 1504 (C-H), 
1367 (C-O), 1215 (C-O), 1044 (C-N); δH (400 MHz, CDCl3) 7.62 (3H, s, CH 
triazole), 5.38 (3H, dd, J3-4=3.2, J4-5=0.8, H-4), 5.17 (3H, dd, J1-2=8, J2-3=10.4, H-2), 
5.05 (1H, s, NH), 4.98 (3H, dd, J2-3, J3-4, H-3), 4.64-4.61 (3H, m, N-CH2), 4.60 (6H, 
s, CH2-triazole), 4.54 (3H, dd, J1 =8.6, J2=3.8, N-CH2), 4.47 (3H, d, J1-2, CH 
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anomeric), 4.26 (3H, dt, J1 =8.6, J2=3.8, GalO-CH2), 4.18-4.09 (6H, m, H-6), 3.96-
3.90 (6H, m, H-5, GalO-CH2), 3.77 (6H, s, CH2-CNH), 2.15 (9H, s, O=C-Me), 2.04 
(9H, s, O=C-Me), 1.97 (9H, s, O=C-Me), 1.93 (9H, s, O=C-Me), 1.39 (9H, s, C-
Me3); δC (100 MHz, CDCl3) 170.5 (C=O, Ac), 170.3 (C=O, Ac), 170.2 (C=O, Ac), 
169.6 (C=O, Ac), 154.9 (C=O, Boc), 144.7 (C, triazole), 124.3 (CH, triazole), 101.1  
(CH, anomeric), 71.0 (C-5), 70.7 (C-3), 69.5 (CH2-CNH), 68.5 (C-2), 67.7 (GalO-
CH2), 67.0 (C-4), 64.8 (CH2-triazole) , 61.3 (C-6), 58.6 (C-NH), 50.2 (N-CH2), 28.5 
(Me, Boc), 20.8 (Me, Ac), 20.8 (Me, Ac), 20.7 (Me, Ac); Calculated Mass for 
C66H94N10O35 1587.5956 m/z (MALDI) 1488.92 (M
+
 -BOC); HRMS (ES
+
): 
1587.5954 (M
+
)  
 
N-acetyl 1,3,4,6-tetraacetate α-D-Glucosamine,  6: 
O
AcO
AcO
OAc
AcHN
OAc
 
α-D-Glucosamine (2.64 g, 11.94 mmol) was suspended in  pyridine (27 ml). Acetic 
anhydride (5.7 ml, 60.30 mmol) was added and the mixture was stirred for 17 hrs. 
The mixture was then concentrated and extracted with DCM (300 ml). The organic 
layer was washed with 1M aqueous HCl (100 ml), saturated copper sulphate solution 
(100 ml) and brine (150 ml, x4), separated, dried over magnesium sulphate, filtered 
and solvent removed under vacuum. The resulting concentrated suspension in DCM 
was left in air overnight to crystallise. This gave 6 as pale crystals (3.87 g, 83%).  
mp 133.4-136.8
o
C (from ethyl acetate) (lit.,
67
 134-135
o
C from ethyl 
acetate:petroleum ether); [α]D
18.2 
+89.4 (c 1.19, MeOH) (lit.,
67
 [α]D
21 
+94 (c 1, 
CHCl3)); υmax (ATR) 3437 (N-H), 1739 (C=O ester), 1734 (C=O ester), 1672 (C=O 
amide), 1517 (N-H bend), 1381 (C-H), 1239 (C-O), 1222 (C-O), 1038 (C-N); δH 
(400 MHz, CDCl3) 6.17 (1H, d, J1-2=3.6, C-H, anomeric), 5.53 (1H, d, JNH-2=9.0, 
NH), 5.26-5.18 (2H, m, H-3, H-4), 4.51-4.45 (1H, m, H-2), 4.25 (1H, dd, J5-6a=4.0, 
J6-6=12.4, H-6), 4.06 (1H, dd, J5-6b=2.4, J6-6, H-6), 3.99 (1H, dt, J4-5=9.2, J5-6a, J5-6b, 
H-5), 2.19 (3H, s, Me), 2.08 (3H, s, Me), 2.06 (3H, s, Me), 2.04 (3H, s, Me), 1.94 
(3H, s, NH-Ac); δC (100 MHz, CDCl3) 171.9 (C=O), 170.8 (C=O), 170.0 (C=O), 
169.2 (C=O), 168.7 (C=O), 90.8 (CH, anomeric), 70.8 (C-4 or C-3), 69.9 (C-5), 67.6 
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(C-4 or C-3), 61.7 (C-6), 51.2 (C-2), 23.2 (NH-Ac), 21.1 (Me), 20.9 (Me), 20.8 
(Me), 20.7 (Me); Calculated Mass for C16H23NO10 389.35 m/z (ES
+
) 412.1 (MNa
+
) 
 
2-Methyl-(3,4,6-tri-O-acetyl-1,2-dideoxy-α-D-glucopyrano)-[2,1-d]-2-oxazoline, 
7: 
65
 
O
AcO
AcO
O
N
OAc
 
6 (499 mg, 1.28 mmol) was dissolved in dichloroethane (3 ml) in a round bottomed 
flask oven dried and cooled under nitrogen. Trimethylsilyl trifluoromethanesulfonate 
(0.25 ml, 1.38 mmol) was added. The mixture was then heated to 50
o
C and stirred 
for 18 hrs.  
The mixture was then cooled and diluted with DCM (200 ml). The organic mixture 
was washed with saturated sodium hydrogen carbonate solution (150 ml, x2) and 
brine (150 ml, x3), separated, dried over magnesium sulphate, filtered and solvent 
removed under vacuum giving 7 as a dark oil (401 mg, crude) 
[α]D
18.4 
+6.0 (c 1.05, MeOH) (lit.,
68
 [α]D
18 
+12.2 (c 1, CHCl3)); υmax (ATR) 2961 (C-
H), 1737 (C=O), 1672 (C=N), 1368 (C-H bend), 1218 (C-O), 1035 (C-N); δH (400 
MHz, CDCl3) 5.96 (1H, d, J1-2=7.2, C-H anomeric), 5.26 (1H, t, J2-3=2.6, J3-4=1.0 H-
3), 4.92 (1H, dq, J3-4, J4-5=9.2, H-4), 4.17-4.16 (2H, m, H-6), 4.14-4.11 (1H, m, H-2), 
3.62-3.58 (1H, m H-5), 2.11 (3H, s, Me), 2.09 (3H, s, Me), 2.08 (3H, d, J=1.6, Me-
C=N), 2.07 (3H, s, Me); δC (100 MHz, CDCl3) 170.7 (C=O), 169.7 (C=O), 169.3 
(C=O), 166.8 (C=N), 99.5 (C-H anomeric), 70.5 (C-3), 68.5 (C-4), 67.7 (C-5), 65.1 
(C-2), 63.5 (C-6), 21.1 (Me), 21.0 (Me), 20.9 (Me), 14.1 (Me-C=N); Calculated 
Mass for C14H19NO8 329.30 m/z (ES
+
) 330.1 (MH
+
) 
 
2-Azidoethyl 2-(acetylamino)-2-deoxy-, 3,4,6-triacetate β-D-glucopyranoside,  8: 
65
 
O
AcO
AcO
AcHN
OAc
O
N3  
7 (679 mg, 2.06 mmol) and 3 (368 mg, 4.23 mmol) were dried by co-evaporation 
with toluene. The reagents were then dissolved in dry DCM (10 ml) and transferred 
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to apparatus oven dried and cooled under nitrogen. Anhydrous CuCl2 dried under 
vacuum was then added (300 mg, 2.23 mmol) giving a dark blue mixture. The 
mixture was heated to reflux, turning dark green. 
The mixture was refluxed for 73 hrs then allowed to cool to room temperature. The 
mixture was diluted with DCM (200 ml) and filtered. The organic mixture was then 
washed with saturated sodium hydrogen carbonate solution (200 ml) and brine (150 
ml, x3), separated, dried over magnesium sulphate, filtered and solvent removed 
under vacuum giving a pale semi-solid. 
This was purified by flash column chromatography on silica using ethyl acetate and 
methanol (99:1) giving 8 as a white semi-solid (138 mg, 16%) 
[α]D
23.6 
-31.0 (c 3.66, MeOH) (lit.,
158
 [α]D
19-21 
-30 (c 1, CHCl3)); υmax (ATR) 3251 
(N-H), 2111 (N3), 1744 (C=O ester), 1655 (C=O amide), 1570 (N-H bend), 1367 (C-
H), 1243 (C-O), 1228 (C-O), 1032 (C-N); δH (400 MHz, CDCl3) 5.58 (1H, d, JNH-
2=8.4, NH), 5.36 (1H, dd, J2-3=9.2, J3-4=10.2, H-3), 5.07 (1H, t, J3-4, H-4), 4.83 (1H, 
d, J1-2=8.4, CH anomeric), 4.25 (1H, dd, J5-6a=4.8, J6-6=12.0, H-6), 4.15 (1H, dd, J5-
6b=2.4, J6-6, H-6), 4.07-4.02 (1H, m, O-CH2CH2), 3.84-3.77 (1H, m, H-2), 3.75-3.68 
(2H, m, H-5, O-CH2-CH2), 3.54-3.45 (1H, m, CH2-N3), 3.29-3.23 (1H, m, CH2-N3), 
2.08 (3H, s, Me), 2.03 (3H, s, Me), 2.02 (3H, s, Me), 1.95 (3H, s, NH-Ac); δC (100 
MHz, CDCl3) 170.9 (C=O), 170.8 (C=O), 170.6 (C=O), 169.6 (C=O), 100.6 (CH, 
anomeric), 72.2 (C-5), 72.1 (C-3), 68.7 (C-4), 68.6 (O-CH2-CH2), 62.1 (C-6), 55.0 
(C-2), 50.8 (CH2-N3), 23.5 (NH-Ac), 20.9 (Me), 20.8 (Me), 20.8 (Me); Calculated 
Mass for C16H24N4O9 416.38 m/z (ES
+
) 417.1 (MH
+
) 
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Tert-butyl 1,3-bis((1-(2-ethyl 2-(acetylamino)-2-deoxy-, 3,4,6-tri-O-acetyl-β-D-
glucopyranoside)-1H-1,2,3-triazol-4-yl)methoxy)-2-(((1-(2-ethyl 2-
(acetylamino)-2-deoxy-, 3,4,6-tri-O-acetyl-β-D-glucopyranoside)-1H-1,2,3-
triazol-4-yl)methoxy)methyl)propan-2-ylcarbamate, 9: 
NHBoc
O
O
O
N
N
N
NN
N
N
N
N
O
O
AcO
NHAc
OAc
O
AcO
NHAc
O
OAc
O
AcO
NHAc
O
OAc
AcO
AcO
AcO
 
8 (236 mg, 0.57 mmol) was added to a solution of 2 (58 mg, 0.17 mmol), sodium 
ascorbate (32 mg, 0.16 mmol) and copper sulphate (43 mg, 0.17 mmol) in DMF (4 
ml). The mixture was stirred at room temperature for 22 hrs then extracted with ethyl 
acetate (300 ml). The organic layer was washed with brine (150 ml, x4), separated, 
dried over magnesium sulphate, filtered and solvent removed under vacuum giving 
the crude as a pale oil.   
This was purified by flash column chromatography on silica using DCM and 
methanol (9:1) giving 9 as a white semi-solid (14.6 mg, 5%) 
[α]D
23.5 
-15.7 (c 0.89, MeOH); υmax (ATR) 3282 (N-H), 2960 (C-H), 1742 (C=O 
ester), 1661 (C=O amide), 1532 (N-H bend), 1367 (C-H), 1223 (C-O), 1165 (C-N), 
1035 (C-N); δH (400 MHz, CDCl3) 7.70 (3H, s, CH triazole), 7.10 (3H, d, JNH-2=8.8, 
NH, GlcNAc), 5.33-5.28 (3H, m, H-3), 5.05 (3H, t, J4-5=9.8, H-4), 4.95 (1H, br, NH, 
Tris), 4.84 (3H, d, J1-2=8.4, CH, anomeric), 4.67-4.61 (3H, m, O-CH2-CH2), 4.53 
(6H, s, O-CH2-triazole), 4.50-4.44 (3H, m, O-CH2-CH2), 4.32-4.23 (6H, m, H-6, 
CH2-N), 4.16 (3H, dd, J5-6a=2.4, J6-6=12.4, H-6), 3.98 (3H, dd, JNH-2, J1-2, J2-3=10.2, 
H-2), 3.89-3.83 (3H, m, CH2-N), 3.77 (3H, ddd, J4-5, J5-6a, J5-6b=4.6, H-5), 3.61 (6H, 
s, NHC-CH2), 2.09 (9H, s, Me), 2.01 (9H, s, Me), 2.00 (9H, s, Me), 1.91 (9H, s, Me, 
N-Ac), 1.42 (9H, s, C-Me3); δC (100 MHz, CDCl3) 171.0 (C=O, Ac), 170.8 (C=O, 
Ac), 169.6 (C=O, Ac), 144.4 (C, triazole), 124.5 (CH, triazole), 100.5 (CH, 
anomeric), 72.4 (C-3), 72.0 (C-5), 69.4 (NHC-CH2), 69.0 (C-4), 67.1 (CH2-N), 64.3 
 157 
 
(O-CH2-triazole), 62.2 (C-6), 54.3 (C-2), 50.2 (O-CH2-CH2), 28.5 (Me, Boc), 23.3  
(Me, N-Ac), 20.9 (Me, Ac), 20.8 (Me, Ac), 20.8 (Me, Ac); Calculated Mass for 
C66H97N13O32 1584.6430 (MALDI) 1486.77 (M
+
 -BOC), 1608.97 (MNa
+
); HRMS 
(ES
+
): 1584.6428 (M
+
) 
 
2-Bromoethyl 2,3,4,6-tetra-O-acetyl β-D-glucopyranoside, 10: 
71
 
O
AcO
AcO
OAc
OAc
O
Br  
α-D-Glucose pentacetate (507 mg, 1.30 mmol) was dissolved in dry DCM (2 ml) in 
glassware oven dried and cooled under nitrogen. The solution was cooled to -15
o
C 
and bromoethanol (0.1 ml, 176 mg, 1.41 mmol) added followed by boron trifluoride 
diethyl etherate (0.6 ml, 690 mg, 4.86 mmol). The mixture was stirred for an hour 
before being allowed to warm to room temperature.  
The mixture was stirred for 4 days then diluted with DCM (200 ml). The organic 
layer was washed with sat sodium hydrogen carbonate solution (150 ml, x2) and 
brine (150 ml, x3), separated, dried over magnesium sulphate, filtered and solvent 
removed under vacuum giving the crude as a yellow oil. This was purified by flash 
column chromatography on silica using ethyl acetate and petroleum ether (2:3) 
giving a mixture of 10 and glucose pentacetate as a clear oil (201 mg). This was 
further purified by recrystallizing from petroleum ether:ether (9:1) giving 10 as a 
white semi-solid (9 mg, 2%) 
[α]D
23.6 
-16.8 (c 0.9, MeOH) (lit.,
159
 [α]D
25 
-12.5 (c 0.78, CHCl3)); υmax (ATR) 1751 
(C=O), 1740 (C=O), 1734 (C=O), 1730 (C=O), 1375 (C-H), 1366 (C-H), 1218 (C-
O); δH (400 MHz, CDCl3) 5.22 (1H, t, J3-4=9.6, H-3), 5.08 (1H, t, J3-4, H-4), 5.01 
(1H, dd, J1-2=8.0, J2-3=9.6, H-2), 4.57 (1H, d, J1-2, C-H anomeric), 4.26 (1H, dd, J5-
6a=4.8, J6-6=12.4, H-6), 4.18-4.12 (2H, m, H-6, O-CH2-CH2), 3.85-3.78 (1H, m, O-
CH2-CH2), 3.71 (1H, ddd, J4-5=10.0, J5-6a, J5-6b=2.4, H-5), 3.48-344 (2H, m, CH2-Br), 
2.09 (3H, s, Me), 2.07 (3H, s, Me), 2.02 (3H, s, Me), 2.01 (3H, s, Me); δC (100 MHz, 
CDCl3) 170.8 (C=O), 170.4 (C=O), 169.6 (C=O), 169.5 (C=O), 101.2 (C-H 
anomeric), 72.8 (C-3), 72.1 (C-5), 71.2 (C-2), 69.9 (O-CH2-CH2), 68.5 (C-4), 62.0 
(C-6), 30.0 (CH2-Br), 20.9 (Me), 20.9 (Me), 20.8 (Me), 20.7 (Me); Calculated Mass 
for C16H23BrO10 455.25 m/z (ES
+
) 476.9 (MNa
+
) 
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2-Azidoethyl 2,3,4,6-tetra-O-acetyl β-D-glucopyranoside, 11: 
71
 
O
AcO
AcO
OAc
OAc
O
N3  
Crude 10 (3.27 g, 7.174 mmol) was dissolved in dry DMF (30 ml) and sodium azide 
(2.30 g, 35.333 mmol) added. The mixture was heated to 63
o
C and stirred overnight. 
The mixture was allowed to cool and extracted with ethyl acetate (200 ml). The 
mixture was then washed with brine (150 ml, x3), separated, dried over magnesium 
sulphate, filtered and solvent removed under vacuum giving an orange oil.  
This was purified by flash column chromatography on silica using petroleum ether 
and ethyl acetate (3:2) giving 11 as a white solid (483 mg, 23% over two steps from 
glucose penta actetate) 
mp 98.6-103.8
o
C (from hexane); [α]D
25.0 
-48.4
 
(c 1.96, MeOH) (lit.,
72
 [α]D
20 
-31.2
 
(c 
1.14, CH2Cl2)); υmax (ATR) 2950 (C-H), 2105 (N3), 1755 (C=O), 1737 (C=O), 1207 
(C-O); δH (400 MHz, CDCl3) 5.21 (1H, t, J3-4=9.4, H-3), 5.10 (1H, dd, J3-4, J4-5=10.0, 
H-4), 5.02 (1H, dd, J1-2=8.0, J2-3=9.4, H-2), 4.59 (1H, d, J1-2, C-H anomeric), 4.25 
(1H, dd, J5-6a=4.8, J6-6=12.2, H-6), 4.16 (1H, dd, J5-6b=2.4, J6-6=12.2, H-6), 4.03 (1H, 
dq, J1=10.8, J2=4.8, O-CH2-CH2), 3.73-3.66 (2H, m, H-5, O-CH2-CH2), 3.52-3.46 
(1H, m, CH2-N3), 3.29 (1H, dq, J1=13.6, J2=4.8 CH2-N3), 2.09 (3H, s, Me), 2.05 (3H, 
s, Me), 2.03 (3H, s, Me), 2.00 (3H, s, Me); δC (100 MHz, CDCl3) 170.8 (C=O), 
170.4 (C=O), 169.5 (C=O), 169.5 (C=O), 100.8 (C-H, anomeric), 72.9 (C-3), 72.1 
(C-5), 71.2 (C-2), 68.7 (C-4), 68.5 (O-CH2-CH2), 62.0 (C-6), 50.7 (CH2-N3), 20.9 
(Me), 20.8 (Me), 20.7 (Me); Calculated Mass for C16H23N3O10 417.37 m/z (ES
+
) 
440.1 (MNa
+
)  
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Tert-butyl 1,3-bis((1-(2-ethyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside)-1H-
1,2,3-triazol-4-yl)methoxy)-2-(((1-(2-ethyl 2,3,4,6-tetra-O-acetyl-β-D-
glucopyranoside)-1H-1,2,3-triazol-4-yl)methoxy)methyl)propan-2-ylcarbamate, 
12: 
NHBoc
O
O
O
N
N
N
NN
N
N
N
N
O
O
AcO
AcO
OAc
O
AcO
OAc
O
OAc
O
AcO
OAc
O
OAc
AcO
AcO
AcO
 
11 (415 mg, 0.994 mmol) was added to 2 (104 mg, 0.31 mmol) as a solution in DMF 
(5 ml). Sodium ascorbate (49 mg, 0.247 mmol) and copper sulphate (85 mg, 0.340 
mmol) were then added followed by catalytic TBTA. The mixture was stirred at 
room temperature for 5 days then extracted with DCM (300 ml). The organic layer 
was washed with water (150 ml, x4), separated, dried over magnesium sulphate, 
filtered and solvent removed under vacuum giving the crude as an orange oil. 
This was purified by flash column chromatography on silica using ethyl acetate and 
methanol (9:1) giving 12 as a clear oil (170 mg, 35%) 
[α]D
25.0 
-18.3 (c 1.74, MeOH); υmax (ATR) 1744 (C=O), 1215 (C-O); δH (400 MHz, 
CDCl3) 7.60 (3H, s, C-H triazole), 5.17 (3H, t, JH3-H4=9.6, H-3), 5.05 (3H, t, JH4-
H5=9.6, H-4), 5.01 (1H, br, N-H), 5.00-4.95 (3H, dd, JH1-H2=8, JH2-H3=9.6, H-2), 4.62-
4.56 (9H, m, N-CH2-CH2, O-CH2-triazole), 4.74-4.54 (6H, m, CH anomeric, N-CH2-
CH2), 4.27-4.21 (6H, m, O-CH2-CH2, H-6), 4.14-4.10 (3H, m, H-6), 3.97-3.91 (3H, 
m, O-CH2-CH2), 3.75 (6H, s, HNC-(CH2)3), 3.72-3.68 (3H, m, H-5), 2.08 (9H, s, 
Me), 2.01 (9H, s, Me), 1.98 (9H, s, Me), 1.93 (9H, s, Me), 1.39 (9H, s, C-Me3); δC 
(100 MHz, CDCl3) 170.7 (C=O, Ac), 170.2 (C=O, Ac), 169.5 (C=O, Ac), 169.4 
(C=O, Ac), 154.9 (C=O, Boc), 145.0 (C, triazole), 124.0 (CH, triazole), 100.7 (CH, 
anomeric), 72.6 (C-3), 72.1 (C-5), 71.0 (C-2), 69.5 (HN-C-(CH2)3), 68.4 (C-4), 67.9 
(O-CH2-CH2), 64.9 (O-CH2-triazole), 61.9 (C-6), 58.6 (HN-C-(CH2)3), 50.0 (N-CH2-
CH2), 28.5 (Me, Boc), 20.9 (Me, Ac), 20.7 (Me, Ac), 20.7 (Me, Ac); Calculated 
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Mass for C66H94N10O35 1587.5937 m/z MALDI 1611.31 (MNa
+
); HRMS (ES
+
): 
1587.5938 (M
+
) 
 
(2-(2-Cyanoethoxy)-1,1-bis((2-cyanoethoxy)methyl)ethyl)amine; Tris(2-
cyanoethoxymethyl)aminomethane, 13: 
99
 
NH2
O
O
O
N
N
N
 
Tris(hydroxymethyl)aminomethane hydrochloride (3.03 g, 19.213 mmol) was 
suspended in tetrahydrofuran (50 ml) and potassium hydroxide (3.21 g, 57.209 
mmol) added as an aqueous 40wt% solution. The mixture was stirred for 15 min and 
acrylonitrile (7.6 ml, 6.156g, 114.587 mmol) added. The mixture was stirred 
overnight then concentrated before extracting with DCM (200 ml). This was washed 
the water (150 ml) and the aqueous layer extracted with further portions of DCM 
(100 ml, x2). The organic fractions were combined, dried over magnesium sulphate, 
filtered and solvent removed giving a yellow oil. This was purified by flash column 
chromatography on silica using DCM and methanol (9:1) giving the product as a 
yellow oil (2.55 g, 48%) 
υmax (ATR) 3378 (N-H), 2874 (C-H), 2251 (CN), 1587 (N-H), 1465 (C-H), 1270 (C-
O), 1105 (C-NH2), 733 (C-H); δH (400 MHz, CDCl3) 3.67 (6H, t, J=6.0, O-CH2-
CH2), 3.44 (6H, s, C-CH2-O), 2.60 (6H, t, J=6.0, CH2-CN), 2.54 (2H, br, NH2); δC 
(100 MHz, CDCl3) 118.1 (CN), 72.4 (C-CH2-O), 65.8 (O-CH2-CH2), 56.3 (C-NH2), 
18.9 (CH2-CN); Calculated Mass for C13H20N4O3 280.32 m/z (ES
+
) 302.9 (MNa
+
) 
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Carbamic acid, N-[2-(2-cyanoethoxy)-1,1-bis[(2-cyanoethoxy)methyl]ethyl]-, 1,
1-dimethylethyl ester, 14: 
99
 
NHBoc
O
O
O
N
N
N
 
13 (497 mg, 1.773 mmol), was dissolved in tetrahydrofuran (5 ml) and cooled to 
0
o
C. A solution of di-tert-butyl dicarbonate (494 mg, 2.263 mmol) in tetrahydrofuran 
(1 ml) was then added followed by triethylamine (0.3 ml, 2.152 mmol). The mixture 
was allowed to warm to room temperature and stirred for 6 hrs. The mixture was 
extracted with ethyl acetate (100 ml), washed with brine (100 ml, x3), separated, 
dried over magnesium sulphate, filtered and solvent removed giving a pale oil. This 
was purified by flash column chromatography on silica using DCM and methanol 
(49:1) giving 14 as a yellow oil (606 mg, 89%). 
υmax (ATR) 3426 (N-H), 2975 (C-H), 2933 (C-H), 2882 (C-H), 2251 (CN), 1708 
(C=O), 1500 (N-H), 1269 (C-O), 1245 (C-O), 1108 (C-NH); δH (400 MHz, CDCl3) 
4.86 (1H, br, NH), 3.77 (6H, s, C-CH2-O), 3.69 (6H, t, J=6.0, O-CH2-CH2), 2.60 
(6H, t, J=6.0, CH2-CN), 1.42 (9H, s, Me); δC (100 MHz, CDCl3) 154.9 (C=O), 118.0 
(CN), 79.8 (C-Me3), 69.5 (C-CH2-O), 65.9 (O-CH2-CH2), 58.6 (C-NH), 28.4 (Me), 
18.9 (CH2-CN); Calculated Mass for C18H28N4O5 380.44 m/z (ES
+
) 403.0 (MNa
+
) 
 
Carbamic acid, [2-(2-propenyloxy)-1,1-bis[(2-propenyloxy)methyl]ethyl]-, 1,1-
dimethylethyl ester, 15: 
160
 
NHBoc
O
O
O
 
1 (1.00 g, 4.520 mmol) was suspended in dry DMF (10 ml) in glassware oven dried 
under N2. Allyl bromide (2.4 ml, 3.36 g, 27.734 mmol) was added and the mixture 
cooled to 0
o
C. Ground potassium hydroxide (991 mg, 17.662 mmol) was then added 
in portions over 15 min. The mixture was allowed to warm to room temperature and 
stirred overnight. The mixture was extracted with ethyl acetate (200 ml), washed 
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with brine (150 ml, x3), separated, dried over magnesium sulphate, filtered and 
solvent removed giving a yellow oil. This was purified by flash column 
chromatography on silica using petroleum ether and ethyl acetate (9:1) giving the 
product as a clear oil (393 mg, 25%) 
υmax (ATR) 3447 (N-H), 3079 (C-H, alkene), 2977 (C-H), 2929 (C-H), 2871 (C-H), 
1716 (C=O), 1647 (C-C, alkene), 1497 (C-H), 1243 (C-O), 1167 (C-O), 1089 (C-N), 
990 (C-H, alkene), 921 (C-H, alkene); δH (400 MHz, CDCl3) 5.93-5.83 (3H, m, CH), 
5.28-5.14 (6H, m,  CH2CH-CH2), 4.96 (1H, br, NH), 3.98 (6H, dt, J1=5.6, J2=1.2, O-
CH2CH), 3.70 (6H, s, C-CH2), 1.42 (9H, s, Me); δC (100 MHz, CDCl3) 155.0 (C=O), 
134.9 (CH), 116.9 (CH2CH-CH2), 79.1 (C-Me3), 72.4 (CH2-CHCH2), 69.3 (C-CH2), 
58.7 (C-NH), 28.5 (Me); Calculated Mass for C18H31NO5 341.44 m/z (ES
+
) 364.0 
(MNa
+
) 
 
2-Azidoethyl tosylate, 16: 
161
 
O
N3S
O
O
 
Azidoethanol 3 (1.02 g, 11.656 mmol) was dissolved in dry chloroform (5 ml) in 
glassware previously oven dried and cooled under nitrogen. Dry pyridine (0.95 ml, 
11.746 mmol) was added and the mixture cooled to 0
o
C. Para tosyl chloride (2.21 g, 
11.581 mmol) was dissolved in dry chloroform (20 ml) and this was added dropwise 
to the cooled mixture. Following addition the mixture was allowed to warm to room 
temperature and stirred overnight. The mixture was diluted with chloroform (200 
ml), washed with sat sodium hydrogen carbonate solution (150 ml) and water (150 
ml, x3), separated, dried over magnesium sulphate, filtered and solvent removed 
giving a yellow oil. This was purified by flash column chromatography on silica 
using petroleum ether and ethyl acetate (7:3) giving 16 as a yellow oil (264 mg, 9%). 
υmax (ATR) 2928 (C-H), 2109 (N3), 1597 (C=C), 1495 (C=C), 1441 (C=C), 1360 
(S=O), 911 (S-O); δH (400 MHz, CDCl3) 7.84 (2H, d, J=8.0, Ar), 7.37 (2H, d, J=8.0, 
Ar), 4.17 (2H, t, J=5.2, O-CH2), 3.49 (2H, t, J=5.2, CH2-N3), 2.46 (3H, s, Me); δC 
(100 MHz, CDCl3) 145.4 (Ar-SO3), 132.8 (Ar-Me), 130.1 (Ar), 128.1 (Ar), 68.2 (O-
CH2), 49.7 (CH2-N3), 21.8 (Me) 
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2-(methoxyamino) ethanol, 17: 
162
 
H
N
O
OH 
O-methylhydroxyamine was produced from the hydrochorlic salt by stirring with 
sodium hydroxide in dry THF for 3 days. The solution was filtered and the 
concentration of free amine determined by quantitive NMR using toluene as a 
reference. O-methylhydroxyamine solution (3.4 ml, 600 mg, 12.75 mmol) was 
mixed with bromoethanol (0.3 ml, 529mg, 4.233 mmol). The mixture was warmed to 
45
o
C and stirred overnight, then heated to reflux and stirred for a further day. Solvent 
was removed giving an orange oil which was purified by flash column 
chromatography on silica using DCM and methanol (9:1) giving 17 as a pale oil (66 
mg, 17%) 
υmax (ATR) 3365 (O-H), 2945 (C-H), 1464 (CH2), 1048 (C-N); δH (400 MHz, 
CD3OD) 3.66 (2H, t, J=5.6, CH2-OH), 3.51 (3H, s, Me), 2.97 (2H, t, J=5.6, CH2-N); 
δC (100 MHz, CD3OD) 61.5 (OMe), 59.4 (CH2-OH), 54.2 (CH2-N); Calculated Mass 
for C3H9NO2 91.11 m/z (ES
+
) 91.9 (MH
+
) 
 
N-Boc-O-methyl hydroxylamine, 18: 
163
 
H
NBoc
O
 
Ditertbutyl dicarbonate (14.79 g, 67.766 mmol) was dissolved in DCM (80 ml) and a 
solution of sodium carbonate (16.35 g, 195.773 mmol) in water (70 ml) was added. 
This was followed by addition of a solution of O-methylhydroxylammonium 
chloride (20.18 g, 190.386 mmol) in water (70 ml). A gas was evolved and the 
mixture stirred overnight. The mixture was then diluted with DCM (300 ml), washed 
with water (150 ml, x2), dried over magnesium sulphate, filtered and solvent 
removed giving 18 as a clear oil (8.43 g, 84%)  
υmax (ATR) 3283 (N-H), 2978 (C-H), 1715 (C=O), 1367 (C-H bend), 1250 (C-H), 
1165 (C-N); δH (400 MHz, CDCl3) 3.71 (3H, s, O-Me), 1.48 (9H, s, Me3); δC (100 
MHz, CDCl3) 157.0 (C=O), 81.7 (C-Me3), 64.5 (O-Me), 28.3 (Me) 
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2-Bromoethyl acetate, 19: 
Br
OAc
 
Bromoethanol (5.6 ml, 9.87g, 78.963 mmol) was dissolved in dry DCM (25 ml) and 
cooled to 0
o
C. Acetic anhydride (7.6 ml, 8.21g, 80.4 mmol) was then added. The 
mixture was allowed to warm to room temperature and stirred in the dark overnight. 
The mixture was then diluted with DCM (250 ml), washed with water (200 ml, x3), 
separated, dried over magnesium sulphate, filtered and solvent removed giving the 
product as a pale oil (11.79 g, 89%)  
υmax (ATR) 2971 (C-H), 1737 (C=O), 1215 (C-H); δH (400 MHz, CDCl3) 4.37 (2H, t, 
J=6.0, CH2-OAc), 3.50 (2H, t, J=6.0, CH2-Br), 2.09 (3H, s, Me); δC (100 MHz, 
CDCl3) 170.7 (C=O), 63.9 (CH2-OAc), 28.8 (CH2-Br), 20.9 (Me) 
 
2-(tert-butoxycarbonyl(methoxy)amino)ethyl acetate, 20: 
BocN
OAc
O
 
18 (511 mg, 3.449 mmol) was dissolved in dry DMF (5 ml) and cooled to 0
o
C. 
Concurrently 19 (0.6 ml, 908mg, 5.440 mmol) was mixed with sodium iodide (65 
mg, 0.434 mmol). Sodium hydride (267 mg, 6.675 mmol) was added to the solution 
of 18 and a gas evolved. The mixture of 19 and sodium iodide was then added 
dropwise. The reaction was allowed to warm to room temperature and stirred 
overnight in the dark. The mixture was quenched with water and extracted with 
DCM (200 ml). The mixture was then washed with water (100 ml, x4), separated, 
dried over magnesium sulphate, filtered and solvent removed giving a yellow oil 
(975 mg crude).  
υmax (ATR) 2934 (C-H), 1740 (C=O), 1675 (C=O), 1367 (C-H bend), 1229 (C-H), 
1166 (C-O), 1137 (C-O); δH (400 MHz, CDCl3) 4.23 (2H, t, J=5.8, O-CH2), 3.71-
3.68 (5H, m, O-Me, CH2-N), 2.05 (3H, s, Me, Ac), 1.50 (9H, s, Me, Boc); δC (100 
MHz, CDCl3) 170.9 (C=O, Ac), 156.3 (C=O, Boc), 81.6 (C-Me3), 62.5 (O-Me), 60.7 
(O-CH2), 47.9 (CH2-N), 28.3 (Me, Boc), 20.9 (Me, Ac); Calculated Mass for 
C10H19NO5 233.26 m/z (ES
+
) 255.9 (MNa
+
) 
 
 
 
 165 
 
Tert-butyl 2-hydroxyethyl(methoxy)carbamate, 21: 
BocN
OH
O
 
20 (2.34 g, 10.010 mmol) was dissolved in dry methanol (15 ml) and cooled to 0
o
C. 
Sodium methoxide (281 mg, 5.202 mmol) was then added and the mixture stirred for 
3 hrs.  
The mixture was then diluted with methanol and filtered through protonated ion 
exchange resin. Solvent was removed giving 21 as a yellow oil (1.50 g, 47% over 
two steps from 18 and 19)   
υmax (ATR) 3435 (O-H), 2976 (C-H), 2935 (C-H), 1698 (C=O), 1366 (C-H bend), 
1161 (C-O), 1113 (C-O); δH (400 MHz, CDCl3) 3.77 (2H, t, J=5.2, CH2-OH), 3.68 
(3H, s, O-Me), 3.60 (2H, t, J=5.2, CH2-N), 2.46 (1H, br, OH), 1.48 (9H, s, Me); δC 
(100 MHz, CDCl3) 157.0 (C=O), 81.9 (CMe3), 62.5 (O-Me), 60.5 (CH2-OH), 51.8 
(CH2-N), 28.4 (Me, Boc); Calculated Mass for C8H17NO4 191.22 m/z (ES
+
) 213.9 
(MNa
+
) 
  
Tert-butyl 2-(diphenoxyphosphoryloxy)ethyl(methoxy)carbamate, 22: 
BocN
O
O
P
O O
O
 
21 (51 mg, 0.267 mmol) was dissolved in dry toluene (3 ml) in a round bottomed 
flask oven dried and cooled under nitrogen. The solution was cooled to 0
o
C. 
Diphenyl phosporyl azide (0.2 ml, 255mg, 0.928 mmol) was added followed by 
DBU (0.1 ml, 102mg, 0.669 mmol). The mixture was stirred at 0
o
C for 3 hrs and 
sodium azide (52 mg, 0.800 mmol) added. The mixture was allowed to warm to 
room temperature and stirred overnight. The mixture was quenched with 1M 
aqueous HCl (4 ml) and extracted with chloroform (50 ml). It was then washed with 
water (30 ml, x2), separated, dried over magnesium sulphate, filtered and solvent 
removed giving a brown oil. This was purified by flash column chromatography on 
silica using DCM and methanol (50:1) giving 22 as a clear oil (56 mg, 50%) 
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υmax (ATR) 2975 (C-H), 1701 (C=O), 1589 (C=C), 1488 (C=C), 1187 (P=O), 946 
(P-O); δH (400 MHz, CDCl3) 7.36-7.32 (4H, m, Ar), 7.24-7.18 (6H, m, Ar), 4.41-
4.37 (2H, m, O-CH2), 3.75 (2H, dt, J1=5.6, J2=1.2, N-CH2), 3.66 (3H, s, O-Me), 1.48 
(9H, s, Me); δC (100 MHz, CDCl3) 156.3 (C=O), 150.6 (d, J=7.1, Ar, ipso), 129.9 (d, 
J=0.4, Ar, meta), 125.5 (d, J=1.1, Ar, para), 120.2 (d, J=4.9, Ar ortho), 82.0 (C-Me3), 
65.2 (d, J=6.2, O-CH2), 62.8 (O-Me), 49.7 (d, J=8.0, N-CH2), 28.3 (Me); δP (162 
MHz, CDCl3) -12.0 (P); Calculated Mass for C20H26NO7P 423.40 m/z (ES
+
) 446.1 
(MNa
+
) 
 
2-(tert-butoxycarbonyl(methoxy)amino)ethyl methanesulfonate, 23: 
BocN
O
S
O
O
O
 
21 (722 mg, 3.776 mmol) was dissolved in DCM (15 ml) and triethylamine added 
(1.3 ml, 944mg, 9.327 mmol). The mixture was cooled to 0
o
C and mesyl chloride 
(0.75 ml, 1.11g, 9.690 mmol) added. The mixture was allowed to warm to room 
temperature, stirred for 1½hrs then quenched by stirring with excess sat sodium 
hydrogen carbonate solution. The mixture was extracted with dichloromethane (150 
ml), washed with sat sodium hydrogen carbonate solution (100 ml) and brine (100 
ml, x3), separated, dried over magnesium sulphate, filtered and solvent removed 
giving the product as a yellow oil (488 mg, 48%) 
υmax (ATR) 2977 (C-H), 1701 (C=O), 1350 (SO2OR), 1171 (SO2OR), 1121 (C-O); 
δH (400 MHz, CDCl3) 4.36 (2H, t, J=5.6, O-CH2), 3.78 (2H, t, J=5.6, N-CH2), 3.71 
(3H, s, O-Me), 3.02 (3H, s, S-Me), 1.50 (9H, s, Me); δC (100 MHz, CDCl3) 156.3 
(C=O), 82.3 (C-Me3), 65.7 (O-Me), 62.7 (O-CH2), 48.5 (N-CH2), 37.7 (S-Me), 28.3 
(C-Me3); Calculated Mass for C9H19NO6S 269.32 m/z (ES
+
) 292.1 (MNa
+
) 
 
Tert-butyl 2-azidoethyl(methoxy)carbamate, 24: 
BocN
N3
O
 
23 (488 mg, 1.812 mmol) was dissolved in dry DMF (4 ml) and sodium azide (381 
mg, 5.853 mmol) added. The mixture was heated to 50
o
C and stirred overnight. The 
mixture was allowed to cool to room temperature and extracted with chloroform 
(150 ml). The mixture was washed with brine (100 ml, x3), separated, dried over 
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magnesium sulphate, filtered and solvent removed giving the product as a yellow oil 
(327 mg, 83%) 
υmax (ATR) 2977 (C-H), 2935 (C-H), 2100 (N3), 1701 (C=O), 1366 (C-H bend), 
1162 (C-O), 1111 (C-O); δH (400 MHz, CDCl3) 3.71 (3H, s, O-Me), 3.63 (2H, t, 
J=6.0, N-CH2), 3.46 (2H, t, J=6.0, N3-CH2), 1.51 (9H, s, Me); δC (100 MHz, CDCl3) 
156.3 (C=O), 82.1 (C-Me3), 62.7 (O-Me), 48.5 (N3-CH2), 48.3 (N-CH2), 28.4 (C-
Me3) 
 
Tert-butyl 2-tri((1-(2-(tert-butoxycarbonyl(methoxy)amino)ethyl)-1H-1,2,3-
triazol-4-yl)methoxy)ethylcarbamate, 25: 
NHBoc
O
O
O N
NN
N
N
N
NN
N
N
Boc
NBoc
BocN
O
O
O
 
Tripropargyl Tris core 2 (79 mg, 0.236 mmol) was added to a solution of 24 (200 
mg, 0.925 mmol) in DMF (3 ml). Sodium ascorbate (36 mg, 0.182 mmol) and 
copper sulphate (143 mg, 0.573 mmol) were then added followed by catalytic 
TBTA. The mixture was stirred at room temperature for 3 days then extracted with 
chloroform (150 ml). The organic layer was washed with water (100 ml, x4) , 
separated, dried over magnesium sulphate, filtered and solvent removed under 
vacuum giving the crude as a green oil. 
This was purified by flash column chromatography on silica using DCM and 
methanol (19:1) giving 25 as a clear oil (182 mg, 79%) 
υmax (ATR) 2977 (C-H), 1707 (C=O), 1672 (C=O); δH (400 MHz, CDCl3) 7.60 (3H, 
s, CH triazole), 4.93 (1H, s, NH), 4.59-4.56 (12H, m, O-CH2, N-CH2 triazole), 3.94 
(6H, t, J=6.0, MeON-CH2), 3.73 (6H, s, HNC-CH2), 3.64 (9H, s, O-Me), 1.40 (27H, 
s, Me Boc aminoxy), 1.40 (9H, s, Me Boc amine); δC (100 MHz, CDCl3) 155.7 
(C=O), 154.9 (C=O), 145.1 (C, triazole), 123.5 (CH, triazole), 82.2 (C-Me3), 82.2 
(C-Me3), 69.5 (HNC-CH2), 65.0 (O-CH2-triazole), 62.5 (O-Me) , 58.5 (HNC-CH2), 
49.1 (MeON-CH2), 47.3 (N-CH2 triazole), 28.5 (Me, Boc amine), 28.2 (Me, Boc 
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aminoxy); Calculated Mass for C42H73N13O14 984.5473 m/z (MALDI) 1007.22 
(MNa
+
), 1047.23 (MCu
+
); HRMS (ES
+
) 984.5460 (MH
+
) 
 
Mono(1,3-bis((1-(2-(methoxyammonio)ethyl)-1H-1,2,3-triazol-4-yl)methoxy)-2-
(((1-(2-(methoxyammonio)ethyl)-1H-1,2,3-triazol-4-yl)methoxy)methyl)propan-
2-aminium) monochloride, 26: 
NH3
O
O
O N
NN
N
N
N
NN
N
N
H2
NH2
H2N
O
O
O
4 Cl
 
25 (35 mg, 0.036 mmol) was dissolved in 2M hydrochloric methanol (10 ml) and 
stirred for 30 min. The solvent was then removed under vacuum giving the product 
as a pale oil (32 mg, crude) 
υmax (ATR) 2439 (N-H ammonium), 1147 (C-N), 1095 (C-O); δH (400 MHz, D2O) 
8.09 (3H, s, C-H triazole), 4.84 (6H, t, J=5.6, N-CH2 triazole), 4.59 (6H, s, O-CH2 
triazole), 3.89 (6H, t, J=5.6, MeONH-CH2), 3.80 (9H, s, OMe), 3.58 (6H, s, H2NC-
(CH2)3); δC (100 MHz, D2O) 144.1 (C triazole), 126.4 (C-H triazole), 67.8 (H2NC-
(CH2)3), 63.8 (O-CH2 triazole), 62.2 (O-Me), 59.7 (H2NC-(CH2)3), 48.2 (MeONH-
CH2), 44.9 (N-CH2 triazole); Calculated Mass for C22H41N13O6 583.64 m/z (ES
+
) 
584.3 (MH
+
), 606.3 (MNa
+
) 
 
1,3-bis(prop-2-ynyloxy)-2-((prop-2-ynyloxy)methyl)propan-2-aminium chloride, 
27: 
NH3
O
O
O
Cl
 
Tri propargyl Tris core 2 (98 mg, 0.292 mmol) was dissolved in 2M hydrochloric 
methanol (3 ml) and stirred for 3 hrs. The solvent was removed under vacuum giving 
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the crude as a brown oil. This was washed with cold ether (10 ml, x2), giving the 
product as a yellow oil (40 mg, 51%) 
υmax (ATR) 3287 (C-H alkyne), 2884 (N-H ammonium), 2114 (C≡C alkyne); δH (400 
MHz, CD3OD) 4.26 (6H, d, J=2.4, O-CH2C), 3.73 (6H, s, NC(CH2)3), 2.97 (3H, t, 
J=2.4, C-H); δC (100 MHz, CD3OD) 79.6 (O-CH2C), 77.1 (CH), 68.8 (O-CH2C), 
60.1 (NH-C), 59.6 (NC(CH2)3); Calculated Mass for C13H17NO3 236.1281 m/z (ES
+
) 
236.0 (M
+
); HRMS (ES
+
): 236.1282 (M
+
)  
 
N-(1,3-bis(prop-2-ynyloxy)-2-((prop-2-ynyloxy)methyl)propan-2-yl)-4-
nitrobenzamide, 28: 
HN
O
O
O
O
NO2  
27 (40 mg, 0.148 mmol) was dissolved in a 1:1 mixture of DCM and triethylamine 
(2 ml). 4-Nitrobenzoyl chloride was added (35 mg, 0.189 mmol) and the mixture 
stirred for 3 hrs. A further 3 ml of triethylamine was then added and the mixture 
stirred overnight. 
The mixture was extracted with DCM (50 ml) washed with water (40 ml, x3), 
separated, dried over magnesium sulphate, filtered and solvent removed under 
vacuum giving the crude as a yellow oil.  
This was purified by flash column chromatography on silica using petroleum ether 
and ethyl acetate (3:2) giving the product as a clear oil (22 mg, 38%) 
υmax (ATR) 3289 (C-H alkyne), 2854 (C-H), 2116 (C≡C), 1663 (C=O), 1602 (C=C), 
1523 (N-O), 1346 (N-O); δH (400 MHz, CDCl3) 8.28-8.25 (2H, m, Ar-H ortho nitro), 
7.92-7.89 (2H, m, Ar-H ortho C=O), 6.50 (1H, s, NH), 4.19 (6H, d, J=2.4, O-CH2-
CCH), 3.97 (6H, s, HNC(CH2)3), 2.45 (3H, t, J=2.4, C-H); δC (100 MHz, CDCl3) 
165.5 (C=O), 149.7 (Ar, ipso C=O), 140.9 (Ar, ipso nitro), 128.3 (Ar ortho C=O), 
123.9 (Ar, ortho nitro), 79.6 (C-CH), 75.0 (C-H), 68.5 (O-CH2-CCH), 60.0 (HN-
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C(CH2)3), 58.9 (HN-C(CH2)3); Calculated Mass for C20H20N2O6 385.1394 m/z (ES
+
) 
385.1 (MH
+
), 407.0 (MNa
+
); HRMS (ES
+
): 385.1394 (MH
+
) 
 
Tert-butyl N-(1,3-bis((1-(2-(methoxyamino)ethyl)-1H-1,2,3-triazol-4-
yl)methoxy)-2-(((1-(2-(methoxyamino)ethyl)-1H-1,2,3-triazol-4-
yl)methoxy)methyl)propan-2-yl)-4-nitrobenzamide carbamate, 29: 
NH
O
O
O N
NN
N
N
N
NN
N
N
Boc
NBoc
BocN
O
O
O
O
NO2
 
28 (508 mg, 1.322 mmol) was dissolved in DMF (21 ml) with 24 (1.13 g, 5.224 
mmol). Copper sulphate (310 mg, 1.242 mmol), sodium ascorbate (238 mg, 1.201 
mmol) and catalytic TBTA were then added and the mixture stirred overnight. The 
mixture was extracted with chloroform (250 ml) washed with water (200 ml, x4), 
separated, dried over magnesium sulphate, filtered and solvent removed under 
vacuum giving the crude as a green oil.  
This was purified by flash column chromatography on silica using DCM and 
methanol (19:1) giving the product as a yellow oil (675 mg, 49%) 
λmax(MeOH)/nm 264 (ε/dm3 mol
-1
 cm
-1
 9800); υmax (ATR) 2936 (C-H), 1701 (C=O), 
1663 (C=O), 1602 (C=C), 1525 (N-O, nitro), 1346 (N-O, nitro); δH (400 MHz, 
CDCl3) 8.24-8.20 (2H, m, Ar ortho nitro), 8.02-7.98 (2H, m, Ar meta nitro), 7.50-
7.49 (3H, m, CH triazole), 7.35 (1H, d, J=4.4, N-H), 4.56 (6H, s, O-CH2 triazole), 
4.52-4.48 (6H, m, N-CH2 triazole), 3.93-3.85 (12H, m, HNC-CH2, MeON-CH2), 
3.58 (9H, s, O-Me), 1.32 (24H, s, Me, Boc); δC (100 MHz, CDCl3) 165.6 (C=O, 
amide), 155.6 (C=O, Boc), 149.6 (Ar, ipso nitro), 144.9 (C, triazole), 140.8 (Ar, ipso 
amide), 128.7 (Ar, meta nitro), 123.8 (Ar, ortho nitro), 123.3 (CH, triazole), 82.2 (C-
Me3), 69.0 (HNC-CH2), 64.8 (O-CH2 triazole), 62.5 (O-Me), 60.7 (HNC-CH2), 48.9 
(MeON-CH2), 47.2 (N-CH2 triazole), 28.2 (Me, Boc); Calculated Mass for 
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C44H68N14O15 1033.5070 m/z  (ES
+
) 1033.7 (MH
+
), 1055.6 (MNa
+
); HRMS (ES
+
): 
1033.5069 (M
+
) 
 
N-(1,3-bis((1-(2-(methoxyamino)ethyl)-1H-1,2,3-triazol-4-yl)methoxy)-2-(((1-(2-
(methoxyamino)ethyl)-1H-1,2,3-triazol-4-yl)methoxy)methyl)propan-2-yl)-4-
nitrobenzamide, 30: 
NH
O
O
O N
NN
N
N
N
NN
N
N
H
NH
HN
O
O
O
O
NO2
 
29 (51 mg, 0.049 mmol) was dissolved in 2M hydrochloric methanol (5 ml) and 
stirred for 3½hrs. The solvent was then removed under vacuum, giving the 
protonated product as a pale oil (47 mg). 
This was then dissolved in D2O and neutralised by addition of excess ammonium 
bicarbonate. Repeated co-evaporations with D2O gave the neutral product as a pale 
semi-solid (40 mg, crude) 
λmax(H2O pH 6)/nm 269 (ε/dm3 mol
-1
 cm
-1
 4700); υmax (ATR) 3361 (D2O), 1646 
(C=O amide), 1600 (C=C, aromatic), 1525 (N-O nitro), 1448 (C=C aromatic), 1348 
(N-O nitro); δH (400 MHz, D2O) At pH6, 8.32 (2H, d, J=8.8, Ar, ortho nitro), 8.01 
(3H, s, CH triazole), 7.81-7.77 (2H, m, Ar, meta nitro), 4.64 (6H, s, O-CH2 triazole), 
4.56 (6H, t, J=5.8, MeON-CH2-CH2), 3.85 (6H, s, HNC-CH2), 3.46 (9H, s, O-Me), 
3.35 (6H, t, J=5.8, MeON-CH2-CH2); δC (100 MHz, D2O) At pH 6 reference to 
acetonitrile 1.47, 169.2 (C=O), 158.4 (Ar, ipso nitro), 150.0 (Ar, ipso amide), 144.5 
(C, triazole) , 129.0 (Ar, meta nitro), 126.0 (CH, triazole), 124.4 (Ar, ortho nitro), 
67.8 (HNC-CH2), 64.0 (O-CH2 triazole), 61.4 (O-Me), 61.2 (HNC-CH2), 50.3 
(MeON-CH2-CH2-N), 48.2 (MeON-CH2-CH2-N); Calculated Mass for C29H44N14O9 
733.3488 m/z (ES
+
) 755.4 (MNa
+
); HRMS (ES
+
): 733.3487 (MH
+
) 
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P-tert-butylcalix(4)arene, 31: 
133
 
OHOH HOOH  
Ground t-butyl phenol (50 g, 0.333 mol), and 31 ml formaldehyde solution (38% aq) 
was added to 1M aqueous sodium hydroxide (6 ml). The mixture was heated to 
120
o
C under a stream of nitrogen for 5½ hrs, until a thick foam was formed. This 
was allowed to cool to room temperature and left overnight. 
Diphenyl ether (400 ml) and toluene (20 ml) were then added to the foam and the 
mixture heated to reflux for 4½ hrs. It was then allowed to cool to room temperature 
over 24 hrs. Ethyl acetate (300 ml) was then added to precipitate the product, which 
was left for 5 days before filtering and washing with acetone (500 ml) giving product 
as a white solid (34.06 g, 16%). 
υmax (ATR) 3221 (O-H), 2950 (C-H), 1582 (C=C), 1486 (C=C), 1454 (C=C), 1237 
(C-O), 1201 (C-O); δH (400 MHz, CDCl3) 9.63 (4H, s, OH) , 7.19 (8H, s, Ar), 4.38 
(4H, d, J=13.2, CH2), 3.51 (4H, d, J=13.2 CH2), 1.26 (36H, s, CH3); δC (100 MHz, 
CDCl3) 146.8 (Ar-OH), 144.9 (Ar-tButyl), 128.9 (Ar), 125.7 (Ar-CH2), 34.2 (C-
CH3), 32.5 (CH2), 31.6 (CH3) 
 
Calix(4)arene, 32:
 164
 
OHOH HOOH  
Aluminium chloride (13.01 g, 97.752 mmol) was added to a solution of 31 (10.22 g, 
15.767 mmol) and phenol (7.06 g, 36.263 mmol) in toluene (100 ml). The mixture 
was stirred for 1½ hrs then quenched with ice, giving a dark orange mixture.  
The reaction mixture was diluted with DCM. The aqueous layer was washed with 
portions of DCM (100 ml, x4) and the combined organic layer washed with water 
(100 ml). The organic layer was then separated, dried over magnesium sulphate, 
filtered and concentrated under reduced pressure. Methanol (200 ml) was then 
added, the product precipitated as a white powder (5.41 g, 81%).  
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υmax (ATR) 3139 (O-H), 2933 (C-H), 1594 (C=C); δH (400 MHz, CDCl3) 10.20 (4H, 
s, OH), 7.06 (8H, d, J=7.2 Ar), 6.73 (4H, t, J=7.2 Ar), 4.26 (4H, br, CH2), 3.55 (4H, 
br, CH2); δC (100 MHz, CDCl3) 148.9 (Ar-OH), 129.1 (Ar), 128.4 (Ar-CH2), 122.4 
(Ar, para OH), 31.8 (CH2); Calculated Mass for C28H24O4 424.49 m/z (ES
-
) 423 (M –
H) 
 
26,28-dipropoxypentacyclo[19.3.1.1^3,7 .1^9,13
 
.1^15,19]octacosa-
1(25),3,5,7(28),9(27),10,12,15(26),16,18,21,23-dodecaene-25,27-diol, 33: 
165
 
OO HOOH
 
32 (2.50 g, 5.89 mmol) and potassium carbonate (2.04 g, 14.72 mmol) were 
suspended in  acetonitrile (40 ml) and stirred for 5 min. Iodopropane (1.45 ml, 2.50 
g, 14.72 mmol) was then added and the mixture heated to reflux. After 16 hrs the 
mixture was cooled and white precipitate filtered off. Solvent was removed under 
vacuum giving a white solid and both portions were worked up separately as 
follows. The solid was dissolved in DCM (200 ml), washed with 1M aqueous HCl 
(150 ml, x2), and with distilled water (150 ml, x2). The organic layer was separated, 
dried over magnesium sulphate, filtered and solvent removed under vacuum.  
The precipitated solid gave the product as a white solid (1.32 g, 44%). The residue 
gave a mixture of product and starting material as a yellow solid (852 mg).  
υmax (ATR) 3260 (O-H), 2958 (C-H), 2925 (C-H), 2875 (C-H), 1592 (C=C); δH (400 
MHz, CDCl3) 8.31 (2H, s, OH), 7.06 (4H, d, J=7.6, Ar), 6.93 (4H, d, J=7.6, Ar), 6.75 
(2H, t, J=7.6, Ar), 6.65 (2H, t, J=7.6, Ar), 4.33 (4H, d, J=12.8, CH2), 3.99 (4H, t, 
J=6.6, O-CH2-CH2), 3.39 (4H, d, J=12.8, CH2), 2.08 (4H, sextet, J1=7.4, J2=6.6, O-
CH2-CH2), 1.32 (6H, t, J=7.4, CH3); δC (100 MHz, CDCl3) 153.5 (Ar-OPr), 152.0 
(Ar-OH), 133.6 (Ar), 129.1 (Ar), 128.6 (Ar), 128.3 (Ar), 125.4 (Ar), 119.1 (Ar, para 
OPr), 78.5 (O-CH2-CH2), 77.4 (O-CH2-CH2), 31.6 (CH2), 23.7 (O-CH2-CH2), 11.1 
(CH3); Calculated Mass for C34H36O4 508.65 m/z (ES
+
) 509 (MH
+
) 
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11,23-dibromo-26,28-dipropoxypentacyclo[19.3.1.1^3,7 .1^9,13 
.1^15,19]octacosa-1(25),3,5,7(28),9(27),10,12,15(26),16,18,21,23-dodecaene-
25,27-diol, 34: 
134
 
OO HOOH
BrBr
 
33 (506 mg, 0.995 mmol) was dissolved in dry DCM (25 ml) in a round bottomed 
flask oven dried and cooled under nitrogen. Bromine (0.13 ml, 393 mg, 2.46 mmol) 
was added and the mixture stirred at room temperature for 45 min.  
The mixture was then filtered and the precipitate washed with DCM (10 ml, x3). 
This gave the product as a pale yellow solid (477 mg, 72%)  
υmax (ATR) 3221 (O-H), 2960 (C-H), 2934 (C-H), 2876 (C-H), 1576 (C=C); δH (400 
MHz, CDCl3) 8.36 (2H, s, OH), 7.17 (4H, s, Ar), 6.95-6.93 (4H, m, Ar), 6.81 (2H, 
br, Ar), 4.25 (4H, d, J=13.0, CH2), 3.95 (4H, br, O-CH2), 3.32 (4H, d, J=13.0, CH2), 
2.04 (4H, br, CH2-CH2), 1.31-1.27 (6H, m, CH3) 
 
5,17-dibromo-26,28-bis(prop-2-en-1-yloxy)-25,27-
dipropoxypentacyclo[19.3.1.1^3,7 .1^9,13 .1^15,19]octacosa-
1(25),3,5,7(28),9(27),10,12,15(26),16,18,21,23-dodecaene, 35: 
OO OO
BrBr
 
34 (207 mg, 0.31 mmol) was added to dry DMF (10 ml) in a round bottomed flask 
oven dried and cooled under nitrogen. Sodium hydride (34 mg, 0.855 mmol) was 
added and the mixture stirred for 30 min before allyl bromide (0.07 ml, 91 mg, 0.75 
mmol) was added. The mixture was stirred at room temperature for 28 hrs. The 
mixture was then quenched with distilled water giving a cloudy white mixture. This 
was extracted with ether (150 ml), washed with distilled water (100 ml, x3), 
separated, dried over magnesium sulphate, filtered and the solvent removed under 
vacuum. This gave the crude as a pale yellow solid (190 mg) 
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Washing with petroleum ether (50 ml, x3) gave the product as a white solid (58 mg, 
25%)  
δH (400 MHz, CDCl3) 7.16 (4H, s, Ar), 6.45-6.34 (4H, m, Ar, para OPr, CH), 6.29 
(4H, d, J=7.6, Ar), 5.17-5.16 (2H, m, CH=CH2),  5.15-5.12 (2H, m, CH=CH2), 4.59 
(4H, d, J=6.6, O-CH2-CH), 4.37 (4H, d, J=13.4, CH2), 3.71 (4H, t, J=6.6, O-CH2-
CH2), 3.11 (4H, d, J=13.4, CH2), 1.90 (4H, sextet, J=7.4, CH2-CH2), 1.07 (6H, t, 
J=7.4, CH3); δC (100 MHz, CDCl3) 156.0 (Ar-O), 155.6 (Ar-O), 139.2 (Ar-CH2), 
135.7 (CH), 132.9 (Ar-CH2), 131.3 (Ar), 127.9 (Ar), 122.5 (Ar-H, para O), 117.4 
(CH=CH2), 115.0 (Ar-Br), 77.3 (O-CH2), 75.9 (O-CH2), 31.2 (CH2), 23.6 (CH2-
CH2), 10.8 (Me) 
 
26,28-dihydroxy-25,27-dipropoxypentacyclo[19.3.1.1^3,7 .1^9,13 
.1^15,19]octacosa-1(25),3,5,7(28),9(27),10,12,15(26),16,18,21,23-dodecaene-5,17-
dicarbaldehyde, 36: 
135
 
OO HOOH
OO
 
33 (452 mg, 0.889 mmol) was dissolved in dry chloroform (15 ml) and cooled to -
15
o
C in a round bottomed flask flushed with nitrogen. Tin (IV) chloride (1.1 ml, 2.32 
g, 8.886 mmol) was added followed by dichloro methyl methylether (0.2 ml, 255 
mg, 2.222 mmol). The mixture was allowed to warm to room temperature and stirred 
for 1¼ hrs before quenching with distilled water. The mixture was diluted with 
chloroform (250 ml), washed with distilled water (200 ml, x3), separated and filtered 
to remove a pink solid that was insoluble in both chloroform and water. The organic 
layer was then dried over magnesium sulphate, filtered and solvent removed under 
vacuum. This gave a pale pink solid, which was washed with methanol (50 ml), 
giving the product as a pale pink solid (467 mg, 93%)  
υmax (ATR) 3171 (O-H), 2924 (C-H), 1671 (C=O), 1583 (C=C); δH (400 MHz, 
CDCl3) 9.79 (2H, s, O=CH), 9.26 (2H, s, OH), 7.64 (4H, s, Ar), 6.98 (4H, d, J=7.4 
Ar), 6.81 (2H, t, J=7.4, Ar), 4.31 (4H, d, J=13.2, CH2), 4.02 (4H, t, J=6.4, O-CH2-
CH2), 3.51 (4H, d, J=13.2, CH2), 2.09 (4H, sextet, J1=7.6, J2=6.4, O-CH2-CH2), 1.33 
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(6H, t, J=7.6, CH3); δC (100 MHz, CDCl3) 191.0 (C=O), 159.8 (Ar-OH), 151.8 (Ar-
OPr), 132.5 (Ar, ortho C=O), 131.1 (Ar, meta O-Pr), 129.6 (Ar), 128.7 (Ar), 128.7 
(Ar), 125.8 (Ar, para O-Pr), 78.7 (O-CH2-CH2), 77.3 (O-CH2-CH2), 31.4 (CH2), 23.6 
(O-CH2-CH2), 11.0 (Me); Calculated Mass for C36H36O6 564.67, m/z (ES
+
) 1130 
(2M) 
 
26,28-bis(prop-2-en-1-yloxy)-25,27-dipropoxypentacyclo[19.3.1.1^3,7 .1^9,13 
.1^15,19]octacosa-1(25),3,5,7(28),9(27),10,12,15(26),16,18,21,23-dodecaene-5,17-
dicarbaldehyde, 37: 
OO OO
OO
 
36 (467 mg, 0.827 mmol) was dissolved in dry methanol (40 ml) and trimethyl 
orthoformate (1.55 ml, 1.50 g, 14.17 mmol) and paratoluene sulphonic acid (40 mg, 
2.1 mmol) added under nitrogen. The mixture was heated to reflux for 4 hrs, then 
allowed to cool and quenched with saturated sodium hydrogen carbonate solution. 
The mixture was extracted with DCM (200 ml), washed with distilled water (100 
ml), separated, dried over magnesium sulphate, filtered and solvent removed under 
vacuum giving the crude brown semi-solid.  
This was dissolved in dry DMF (25ml) and transferred to a round bottomed flask 
oven dried and cooled under nitrogen. Sodium hydride (1.00 g, 25. 3 mmol) was 
then added and stirred for 15 min (a gas was evolved) before allyl bromide (0.36 ml, 
503 mg, 4.16 mmol) was added. The mixture was stirred at room temperature for 19 
hrs then quenched by slow addition of 1M aqueous hydrochloric acid (35 ml), 
producing a gas. The mixture was extracted with ether (250 ml), washed with 
saturated sodium thiosulphate solution (200 ml) and distilled water (200 ml, x3), 
separated, dried over magnesium sulphate, filtered and solvent removed under 
vacuum. This gave the crude as a yellow tacky solid (364 mg) 
This was washed with petroleum ether (70 ml, x3) giving the product as a white 
solid (82 mg, 16%)  
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υmax (ATR) 2922 (C-H), 2853 (C-H, aldehyde), 1694 (C=O), 1596 (C=C, aromatic), 
1456 (C=C, aromatic), 1127 (C-O), 988 (C-H, alkene), 760 (C-H); δH (400 MHz, 
CDCl3) 9.82 (2H, s, O=CH), 7.48 (4H, s, Ar), 6.41-6.37 (4H, m, Ar, CH-CH2), 6.31 
(4H, d, J=7.6 Ar), 5.20-5.15 (4H, m, CH-CH2), 4.68 (4H, d, J=6.4, O-CH2-CH), 4.45 
(4H, d, J=13.6, CH2), 3.76 (4H, t, J=7.4, O-CH2-CH2), 3.27 (4H, d, J=13.6, CH2), 
1.91 (4H, sextet, J=7.4, O-CH2-CH2), 1.07 (9H, t, J=7.4, CH3); δC (100 MHz, 
CDCl3) 191.9 (C=O), 162.5 (Ar-O), 155.8 (Ar-O), 137.9 (Ar-C=O), 135.1 (CH-
CH2), 133.2 (Ar-CH2), 131.4 (Ar-CH2), 130.6 (Ar), 128.2 (Ar), 122.7 (Ar, para O), 
118.0 (CH-CH2), 77.4 (O-CH2), 76.1 (O-CH2), 32.1 (CH2), 23.6 (O-CH2-CH2), 10.8 
(Me); Calculated Mass for C42H44O6 645.3202, MALDI 702.98 (MNaCl
+
); HRMS 
(ES
+
) 645.3205 (M
+
), 662.3472 (MH2O
+
) 
 
Allyl phenyl ether, 38: 
166
 
O
 
Phenol (494 mg, 5.25 mmol) was dissolved in DMF (5 ml) and potassium carbonate 
(1.48 g, 10.74 mmol) added. The mixture was stirred for 10 min before allyl bromide 
was added (0.92 ml, 1.29g, 10.63 mmol). The mixture was stirred overnight then 
quenched with water. The mixture was extracted with ether (150 ml), washed with 
distilled water (100 ml, x3), separated, dried over magnesium sulphate, filtered and 
solvent removed under vacuum giving the product as a yellow oil (531 mg, 75%) 
υmax (ATR) 2959 (C-H vinyl), 1455 (C=C aromatic), 1007 (C-H aromatic); δH (400 
MHz, CDCl3) 7.32 (2H, dd, J=7.6, Ar), 6.99-6.94 (3H, m, Ar), 6.13-6.04 (1H, m, 
CH), 5.47-5.41 (1H, m, CH-CH2), 5.33-5.29 (1H, m, CH-CH2), 4.58 (2H, dt, J1=5.2, 
J2=1.2, O-CH2); δC (100 MHz, CDCl3) 158.7 (Ar-O), 133.5 (CH), 129.6 (Ar meta), 
121.0 (Ar para), 117.8 (CH-CH2), 114.9 (Ar ortho), 68.9 (O-CH2) 
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2-(4-Methoxyphenyl)-5-phenyl-2H-tetrazole, 39: 
140
 
N N
N
N O
 
Benzaldehyde (1.02 ml, 1.065g, 10.03 mmol) was dissolved in ethanol (60 ml) and 
benzenesulfonohydrazide (1.72 g, 9.99 mmol) was added slowly. The mixture was 
stirred for an hour and 20 min before quenching with ice water (200 ml). This gave a 
milky precipitate which was centrifuged and the solvent decanted. The solid was 
further dried by vacuum filtering then stored at –18oC overnight. This was then 
dissolved in pyridine (70 ml) and cooled to 0
o
C.  
P-anisidine (1.25 g, 10.17 mmol) was then dissolved in ethanol (8 ml), 8.1M HCl 
(aq, 10.6 ml) was added and the mixture cooled to 0
o
C. A solution of sodium nitrite 
(697 mg, 10.11 mmol) in water (4 ml) was added to the p-anisidine solution 
dropwise over 20 min.  
This mixture was then slowly added to the previously prepared pyridine solution 
which became red. The mixture was stirred for an hour before extracting with 
chloroform (250 ml). The organic layer was washed with water (200 ml, x3), 
separated, dried over magnesium sulphate, filtered and solvent removed giving the 
crude as a tacky red solid. 
This was purified by flash column chromatography on silica using ethyl acetate and 
petroleum ether (1:9) giving the product as a brown solid (2.16 g, 86%)  
υmax (ATR) 3016 (C-H aromatic), 1596 (C=N), 1530 (C=C), 1514 (C=C), 1466 
(C=C), 1450 (C=C), 1436 (C=C), 1257 (C-H methyl); δH (400 MHz, CDCl3) 8.25-
8.23 (2H, m, ortho Ar-C), 8.11-8.07 (2H, m, ortho Ar-N), 7.54-7.48 (3H, m, Ar-C, 
para meta-tetrazole), 7.06-7.02 (2H, m, ortho Ar-OMe), 3.86 (3H, s, Me); δC (100 
MHz, CDCl3) 165.1 (C=N), 160.6 (Ar-OMe), 130.5 (Ar), 129.0 (Ar), 127.4 (Ar-
C=N), 127.1 (Ar), 121.5 (Ar), 114.8 (Ar), 55.7 (Me); Calculated Mass for 
C14H12N4O 252.27 m/z (ES
+
) 253 (MH
+
) 
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Benzyl 3-hydroxypropylcarbamate, 40: 
167
 
HO N
H
O
O
 
3-Amino-1-propanol (5 ml, 4.91 g, 65.37 mmol) was dissolved in DCM (50 ml) and 
cooled to 0
o
C. Triethylamine (7.6 ml, 5.52 g, 54.53 mmol) was then added. A 
solution of benzylchloroformate (7.8 ml, 9.32 g, 54.64 mmol) in DCM (5 ml) was 
added dropwise over 30 min. The mixture was stirred at 0
o
C for a further 30 min 
before being allowed to warm to room temperature. The mixture was stirred at room 
temperature for 1½ hrs, water (100 ml) and ether (100 ml) were then added. The 
aqueous layer was extracted with further ether (100 ml) and the combined organic 
fractions were washed with water (150 ml) and brine (150 ml, x2), separated, dried 
over magnesium sulphate, filtered and the solvent removed under vacuum giving a 
clear oil.  
This was purified by flash column chromatography on silica using petroleum ether 
and ethyl acetate (3:7) giving the product as a white solid (3.57 g, 31%). 
υmax (ATR) 3323 (O-H), 2954 (C-H), 2884 (C-H), 1683 (C=O), 1530 (C=C), 1485 
(C=C), 1453 (C=C), 1255 (C-O ester), 1059 (C-OH); δH (400 MHz, CDCl3) 7.36-
7.29 (5H, m, Ar), 5.10 (2H, s, CH2-Ar), 3.67 (2H, t, J=6.0, HO-CH2), 3.34 (2H, t, 
J=6.0, HN-CH2), 2.42 (1H, br, OH), 1.69 (2H, quintet, J=6.0, CH2); δC (100 MHz, 
CDCl3) 157.4 (O=C), 136.6 (ipso Ar), 128.7 (Ar), 128.3 (Ar), 128.2 (Ar), 67.0 (CH2-
Ar), 59.7 (HO-CH2), 37.9 (HN-CH2), 32.7 (CH2); Calculated Mass for C11H15NO3 
209.24 m/z (ES
+
) 231.9 (MNa
+
) 
 
Benzyl 5-hydroxypentylcarbamate, 41: 
168
 
HO N
H
O
O
 
5-Amino-1-pentanol (5 ml, 4.75 g, 45.997 mmol) and triethylamine (5.2 ml, 3.78 g, 
37.308 mmol) were dissolved in DCM (50 ml) and the mixture chilled to 0
o
C. 
Benzylchloroformate (5.5 ml, 6.57 g, 38.528 mmol) was then added dropwise over 
15 min. The mixture was stirred at 0
o
C for 30 min then allowed to warm to room 
temperature and stirred overnight. The mixture was filtered to remove precipitate and 
extracted with ether (250 ml). The organic layer was washed with brine (200 ml, x2) 
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and water (200 ml), separated, dried over magnesium sulphate, filtered, and solvent 
removed under vacuum giving an opaque oil. 
This was purified by flash column chromatography on silica using petroleum ether 
and ethyl acetate (3:7) giving the product as a white solid (2.83 g, 31%) 
υmax (ATR) 3391 (O-H), 3330 (N-H), 3061 (C-H aromatic), 2942 (C-H), 2862 (C-H), 
1682 (C=O), 1531 (C=C), 1453 (C=C), 1254 (C-O ester), 1020 (C-O); δH (400 MHz, 
CDCl3) 7.35-7.30 (5H, m, Ar), 5.08 (2H, s, CH2-Ar), 4.90 (1H, br, NH), 3.61 (2H, t, 
J=6.4, HO-CH2), 3.19 (2H, q, J=6.4, HN-CH2), 1.60-1.48 (4H, m, HO-CH2-CH2, 
HN-CH2-CH2), 1.42-1.34 (2H, m, CH2-CH2-CH2); δC (100 MHz, CDCl3) 156.6 
(C=O), 136.7 (Ar ipso), 128.6 (Ar), 128.2 (Ar), 66.7 (CH2-Ar), 62.6 (HO-CH2), 41.0 
(HN-CH2), 32.3 (HN-CH2-CH2), 29.8 (HO-CH2-CH2), 23.0 (CH2-CH2-CH2); 
Calculated Mass for C13H19NO3 237.29 m/z (ES
+
) 259.9 (MNa
+
) 
 
Benzyl 3-bromopropylcarbamate, 42: 
Br N
H
O
O
 
40 (484 mg, 2.31 mmol) was dissolved in dry DCM (14 ml) in a round bottomed 
flask oven dried and cooled under nitrogen and the solution cooled to 0
o
C. 
Triphenylphosphine (926 mg, 3.53 mmol) and carbon tetrabromide (1.19 g, 3.59 
mmol) were then added. The mixture was stirred for 20 min at 0
o
C, allowed to warm 
to room temperature and stirred for a further 1½ hrs in the dark. The mixture was 
then quenched with water and diluted with DCM (75 ml). The organic layer was 
washed with water (100 ml) and brine (100 ml, x2), separated, dried over magnesium 
sulphate, filtered and solvent removed under vacuum.  This gave a brown semisolid 
(2.03 g) which was purified by flash column chromatography on silica using 
petroleum ether and ethyl acetate (4:1) giving the product as a clear oil (434 mg, 
69%) 
υmax (ATR) 3330 (N-H), 2945 (C-H), 1692 (C=O), 1521 (C=C), 1454 (C=C), 1244 
(C-O ester); δH (400 MHz, CDCl3) 7.36-7.31 (5H, m, Ar), 5.09 (2H, s, CH2-Ar), 5.02 
(1H, br, NH), 3.42 (2H, t, J=6.2, Br-CH2) 3.34 (2H, q, J=6.2, HN-CH2), 2.06 (2H, 
quintet, J=6.2, CH2); δC (100 MHz, CDCl3) 156.6 (O=C), 136.5 (ipso Ar), 128.6 
(Ar), 128.2 (Ar), 128.2 (Ar), 66.8 (CH2-Ar), 39.5 (HN-CH2), 32.5 (CH2), 30.7 (Br-
CH2); Calculated Mass for C11H14BrNO2 272.14 m/z (ES
+
) 293.7 (MNa
+
) 
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O-Methylbenzaldehyde oxime, 43: 
97
 
N
O
 
Benzaldehyde (0.95 ml, 992 mg, 9.35 mmol) was suspended in pyridine (29 ml) and 
O-methylhydroxylamine hydrochloride (1.01 g, 12.14 mmol) was added. The 
mixture was stirred for 22 hrs at room temperature, the solvent was then removed 
under vacuum. 
The resulting solid was extracted with ethyl acetate (150 ml). The solution was then 
washed with saturated copper sulphate solution (100 ml portions) until the copper-
pyridine complex was no longer visible and water (100 ml, x2). It was then 
separated, dried over magnesium sulphate, filtered through Celite and the solvent 
removed under vacuum giving the product as a clear oil (915 mg, 72%) 
υmax (ATR) 3062 (C-H aromatic), 2936 (C-H methyl), 2898 (C-H methyl), 2817 (C-
H), 1693 (C=N), 1490 (C-H), 1447 (C-H), 1212 (C-O), 1182 (C-O), 946 (N-O), 754 
(C-H aromatic), 691 (C-H aromatic); δH (400 MHz, CDCl3) 8.07 (1H, s, HC=N), 
7.59-7.57 (2H, m, Ar ortho), 7.38-7.36 (3H, m, Ar meta and para), 3.98 (3H, s, Me); 
δC (100 MHz, CDCl3) 148.7 (C=N), 132.4 (Ar ipso), 129.9 (Ar para), 128.8 (Ar 
ortho), 127.1 (Ar meta), 62.1 (O-Me); Calculated Mass for C8H8NO 135.16 m/z 
(ES
+
) 135.8 (M
+
) 
 
N-Benzyl-O-methylhydroxylamine, 44: 
98
 
H
N
O
 
43 (989 mg, 7.31 mmol) was dissolved in ethanol (5 ml) and cooled to 0
o
C. Sodium 
cyanoborohydride (1.40 g, 22.28 mmol) was added and the mixture stirred for 15 
min. 15% hydrochloric acid in ethanol (6 ml) was then added and a gas evolved. The 
mixture was stirred at 0
o
C for 15 min then allowed to warm to room temperature and 
stirred for 2¼ hrs. The mixture was quenched with excess potassium carbonate. The 
mixture was left open in a fumehood to allow cyanide gas to disperse, then 
concentrated under vacuum. The mixture was extracted with dichloromethane (150 
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ml), washed with saturated sodium hydrogen carbonate solution (100 ml, x2), dried 
over magnesium sulphate, filtered and solvent removed under vacuum to give a clear 
oil. This was purified by flash column chromatography on silica using petroleum 
ether and ethyl acetate (9:1) giving the product as a clear oil (436 mg, 43%) 
υmax (ATR) 3251 (N-H), 3062 (C-H Ar), 3029 (C-H Ar), 2979 (C-H), 2934 (C-H), 
2893 (C-H), 2806 (C-H), 1603 (C=C), 1495 (C=C), 1453 (C-H), 1247 (C-O), 1058 
(C-N), 993 (N-O), 744 (C-H Ar), 696 (C-H Ar); δH (400 MHz, CDCl3) 7.38-7.30 
(5H, m, Ar), 4.06 (2H, s, CH2), 3.53 (3H, s, OMe); δC (100 MHz, CDCl3) 137.7 (Ar 
ipso), 129.0 (Ar), 128.6 (Ar), 127.6 (Ar para), 62.0 (OMe), 56.3 (CH2-NH); 
Calculated Mass for C8H11NO 137.18 m/z (ES
+
) 137.9 (M
+
) 
 
Benzyl methoxyamine β-D-galactopyranoside, 45: 
77
 
O
HO
HO
OH
OH
N
O
 
D-Galactose (164 mg, 0.911 mmol) was suspended in a mixture of methanol (6 ml) 
and glacial acetic acid (2 ml). 44 (49 mg, 0.358 mmol) was then added as a solution 
in methanol (0.2 ml). The mixture was sonicated for 5 hrs without pause, allowing 
the mixture to warm up.  
The mixture was then purified by flash column chromatography on silica using ethyl 
acetate and methanol (9:1) giving the product as a white solid (70 mg, 65%) 
mp 147.3-149.5
o
C (from methanol); [α]D
17.8 
-5.0 (c 0.8, MeOH) (lit.,
74
 [α]D
22 
-10.3 (c 
1.0, MeOH); υmax (ATR) 3364 (O-H), 2949 (C-H), 1498 (C=C), 1456 (C=C), 1383 
(C-H), 1145 (C-O), 1069 (C-O), 1028 (C-N), 998 (N-O), 735 (C-H Ar); δH (400 
MHz, CD3OD) 7.46-7.43 (2H, m, Ar), 7.33-7.29 (2H, m, Ar), 7.28-7.25 (1H, m, Ar 
para), 4.11 (2H, dd, J=51.6, N-CH2), 3.93 (1H, d, J1-2=8.8, CH anomeric), 3.85-3.79 
(3H, m, H-2, H-6), 3.73 (1H, dd, J2-3=11.2, J3-4=6, H-3), 3.45-3.42 (2H, m, H-4, H-
5), 3.40 (3H, s, O-Me); δC (100 MHz, CD3OD) 138.8 (Ar, ipso), 131.1 (Ar), 129.2 
(Ar), 128.3 (Ar, para), 94.0 (CH Anomeric), 78.5 (C-4 or C-5), 76.4 (C-4 or C-5), 
70.6 (C-2 or C-3), 69.1 (C-2 or C-3), 62.7 (C-6), 62.3 (O-Me), 57.2 (N-CH2); 
Calculated Mass for C14H21NO6 299.32 m/z (ES
+
) 322.1 (MNa
+
) 
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26,28-Dihydroxy-25,27-dipropoxycalix[4]arene-5,17-dicarbaldehyde, O-methyl 
oxime, 46: 
OO HOOH
N N
OO
 
36 (196 mg, 0.346 mmol) was suspended in pyridine (3 ml) and O-
methylhydroxylamine hydrochloride (90 mg, 1.080 mmol) was added. The mixture 
was stirred overnight at room temperature, the solvent was then removed under 
vacuum. The resulting concentrated solution was extracted with chloroform (100 
ml). The solution was then washed with saturated copper sulphate solution (70 ml 
portions) until the copper-pyridine complex was no longer visible and water (100 ml, 
x2). It was then separated, dried over magnesium sulphate, filtered and the solvent 
removed under vacuum giving the product as a pink solid (173 mg, 79%) 
υmax (ATR) 3245 (O-H), 2961 (C-H), 1735 (C=N), 1603 (C=C), 1258 (C-H); δH (400 
MHz, CDCl3) 8.64 (2H, s, HC=N), 7.97 (2H, s, OH), 7.32 (4H, s, Ar), 6.94 (4H, d, 
J=7.6, Ar), 6.75 (2H, t, J=7.6, Ar), 4.29 (2H, d, J=12.8, CH2), 3.99 (4H, t, J=6.2, O-
CH2), 3.96 (6H, s, O-Me), 3.42 (4H, d, J=12.8, CH2), 2.07 (4H, m, J1=7.2, J2=6.2, 
CH2-CH2-CH3), 1.32 (6H, t, J=7.2, CH2-CH3); δC (100 MHz, CDCl3) 155.5 (Ar-
OPr), 152.0 (Ar-OH), 149.0 (C=N), 133.0 (Ar-C=N), 129.3 (Ar), 128.6 (Ar), 127.6 
(Ar), 125.5 (Ar), 123.1 (Ar), 78.5 (O-CH2), 61.8 (O-Me), 31.4 (CH2), 23.6 (CH2-
CH2-CH3), 11.0 (CH2-CH3); Calculated Mass for C38H42N2O6 623.3107 m/z MALDI 
646.67 (MNa
+
); HRMS (ES
+
): 623.3107 (M
+
) 
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Abbreviations 
 
Ac- Acetyl 
Boc- Tert-butyl carbamate 
Calix- Calix(4)arene 
COSY- Correlation Spectroscopy 
Cbz- Benzyl carbamate 
DBU- 1,8-Diazabicyclo[5.4.0]undec-7-ene 
DC-SIGN- Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-
integrin 
DCM- Dichloromethane 
DIBAL- Diisobutylaluminium hydride 
DMF- Dimethylformamide 
DMSO- Dimethyl sulfoxide 
DPPA- Diphenylphosphoryl azide 
EDTA- Ethylenediaminetetraacetic acid 
ELISA- Enzyme-linked immunosorbent assay 
Equiv- Equivalents 
ESI- Elcectrospray Ionisation 
Etc- Etcetera 
Fmoc- 9-Fluorenylmethyl carbamate 
FmocGlyOH- 9-Fluorenylmethyl carbamate protected glycine 
GlcNAc- N-Acetyl-D-glucosamine 
HPLC- High Performance Liquid Chromatography 
HSQC-Heteronuclear Single Quantum Correlation experiment 
Hrs- hours 
IR- Infrared 
L-SIGN- Liver-Specific Intracellular adhesion molecules-3-Grabbing Non-integrin 
MALDI-Matrix-assisted laser desorption ionisation 
Mass spec- Mass spectroscopy 
Me- Methyl 
min- minutes 
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MRI- Magnetic resonance imaging 
NMR- Nuclear Magnetic Resonance spectroscopy 
Ph- Phenyl 
ppm- parts per million 
Pr- Propyl 
Rf- Retention factor 
RT- Room temperature 
SN2- Bimolecular nucleophilic substitution reaction 
STD-NMR- Saturation-Transfer Difference Nuclear Magnetic Resonance 
experiment 
TBTA- Tris(benzyltriazolylmethyl)amine 
Temp- Temperature 
TFA- Trifluoroacetic acid 
THF- Tetrahydrofuran 
TLC- Thin layer chromatography 
TMSOTf- Trimethylsilyl trifluoromethane sulfonate 
Tris- Tris(hydroxymethyl)aminomethane, also Trizma base 
UV- Ultraviolet 
UV-Vis- Ultraviolet-visible  
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